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ABSTRACT
Apoptosis is essential for development and the maintenance of cellular homeostasis and
is frequently dysregulated in disease states. Proteins of the BCL-2 family are key modulators of
this process and are thus ideal therapeutic targets. In response to diverse apoptotic stimuli, the
pro-apoptotic member of BCL-2 family, BAX, redistributes from the cytosol to the mitochondria
or endoplasmic reticulum and primes cells for death. The structural changes that enable this
lethal protein to transition from a cytosolic form to a membrane-bound form remain poorly
understood. Elucidating this process is a necessary step in the development of BAX as a novel
therapeutic target for the treatment of cancer, as well as autoimmune and neurodegenerative
disorders.
A three-part study, utilizing computational modeling and biological assays, was used to
examine how BAX, and similar proteins, transition to membranes. The first part tested the
hypothesis that the C-terminal α9 helix regulates the distribution and activity of BAX by
functioning as a “molecular switch” to trigger conformational changes that enable the protein to
redistribute from the cytosol to mitochondrial membrane. Computational analysis, tested in
biological assays, revealed a new finding: that the α9 helix can dock into a hydrophobic groove
of BAX in two opposite directions – in a self-associated, forward orientation and a previously,
unknown reverse orientation that enables dimerization and apoptosis. Peptides, made to mimic
the α9-helix, were able to induce the mitochondrial translocation of BAX, but not when key
residues in the hydrophobic groove were mutated. Such findings indicate that the α9 helix of
BAX can function as a “molecular switch” to mediate occupancy of the hydrophobic groove and
regulate the membrane-binding activity of BAX.
iii

This new discovery contributes to the

understanding of how BAX functions during apoptosis and can lead to the design of new
therapeutic approaches based on manipulating the occupancy of the hydrophobic groove.
The second and third parts of the study used computational modeling to examine how the
helical stability of proteins relates to their ability to functionally transition. Analysis of BAX, as
a prototypical transitioning protein, revealed that it has a broad variation in the distribution of its
helical interaction energy. This observation led to the hypothesis tested, that proteins which
undergo 3D structural transitions during execution of their function have broad variations in the
distribution of their helical interaction energies. The result of this study, after examination of a
large group of all-alpha proteins, was the development of a novel, predictive computational
method, based on measuring helical interactions energies, which can be used to identify new
proteins that undergo structural transitioning in the execution of their function. When this
method was used to examine transitioning in other members the BCL-2 family, a strong
agreement with the published experimental findings resulted. Further, it was revealed that the
binding of a ligand, such as a small peptide, to a protein can have significant stabilizing or
destabilizing influences that impact upon the activation and function of the protein. This
computational analysis thus contributes to a better understanding of the function and regulation
of the BCL-2 family members and also offers the means by which peptide mimics that modulate
protein activity can be designed for testing in therapeutic endeavors.

iv

V ljubeč spomin moji sestri in dedku
In loving memory of my sister and grandfather
Monika Kropivšek, 1980-2001
Alojz Perša, 1929-2006

v

ACKNOWLEDGMENTS
They say a journey is easier when you travel together. During my dissertation work I was
accompanied and supported by many people. First I would like to thank my supervisor Dr.
Annette R. Khaled for her trust, enthusiasms and never ending optimism. Experiences I earned
during four years of work in her lab are now solid foundation on which I can build my future in
the research. Next I would like to thank Dr. Thomas L. Selby, who showed me the way though
the maze of the computations and bioinformatics. The work with him was unique and priceless
experience. Deep gratitude goes also to my other committee members Dr. Pappachan E.
Kolattukudy, Dr. Antonis Zervos and Program Director Dr. Steven Ebert. For the additional
technical support goes a special thanks to Dr. Christina Fernandez-Valle and Dr. Suren A.
Tatulian. At this point I would like to thank to my lab colleagues Christina Kittipatrin, Amy
Greiner, Ge Zhang, Courtney Thaxton, Shannon Moore and Mounir Chehtane for moral and
technical support and bottomless I.C. Caramels.
At the end, but the most important, I would like to express my deep gratitude to my
husband Dr. Armin Tschammer, who experienced with me all ups and downs. Without his
support I might never make it through. Thanks goes also to my son Kai - for all his
understanding that mommy has to work also during the weekends.

vi

TABLE OF CONTENTS
LIST OF FIGURES .........................................................................................................................x
LIST OF TABLES........................................................................................................................ xii
LIST OF ACRONYMS/ABBREVATIONS ............................................................................... xiii
1 GENERAL INTRODUCTION.....................................................................................................1
1.1 Introduction............................................................................................................... 1
1.2 BCL-2 Family of Proteins......................................................................................... 2
1.3 Structure and function of BAX ................................................................................. 6
1.4 Molecular Modeling................................................................................................. 9
1.5 Thesis Objectives .................................................................................................... 10
2 STRUCTURAL TRANSITIONS THAT MEDIATE THE MEMBRANE-ASSOCIATION
ACTIVITY OF BAX ARE DEPENDENT ON ITS C-TERMINAL α-9 HELIX ........................13
2.1 Introduction............................................................................................................. 13
2.2 Material and Methods ............................................................................................. 15
2.2.1 Cell Lines and Reagents....................................................................................15
2.2.2 Plasmids, Mutagenesis and Transfection..........................................................15
2.2.3 Mitochondrial Translocation Assays, Crosslinking, Co-immunoprecipitation
and Immunoblotting..................................................................................................18
2.2.4 Triton X-114 Phase Partitioning .......................................................................20
2.2.5 pH Assays .........................................................................................................21
2.2.6 Confocal Microscopy........................................................................................21
2.2.7 Computational Docking ....................................................................................22
vii

2.3 Results..................................................................................................................... 24
2.3.1 Lys189 and Lys190 in the C-terminal α9 helix modulate the intracellular
localization of BAX. .................................................................................................24
2.3.2 The C-terminal α9 helix of BAX directs EGFP to apoptotic mitochondria.....32
2.3.3 Intracellular Localization of BAX Controlled by α9 helix...............................37
2.3.4 Occupancy of the hydrophobic pocket by the α9 helix mediates the
translocation of BAX to membranes.........................................................................42
2.3.5 BAX responds on the changes in pH. ...............................................................48
2.3.6 Alkalinization Alters Mitochondrial Physiology ..............................................49
2.4 Discussion ............................................................................................................... 52
3 HELICAL INTERACTION ENERGY DISTRIBUTION IN TRANSITIONAL PROTEINS..60
3.1 Introduction............................................................................................................. 60
3.2 Material and Methods ............................................................................................. 62
3.2.1 Structures ..........................................................................................................62
3.2.2 Energy Calculations ..........................................................................................63
3.2.3 Protons and Ionization States............................................................................65
3.2.4 Statistical Analysis............................................................................................65
3.3. Results and Discussion .......................................................................................... 66
3.3.1. Variation of helical IE values within each structure........................................66
3.3.2. Statistical variation within the randomly selected set......................................73
3.3.3. IE distribution and protein function.................................................................77
3.3.4. Proteins with unknown function ......................................................................79
3.4. Conclusions............................................................................................................ 81
viii

4 ANALYSIS OF HELICAL INTERACTION ENERGIES TO PROBE THE STABILITY AND
MECHANISMS OF STRUCTURAL TRANSITIONS IN THE BCL-2 PROTEIN FAMILY ....83
4.1 Introduction............................................................................................................. 83
4.2 Materials and Methods............................................................................................ 85
4.2.1 Structures ..........................................................................................................85
4.2.2 Energy Calculations ..........................................................................................85
4.2.3 Protons and Ionization States............................................................................87
4.2.4 Statistical Analysis............................................................................................88
4.2.5 Changes in the secondary structure...................................................................88
4.3 Results..................................................................................................................... 89
4.3.1 Helix Stability and Packing of BCL-2 Family Members..................................90
4.3.2 Homology and Topology ..................................................................................95
4.3.3 Peptide Binding Changes Helical IE Distribution ............................................98
4.4 DISCUSSION ....................................................................................................... 104
5 CONCLUSIONS.......................................................................................................................108
REFERENCES ............................................................................................................................111

ix

LIST OF FIGURES
Figure 1: The amino acid sequence of BAX with indicated secondary structure, BH domains and
transmembrane domain................................................................................................................... 7
Figure 2: Ribbon representation of BAX structure......................................................................... 8
Figure 3: Summary of the computational mutagenesis of Lys189. .............................................. 25
Figure 4: Expression of HA-tagged BAX mutants in 293 cells.................................................... 27
Figure 5: Co-expression of HA-tagged BAX mutants with EGFP in BAX-/- HCT116 cells. ...... 29
Figure 6: The BAX-LL mutant exhibits characteristics of an unfolded hydrophobic protein...... 31
Figure 7: EGFP tagged with C-terminus of BAX confers mitochondrial membrane-binding
properties in apoptotic cells. ......................................................................................................... 34
Figure 8: EGFP tagged with C-terminus of BAX does not confers mitochondrial membranebinding properties in cells lacking endogenous BAX................................................................... 35
Figure 9: EGFP-BAX-CT forms heterodimers with BAX-∆CT. ................................................. 36
Figure 10: The helical C-terminus of BAX associates with the hydrophobic pocket of BAX in
two orientations............................................................................................................................. 38
Figure 11: BAX C-terminal peptide, not BIM BH3 peptide, induces the translocation of wildtype and C-terminally truncated BAX. ......................................................................................... 43
Figure 12: BAX-∆CT does not insert into mitochondrial membrane upon addition of BAX-LL
peptide........................................................................................................................................... 44
Figure 13: BAX-∆CT R69R73 does not insert into mitochondrial membrane upon addition of
BAX- peptide. ............................................................................................................................... 47
Figure 14: The intracellular distribution of BAX depends on pH. ............................................... 49
x

Figure 15: EGFP-BAX-CT preferentially associates with alkalinized mitochondria. ................. 51
Figure 16: EGFP-BAX-CT displays different staining pattern in the presence than in the absence
of endogenous BAX upon alkalinization...................................................................................... 52
Figure 17: Non-transitional proteins have less variability in helical stability. ............................. 68
Figure 18: Structural changes for transitional proteins based on Cα overlays. ............................ 76
Figure 19: Graphical representation of the average IE values and standard deviations. .............. 79
Figure 20: BCL-2 family proteins have stabile central helix........................................................ 91
Figure 21: The BH3 only peptide binds into the hydrophobic groove of BCL-XL. .................... 99

xi

LIST OF TABLES
Table 1: Summary of the most prominent mammalian BCL-2 family members. .......................... 4
Table 2: The sequences of BH3 domains of most prominent BCL-2 family proteins. .................. 5
Table 3: The list of BAX mutants and primers............................................................................. 17
Table 4: Summary of BAX mutagenesis in 293 cells................................................................... 27
Table 5: Analysis of BH3 peptides docked into the hydrophobic pocket of BAX....................... 40
Table 6: Analysis of C-terminal peptides docked into the hydrophobic pocket of BAX. ............ 41
Table 7: Summary of the computational mutations of conserved glutamate 69........................... 47
Table 8: Statistical data on helix stabilities................................................................................... 69
Table 9: Helical stability of three non-transitional proteins ......................................................... 71
Table 10: Statistical data on helix stabilities for BCL-2 family proteins. .................................... 92
Table 11: Helical stability of BCL-2, BCL-W and BAX. ............................................................ 94
Table 12: BLAST sequence search of BCL-2 family members ................................................... 96
Table 13a-c Analysis of hidden Markov Models homology of the BCL-2 family members. ...... 97
Table 14: Helical stability of unbound BCL-XL and BCL-XL/BIM complex. ......................... 101
Table 15: Helical stability of unbound BCL-XL and BCL-XL/BAK complex.......................... 102
Table 16: Helical stability of unbound BCL-XL and BCL-XL/BAD complex.......................... 103
Table 17: Helical stability of unbound CED9and CED9/EGL1 complex. ................................. 103

xii

LIST OF ACRONYMS/ABBREVATIONS
AVE

Average

BAX

BCL-2 associated protein

BCL-2

B-cell lymphoma 2 protein

BH

BCL-2 homology

BIM

Bcl-2-like protein 11

BSA

Bovine serum albumin

CHAPS

3-[(3-Cholamidopropyl)-dimethylammonio]}-1-propanesulfonate

DMA

Dimethyl acetamide

DMSO

Dimethyl sulfoxide

DNA

Deoxyribonucleic acid

dsRNA

Double stranded RNA

DSS

Disuccinimidyl suberate

EBI

European Bioinformatics Institute

EBV

Epstein Barr virus

EGFP

Enhanced green fluorescent protein

ER

Endoplasmatic reticulum

EYFP

Enhanced yellow fluorescent protein

FACS

Fluorescence-activated cell sorter

FBS

Fetal bovine serum

HA

Hemaglutinin

HPLC

High Performance Liquid Chromatography
xiii

HRP

Horseradish peroxidase

HSP60

Heat shock protein 60

IL-3

Interleukin 3

IL-7

Interleukin 7

KSHV

Kaposi’s sarcoma-associated virus

MM3

Molecular mechanics 3

MOM

Mitochondrial outer membrane

NHE

Na+/H+ exchange factor

NMR

Nuclear magnetic resonance

PBS

Phosphate Buffer Solution

PCR

Polymer chain reaction

pRNA

Packing RNA

PVDF

Polyvinylidene difluoride

RISC

RNA induced silencing complex

RNA

Ribonucleic acid

SD

Standard deviation

SDS-PAGE

Sodium dodecyl sulfate polyacrylamide gel electrophoresis

siRNA

Short interfering RNA

3D

Three dimensional

xiv

1 GENERAL INTRODUCTION
1.1 Introduction

Apoptosis is a form of cell death by which a programmed series of events leads to the
cell’s demise without initiating the release of intracellular contents that could provoke an
inflammatory response (Nelson, White 2004). A multi-cellular organism typically eliminates
unnecessary or damaged cells through the process of apoptosis (Borner 2003;Cory et al.
2003;Nelson, White 2004). Malfunctions in the regulation of apoptosis characterize a range of
human diseases, including cancer, neurodegenerative, cardiovascular and autoimmune disorders
(Cory et al. 2003;Gross et al. 1999). Diseases caused by excessive cell death, such as myocardial
and cerebral ischemia, are two of three leading causes of death in the developed world (Letai
2005). Cancer, the third leading causing of death in the developed world, is also caused in part
by the defects in the cell death process. It is therefore of great importance that the process of
apoptosis be studied in order to develop novel regimens for therapeutic intervention.
The apoptotic pathway can be initiated by different mechanisms.

A physiological

relevant pathway involves the release of apoptotic factors from mitochondria. Modulators of
mitochondria function and integrity are those proteins found in the BCL-2 (B Cell Lymphoma)
family. The founder of the BCL-2 family, BCL-2, is a proto-oncogene whose activity is
deregulated in a majority of patients with follicular lymphoma (Borner 2003;Gross et al.
1999;Lipford et al. 1987). Other BCL-2 family members include the anti-apoptotic proteins,
BCL-XL, and the pro-apoptotic protein, BAX. Murine models of myocardial and cerebral
ischemia demonstrated that BAX loss-of function mutations or overexpression of BCL-2 could
attenuate apoptosis and reduced infracts size (Letai 2005).
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In contrast, transgenic mice

overexpressing BCL-2 developed leukemia (Borner 2003;Gross et al. 1999). These examples
illustrate the importance of the BCL-2 family member in the regulation of apoptosis in disease
models, and suggest that BCL-2 family members are valid therapeutic targets.

1.2 BCL-2 Family of Proteins
Apoptosis is triggered by a range of physiological and pathological death signals. The
best characterized pathways that lead to apoptotic cell death involve the activation of cysteine
proteases of the caspase family that cleave substrates after aspartate residues (Earnshaw et al.
1999). These enzymes are divided into two groups: (1) the initiator caspases (caspases 2, 8-10,
12), and the effector caspases (caspases 3, 6, 7) (Earnshaw et al. 1999). An initiator caspase acts
at an early point in the apoptotic signaling pathway. After autoproteolysis of the initiator
caspases active dimers are forms which activate effector caspases through proteolitic cleavage
and thus enhances the apoptotic signal (Earnshaw et al. 1999). Effector caspases than cleave the
substrates which lead to the break-down of the cell into apoptotic bodies and subsequent
phagocytosis (Utz, Anderson 2000). The initiator caspases are in mammals activated by at least
two pathways: (1) the death-receptor pathway, and (2) the mitochondrial (BCL-2 family)
pathway. The death-receptor pathway is initiated by extracellular death-inducing ligands of the
TNF superfamily (Krammer 2000;Locksley et al. 2001). The mitochondrial pathway involving
BCL-2 family proteins is mostly triggered by growth factors and cytokines withdrawal,
irradiation, viruses, bacteria and chemotherapeutic drug (Borner 2003;Gross et al. 1999). Various
BCL-2 family members serve as sensors of the death stimuli, other target mitochondrial outer
membrane to release apoptogenic factors (e.g. cytochrome c, Smac/DIABLO, Htr2A/Omi)
2

involved in the formation of apoptosome in mammalian cells (Borner 2003;Bouillet, Strasser
2002;Gross et al. 1999).
Members of the BCL-2 family are crucial regulators of the mitochondrial apoptotic
pathway. The founding member of this family, BCL-2, was initially cloned from the breakpoint
of the t(14;18) chromosomal translocation in human B-cell lymphoma (Gross et al. 1999;Lipford
et al. 1987).

Today this family is comprised of over 30 proteins, sharing one or more BCL-2

homology (BH) domains. Based on their function in apoptosis, the family is divided into two
groups: (1) anti-apoptotic proteins like BCL-2 and BCL-XL which possess three to four BH
domains, (2) pro-apoptotic proteins like BAX and BAK, which possess three to four BH domains
and mediators like BIM that possess only one BH domain (BH3-only proteins) (Borner
2003;Bouillet, Strasser 2002;Cory et al. 2003;Gross et al. 1999) (Table 1).
In the absence of apoptotic stimuli, a significant fraction of pro- and anti- apoptotic BCL2 members sequester to separate subcellular compartments. Anti-apoptotic members like BCL-2
and BCL-XL are largely found membrane-bound in mitochondrial outer membrane (MOM),
endoplasmic reticulum (ER) or nuclear membrane (Borner 2003;Bouillet, Strasser 2002;Gross et
al. 1999). Pro-apoptotic members like BAX localize to cytosol or like BIM to cytoskeleton
(Borner 2003;Bouillet, Strasser 2002;Gross et al. 1999). Upon induction of a death signal,
significant subcellular rearrangement of various family members takes place indicative of their
ability to transition. Pro-apoptotic proteins, like BAX, translocate to membranes, especially
MOM, where they are thought to cause destabilization of the MOM and induce release of the
apoptogenic factors from the mitochondria (Table 1).
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Table 1: Summary of the most prominent mammalian BCL-2 family members.
BCL-2 family
member
BCL-2

Function
Anti-apoptotic

BH
homologies
BH1-BH4

Localization in healthy
cells
MOM-, ER-, nuclear
envelope inserted
Cytosolic, loosely MOMattached
MOM – loosely attached
MOM-, ER-, nuclear
envelope inserted

Localization in apoptotic
cells
MOM-, ER-, nuclear
envelope inserted
MOM-inserted

BCL-XL

Anti-apoptotic

BH1-BH4

BCL-W
MCL-1

Anti-apoptotic
Anti-apoptotic

BH1-BH4
BH1-BH4

BAX

Pro-apoptotic

BH1-BH3
BH1-BH3

Cytosolic, ER-, MOMloosely attached
MOM-, ER- inserted

MOM-inserted, ERinserted(?)
MOM-inserted, ERinserted

BAK

Pro-apoptotic

BID
BAD
BIM

BH3-only
BH3-only
BH3-only

BH3
BH3
BH3

Cytosolic
Cytosolic
DLC1-associated

MOM
MOM
MOM-inserted(?)

MOM-inserted
MOM-, ER-, nuclear
envelope inserted

Analysis of sequence homology among BCL-2 family proteins demonstrated that the
family members posses low sequence homology, mostly limited to the BH regions. Mutagenesis
studies of the BH1, BH2 and BH3 domains imply that these domains strongly influence homoand hetero-dimerization of these proteins (Borner 2003;Gross et al. 1999). Prevailing dogma
states that the BH3 domain is responsible for mediating interactions between anti-apoptotic and
pro-apoptotic proteins and between BAX-like pro-apoptotic and BH3-only proteins (Borner
2003;Gross et al. 1999;Simonen et al. 1997). The sequence comparison among the BH3 domains
of most prominent BCL-2 family proteins is presented in Table 2.
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Table 2: The sequences of BH3 domains of most prominent BCL-2 family proteins.
The strictly conserved residues of BH3 domains are in italic.

BCL-2 family
member
BCL-2
BCL-XL

Function

BH3 domain sequence

Anti-apoptotic
Anti-apoptotic

VHLTLRQAGDDFSRR
VKQALREAGDEFELR

BAX
BAK

Pro-apoptotic
Pro-apoptotic

LSECLRRIGDELDSN
VGRQLALIGDDINRR

BID
BAD
BIM

BH3-only
BH3-only
BH3-only

IARHLAQIGDEMDHN
YGRELRRMSDEFEGS
IAQELRRIGDEFNET

Some studies indicate that the BH3 domain has the ability to promote apoptosis (Bouillet,
Strasser 2002;Kuwana et al. 2005;Putcha et al. 2001;Simonen et al. 1997). This opinion was
strengthened by subsequent studies which used peptides derived from the BH3 domain of proapoptotic BCL-2 family members that bound to anti-apoptotic BCL-XL (Liu et al. 2003;Petros et
al. 2004;Petros et al. 2000;Sattler et al. 1997). Expression of small peptide derive from the BH3
sequence of BAK was sufficient to induce apoptosis (Cosulich et al. 1997), small synthetic
peptides derived from BH3 domains of the BH3-only proteins can suppress the anti-apoptotic
BCL-2 family members (Dharap et al. 2003;Minko et al. 2003;Shangary, Johnson 2002).
In addition to the BH domains, many of the BCL-2 family members process a C-terminal
hydrophobic domain, which is predicted to be responsible for membrane localization.
Intriguingly enough, subcellular localization differs between the anti-apoptotic and pro-apoptotic
proteins, and changes in the subcellular localization of these proteins upon apoptotic stimulus are
characteristic of the early stages of apoptosis (Table 1). BCL-2 is predominantly anchored in the
outer mitochondrial membrane and this membrane localization plays a key role in the ability of
5

BCL-2 to modulate mitochondrial membrane integrity (Borner 2003;Gross et al. 1999). The
release of apoptogenic factors is inhibited by BCL-2 and BCL-XL. Pro-apoptotic BAX resides
in the cytosol of healthy cells and translocates to mitochondria upon apoptotic stimulus (Annis et
al. 2005;Borner 2003;Gross et al. 1999). The release of the apoptogenic factors is enhanced by
membrane-bound BAX.
BH3-only proteins play a significant role in mediating a life or death decision. There is
increasing evidence in the literature that these proteins are apoptotic-stimulus specific and celltype specific. BIM, for example, is required for induction of apoptosis in lymphocytes upon
cytokine withdrawal (Bouillet, Strasser 2002;Dijkers et al. 2000), stimulation of autoreactive
antigen receptors, or treatment with taxol (Bouillet, Strasser 2002;Puthalakath et al. 1999).
Current dogma states that BH3-only proteins directly activate BAX-like proteins to trigger the
mitochondrial membrane disruption and consequently apoptosis (Bouillet, Strasser 2002).
However, for many of these proteins including BIM, no direct binding to BAX was observed. An
alternative model suggests that BIM and related proteins initiate apoptosis by binding of the antiapoptotic proteins like BCL-2 and changing their conformation to enable the dimerization of
BAX and the disruption of the mitochondrial membrane (Borner 2003).

1.3 Structure and function of BAX

The structure of BAX was determined in 2000 (Suzuki et al. 2000). BAX consists of
nine α helices with eight amphipathic α helices clustered around one central hydrophobic α helix
(α5) (Figure 1, 2). The overall fold of BAX closely resembles the fold of C-terminally truncated
BCL-2 and BCL-XL. Helices 2, 3, and 4 form a hydrophobic groove. A portion of the C6

terminal region of BAX forms the helix α9 that binds within a hydrophobic groove, covering the
hydrophobic residues of the groove and burying its own hydrophobic residues.

Figure 1: The amino acid sequence of BAX with indicated secondary structure, BH
domains and transmembrane domain.
Complete amino acid sequence of BAX is shown in this figure. Alpha helices are in red, BH domains in
yellow and transmembrane domain in green.

This may be important for increasing the solubility of the protein and contributes to the
fact that BAX exists predominantly in the cytosol before apoptosis induction. Helix α9 is
positioned in the hydrophobic pocket in a manner similar to the way the BH3 peptide of another
BCL-2 family member, BAK, is positioned in the hydrophobic groove of BCL-XL(Sattler et al.
1997). In essence, the directional sense of the peptide is opposite to that of the self-associated Cterminal helix of BAX.
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Figure 2: Ribbon representation of BAX structure.
The helices are numbered from 1-9, BH1 colored orange, BH2 blue, BH3 yellow, and α9 red.

In previous studies, Khaled et al. reported that a rapid increase in intracellular pH,
associated with cytokine withdrawal in lymphocytes, triggered that translocation of BAX to
mitochondria(Khaled et al. 1999). This concept led to the hypothesis that BAX undergoes
conformational changes at pH 7.8 or higher. However, NMR studies obtained by Suzuki at al.
did not report any conformational changes at high pH (Suzuki et al. 2000). Instead, they
reported that BAX underwent conformational changes upon detergent treatment, which induced
complex formation. This conformational changes exposed hidden epitopes that upon exposure
were detectable by antibodies (Annis et al. 2005;Cartron et al. 2004;del Mar et al. 2001;Khaled
et al. 1999). Conformational changes in BAX resulted in complex formation upon detergent
treatment or in presence of lipids (Antonsson et al. 2000;Antonsson et al. 2001;Hsu, Youle
1998;Hsu, Youle 1997).
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1.4 Molecular Modeling

“Molecular modeling is the science and art of studying molecular structure and function
though model building and computation” (Schlick 2006). Molecular modeling begins with the
refinement of the experimental data obtained by X-ray crystallography and NMR, and continues
with the ab initio and semi-empirical quantum mechanics and empirical mechanics, molecular
dynamics, structure/activity relationships and databases (Hinchliffe 2006;Machida 2007;Schlick
2006). Molecular modeling plays an important role in predicting structural and functional
properties of increasing number of identified and characterized proteins. In my work I used
empirical (molecular) mechanics approach.
Molecular mechanics is known also under terms force-field or potential energy method
(Allinger 1976). An underlying principle in molecular mechanics is that cumulative physical
forces can be used to describe molecular geometries and energies. The spatial conformation
eventually obtained is then a normal adjustment of geometry to minimize the total internal
energy. Molecules are considered as a collection of masses centered at the nuclei (atoms)
connected by springs (bonds) (Hinchliffe 2006;Machida 2007;Schlick 2006). Molecular
mechanics involves assembly of a potential energy, a function of atomic positions. Entropic
contributions are either neglected or approximated (Machida 2007;Schlick 2006). Several
versions force fields are commonly used. Molecular mechanics 2/3/4 is often used for small
molecular systems (Allinger 1976;Lii, Allinger 1998b) , CHARMM (Brooks et al. 1983)
package is preferred by protein modelers, AMBER (Case et al. 2005) is often used by nucleic
acid modelers.

9

1.5 Thesis Objectives

Despite its critical importance in the apoptotic process, the mechanisms by which BAX is
activated are still poorly defined. Research to date has revealed that BAX resides in the cytosol
of healthy cells and upon apoptotic insults translocates to the membranes of organelles,
principally the mitochondria and the endoplasmic reticulum (Borner 2003;Bouillet, Strasser
2002;Gross et al. 1999). Some progress has been made identifying possible proteins that could
interact with BAX and mediate its membrane-binding activity. What is not known, however, is
the actual means by which the apoptotic activity of BAX is triggered – what initiates the change
from a cytosolic-form to a membrane-bound form. Lack of this information represents an
important medical problem because, without an understanding of the conformational and
physiological triggers that regulate the activation of BAX, the therapeutic potential of
manipulating this protein in disease states cannot be fully developed. Current studies in the use
of therapeutic apoptosis, which focus on the inhibition of cell death through manipulating BCL-2
family members, are in the early stages (Letai 2005).
The first objective of the work presented herein was to characterize the “molecular
switch” which mediates the activation of BAX and identify possible physiological triggers that
could “flip the switch”. Based on published data and my preliminary observations, I developed
the hypothesis that the subcellular distribution of BAX was governed by its C-terminal domain,
the α9 helix. Published findings suggested that this domain functioned solely as a membrane
anchor. Based on my initial findings, I proposed to examine a different function: the α9 helix
operates as a “molecular switch” in response to apoptotic stimuli, inducing conformational
changes that enable subsequent membrane integration. To validate this hypothesis, I employed
10

diverse methods of cell biology and computational modeling to demonstrate that basic residues
in the α9 helix interact with residues in the α2 helix and hinge, which form part of a prominent
hydrophobic groove, to mediate the subcellular localization of BAX. Using peptide mimics of
the C-terminal α9 helix, I showed that occupancy of the hydrophobic groove by the α9 helix
mediates the translocation of BAX from cytosol to mitochondria.

To explore possible

physiological triggers that could regulate the membrane-binding activity of the α9 helix, I
observed that a transient raise in intracellular pH facilitated the movement of BAX to
mitochondrial membrane, suggesting that the lipid bilayer of mitochondria could be a pHresponsive component. In total, these findings have significant implications for the development
of novel therapeutic molecules for the modulation of apoptosis in drug development.
Second objective of the work presented herein was to develop a computational method to
identify proteins, like BAX, capable of undergoing structural transitioning. To date, no such
methodology is available for this purpose. Based on the computational analysis of helical
packing energies in BAX, I developed the hypothesis that proteins which undergo significant
conformational changes will have a broader distribution in their helical packing energies
compared to less dynamic or static proteins. To test this hypothesis, multiple groups of proteins
were analyzed by molecular mechanics 3 (MM3) and methods of computational analysis were
developed to enable the prediction of which proteins which undergo conformational changes.
These predications can be used to identify transitional proteins as well as transitional regions
within proteins, indicating where changes are most likely to occur. I used this computational
tool to examine multiple members of the BCL-2 family and was able to correlate their propensity
to transition, as indicated by variations in helical packing energy, to their function. This work
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contributes to the field of proteomics by providing a novel parameter by which transitional
proteins can be identified for subsequent biological testing.
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2 STRUCTURAL TRANSITIONS THAT MEDIATE THE MEMBRANEASSOCIATION ACTIVITY OF BAX ARE DEPENDENT ON ITS CTERMINAL α-9 HELIX
2.1 Introduction

The pro-apoptotic member of BCL-2 family BAX is proposed to be the main executor of
the mitochondria, causing a perforation of mitochondrial outer membrane and release of
apoptogenic factors (Borner 2003;Cory et al. 2003;Degenhardt et al. 2002;Gross et al. 1999).
This cytosolic protein translocates to mitochondrial membrane upon apoptotic stimuli
(Antonsson et al. 2001;Nechushtan et al. 2001). The structural changes involved in the transition
from inactive cytosolic form to an active membrane bound form are not completely understood.
Structural studies suggested that BAX undergoes conformational changes as it translocates to
membranes. The portion of a hydrophobic C-terminal region of BAX forms α9 helix. The helix
α9 helix must disengage from the hydrophobic groove and the α2 helix must rotate to expose the
BH3 domain for dimerization (Suzuki et al. 2000). However, that these are physiological events
occurring during apoptosis has yet to be proven. Nor has conclusive evidence demonstrated how
such conformational changes are accomplished. Diverse findings proposed regulatory
interactions with BH3-only proteins such as BID (Ruffolo et al. 2000), BIM (Marani et al. 2002)
or PUMA (Zhu et al. 2004), other proteins such as ACS (Ohtsuka et al. 2004), clusterin (Zhang
et al. 2005) or Ku70 (Yoshida et al. 2004), and signaling proteins such as p53 (Chipuk et al.
2004), AKT (Gardai et al. 2004), JNK (Tsuruta et al. 2004), 14-3-3 (Nomura et al. 2003) or
GSK-3 (Linseman et al. 2004) with BAX. In contrast to direct intervention by an accessory
protein, Khaled et al. first reported that the activation of BAX coincided with a rise in
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intracellular pH (Khaled et al. 1999), suggesting that BAX assumed a membrane-binding
conformation in response to cytosolic alkalinization.
Several research reports suggested that the α9 helix is a transmembrane region essential
for membrane binding (Nechushtan et al. 1999;Schinzel et al. 2004), while others maintain that it
is either a regulatory domain (Arokium et al. 2004)

or dispensable for apoptotic activity

(Tremblais et al. 1999). Hence, how the α9 helix regulates the activity of BAX remains unclear.
Likewise, the role of the hydrophobic groove also remains speculative – though it incorporates
the critical BH3 domain.

To better understand the function of these domains, I used

computational modeling and targeted mutagenesis to demonstrate that the C-terminal α9 helix
and the hydrophobic groove of BAX are both necessary for membrane association. I observed
that, in the presence of endogenous BAX, the α9 helix could confer membrane-binding capacity
to a cytosolic protein.

To explain this, I propose that the α9 helix associates in reverse

orientation with the hydrophobic pocket of adjacent BAX molecules, enabling dimerization and
the release of additional membrane-binding domains that facilitate the insertion of BAX into
mitochondrial membranes.

Intracellular alkalinization may facilitate this process by altering

mitochondrial membrane dynamics.
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2.2 Material and Methods
2.2.1 Cell Lines and Reagents

The Flp-In T-REx-293 cell line (Invitrogen) was derived from 293 human embryonic
kidney cells(Graham et al. 1977) that stably expressed the lacZ-Zeocin fusion gene and the Tet
repressor. The 293 cell line was maintained in D-MEM (high glucose), 10% FBS (tetracyclinereduced) and 2 mM L-glutamine and 1% Pen-Strep. The HCT116 BAX-/- and BAX+/+ colorectal
cancer cell lines (from Dr. Bert Vogelstein, John Hopkins University) were maintained in
McCoys 5A media, 10% FBS and 1% Pen-Strep. Staurosporine, Z-Vad-FMK (Calbiochem),
nigericin (Molecular Probes), and dimethylamiloride (DMA) (Sigma) were prepared as stock
solutions in DMSO or ethanol.
Peptides:

The

C-terminal

peptide

of

wild-type

BAX

(Ac-

VTIFVAGVLTASLTIWKKMG-NH2) and the BAX-leucine (BAX-LL) mutant peptide, (AcVTIFVAGVLTASLTIWLLMG-NH2) were synthesized by Biopeptide Co., (San Diego, CA)
and were > 90% pure as confirmed by HPLC.

The HPLC-purified, BIM BH3 peptide,

DNRPEIWIAQELRRIGDEFNAYYAR, was donated by Dr. Douglas Green, St. Jude Children’s
Research Hospital. Peptides were resuspended in DMSO at a stock concentration of 10mM.

2.2.2 Plasmids, Mutagenesis and Transfection

For inducible expression of BAX wild-type (WT) and mutant proteins, I employed the
Flp-In T-REx System (Invitrogen). BAX WT and mutant genes were cloned into the expression
vector, pcDNA5/FRT/TO. This expression vector undergoes recombinase-mediated DNA
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recombination at the Flp Recombination Target (FRT) site when co-expressed with the pOG44
plasmid that constitutively expresses the Flp recombinase. BAX constructs were amplified from
the template, pEGFP-BAX (from Dr. Richard Youle, NINDS, NIH) with PCR, digested with
EcoRV and cloned into pcDNA5/ FRT/TO expression vector.
All constructs were confirmed by sequencing. The pOG44 plasmid and the
pcDNA5/FRT/TO vectors were cotransfected into the Flp-In T-REx 293 cell line, at a ratio of
9:1 with the Fugene 6 transfection reagent (Roche) following manufacturer’s protocol. Stable
Flp-In T-REx expression cell lines were then selected for blasticidin resistance (10 μg/ml),
hygromycin resistance (100 μg/ml) and zeocin sensitivity (200 μg/ml). BAX expression was
induced by the addition of tetracycline (1 μg/ml).
For transient, constitutive expression of BAX in HCT116 cells, pcDNA5/FRT/TO
vectors, containing the BAX WT and mutant genes, were transfected using the TransIT-LT1
transfection reagent (Mirus) following manufacturer’s protocol. In the absence of the Tet
repressor, gene expression from pcDNA5/FRT/TO is constitutive. HCT116 cells were examined
24-48 hours after transfection for apoptosis by microscopy as described below.
PCR-directed mutagenesis of BAX was performed using HA-tagged primer sets, with
mutations incorporated within the primer sequences (Table 2). To generate EGFP-BAX-CT,
EGFP fused with the C-terminus of BAX was created by PCR from the template pEGFP
(Clontech), and the PCR insert was cloned into pcDNA5/FRT/TO as previously described.
HCT116 cells were transiently transfected using TransIT-LT1 reagent and cells assayed for
EGFP expression 24-48 hours later.
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Table 3: The list of BAX mutants and primers
BAX mutant
BAX-KK

BAX-ΔNT
(1-19)
BAX-ΔCT
(173-192)
BAX-LL

BAX-DD

BAX-EE

BAX-RR

BAX-QQ

BAX-KMGK

BAX-LK

BAX-KL

BAX-EK

Forward Primer
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-CCGGGGAGCAGCCCCATA
TGTACCCATACGATGTTCCAGATTAC
GCTATGAAGACAGGGGCCCTTTTGC3
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
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Reverse Primer
5’-CGTCGACTGCAGAATTCT
CAGCCCATCTTCTTCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCT
CAGCCCATCTTCTTCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCT
CAGGTCTGCCACGTGGGCGTCCCAA
AG-3’
5’-CGTCGACTG CAGAATTCTC
AGCCCATGAGGAGCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCTC
AGCCCATGTCGTCCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCTC
AGCCCATCTCCTCCCAGATGGTGAG
CGAGG-3’
5’CGTCGATCTCAGCCCATTCGTCGCC
AGATGGTGAGCGAGG-3’

5’-CGTCGACTGCAGAATTC
TCAGCCCATCTGCTGCCAGATGGTG
AGCGAGG-3’
5’CGTCGACTGCAGAATTCTC
ACTTCCCCATCTTCCAGATGGTGAGC
GAGG-3
5’-CGTCGACTGCAGAATTCTC
AGCCCATCTTGAGCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCTC
AGCCCATGAGCTTCCAGATGGTGAG
CGAGG-3’
5’-CGTCGACTGCAGAATTCTC
AGCCCATCTTCTCCCAGATGGTGAGC
GAGG-3’

BAX mutant
BAX-KE

EGFP-BAXCT

BAX-ΔCT
E69W
BAX-ΔCT
E69R

Forward Primer
5’-GGATCACTCTCGGCCTG
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’
5’-GGATCACTCTCGGCCTGG
ACGAGGATATCGTCGCCACCATGGT
GAGCAAG-3
5’-CTCAAGCGCATCGGGGACTGGCT
GGACAGTAACATGGAG-3’
5'-CTCAAGCGCATCGGGGACAAGC
TGGACAGTAACATGGAG-3'

Reverse Primer
5’-CGTCGACT GCAGAATTCTC
AGCCCATCTCCTTCCAGATGGTGAGC
GAGG-3’
5’-TGCAGATATCTCAGCCCAT
CTTCTTCCAGATGGTGAGCGAGGCG
GTGAGCACTCCCGCCACAAAGATGG
TCACGGTCTGCCACGTGGGGTTATCT
AGATC-3’
5’-CTCCATGTTACTGTCCAGCCAGT
CCCCGATGCGCTTGAG-3’
5'-CTCCATGTTACTGTCCAGCGGGT
CCCCGATGCGCTTGAG-3'

2.2.3 Mitochondrial Translocation Assays, Crosslinking, Co-immunoprecipitation and
Immunoblotting

BAX expression was induced in 293 cells by addition of 1 μg/ml tetracycline. EGFPBAX-CT or BAX-ΔCT was constitutively expressed in HCT116 cells. After 48 hours of
induction or expression, 293 or HCT116 cells were harvested and mitochondrial and cytosolic
protein lysates were prepared using a mitochondrial extraction kit with minor modifications
(Pierce). Briefly, 2 x 107 cells were lysed using the mild detergent method. This method is
highly reproducible and does not induce conformational changes that lead to mitochondrial
translocation of BAX. The final mitochondrial pellet was washed in 1M NaCl to remove any
proteins peripherally associated with mitochondria. Mitochondrial and cytosolic protein lysates
were loaded on 12% SDS-PAGE gels (Invitrogen), transferred to PVDF membranes and
immunoblotted. For detection of HA-tagged BAX, an anti-HA mouse monoclonal antibody was
used (16B12, Covance). For detection of endogenous BAX (N-20 Santa Cruz), prohibitin (Ab-2,
Fitzgerald) and p38 MAPK (C20, Santa Cruz), rabbit polyclonal antibodies were used. For
detection of EGFP (A.v. antibody, Clontech) a mouse polyclonal antibody was used. Appropriate
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secondary rabbit or mouse antibodies crosslinked to horse radish peroxidase (HRP) (Cell
Signaling) were used for detection.

Enhanced chemo-luminescence (Pierce) was used for

visualization following the manufacturer’s protocol.
Crosslinking of BAX-/- HCT116 cells, co-transfected with BAX-ΔCT and EGFP-BAXCT was performed using the crosslinking agent, disuccinimidyl suberate (DSS), following
manufacturer’s protocol.

Forty-eight hours after transfection, whole HCT116 cells, after

washing and resuspending in PBS, were treated for 30 minutes on ice with 10 mM DSS. The
reaction was quenched with 10 mM Tris, pH 7.4 and 100 mM glycine. Cells were then lysed in
mitochondrial isolation buffer (Pierce) as described above, and the cytosolic and mitochondrial
protein fractions were combined and 2% CHAPS was added.

Protein lysates were

immunoprecipitated with an antibody specific for an internal BAX epitope (BAX Ab-4,
Calbiochem) and analyzed on a 12% SDS-PAGE gel.

Proteins were immunoblotted and

detected with antibodies for EGFP as previously described.
To examine the direct effect of apoptotic mitochondria on the translocation of BAX,
mitochondria were isolated from 2 x 107 BAX-/- HCT116 cells using the mitochondrial extraction
kit (Pierce).

To isolate EGFP-BAX-CT or BAX cytosolic proteins, these were expressed in

HCT116 cells for 48 hours and cytosolic fractions were isolated from 107 cells using the
mitochondrial extraction kit (Pierce). To determine whether EGFP-BAX-CT could translocate to
apoptotic mitochondria, BAX-/- HCT116 cells were treated for 1 hour with 1 μM staurosporine
or pH fixed at 7.2 or 7.8 for 20 minutes with 5 μM nigericin in a high K+ HEPES buffer (25 mM
Hepes, 145 mM KCl, 0.8 mM MgCl2, 1.8mM CaCl2, 5.5 mM glucose). Control, apoptotic or
alkaline mitochondria were isolated using the mitochondrial extraction kit (Pierce). Cytosolicderived EGFP-BAX-CT from HCT116 cells was incubated for 30 minutes with mitochondria at
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37° C in a volume of 100 μl. Mitochondria were then washed 3 times in isotonic buffer
(mitochondrial extraction kit). The final mitochondrial pellet was washed in 1 M NaCl to remove
peripherally associated proteins. Mitochondrial protein lysates were prepared, resolved by SDSPAGE and immunoblotted for BAX and prohibitin.
To assess the effect of the BAX and BIM peptides on the mitochondrial translocation of
BAX, cytosolic endogenous BAX or constitutively expressed BAX-ΔCT were isolated from 107
HCT116 cells using the mitochondrial extraction kit (Pierce) and incubated with the peptides (525 μM) in a volume of 100 μl for 30 minutes. The cytosol/peptide mixture was then incubated
for 30 minutes with neutral or alkaline mitochondria prepared as described above from 2 x 107
BAX-/- HCT116 cells. Mitochondria were then washed, resolved by SDS-PAGE and
immunoblotted for BAX and prohibitin as previously described.

2.2.4 Triton X-114 Phase Partitioning

The hydrophobicity of BAX-KK and BAX-LL was examined by Triton X-114 phase
partitioning (Brusca, Radolf 1994;Pryde 1998). Briefly, cytosolic extracts prepared in isotonic
buffers were treated with 2% (vol%vol) Triton X-114 (Sigma), and the hydrophobic detergent
phase was partitioned by incubation at 37°C followed by high-speed centrifugation. Bax was
immunoprecipitated from the detergent phase and analyzed by immunoblot, as previously
described.
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2.2.5 pH Assays

The EGFP mutant, EYFP, exhibits pH dependent fluorescence in the pH range 6-8
(Hanson et al. 2002;Wachter et al. 1998).

The fluorescence emission (527 nm peak) and

excitation (514 nm peak) of EYFP decreases with decreasing pH.

HCT116 cells were

transfected with EYFP using TransIT-LT1 reagent (Mirus) and cells were assayed for EYFP
expression 48 hours later. To induce alkalinization, EYFP-expressing cells were treated for 30
minutes to 1 hour with 1 µM staurosporine and changes in EYFP fluorescence were determined
by flow cytometry (BD-FACSCalibur; excitation 488 nm, emissions filtered through a 525 nm
band pass (green fluorescence). Dead cells were excluded by forward and side scatter gating. A
pH calibration curve was generated by incubation of EYFP-expressing cells for 30 minutes in a
high K+ Hepes buffer (described above) at different pH values from 6.8 to 8.0 in the presence of
the ionophore nigericin (5 μM).

Cells were immediately assayed by flow cytometry

(FACSCalibur; Becton, Dickinson and Company).

2.2.6 Confocal Microscopy

HCT116 cells were grown on coverslips coated with 200 µg/ml poly-L-lysine (Sigma)
and transfected with the EGFP-BAX-CT using the Mirus LT-1 reagent according to the
manufacturer’s protocol. After 48 hours, apoptosis was induced with staurosporine (1 µM) or the
cells were exposed to different pH conditions using nigericin and high K+ buffers as described
above. Cells were rinsed with PBS, fixed and permeabilized with ice cold methanol for 10 min
at -200C. Cells were blocked with 1% BSA in PBS for 1 hour and stained with a primary
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antibody HSP60 (H-300, Santa Cruz) for 45 min followed by secondary anti-rabbit IgG-Texas
Red (Santa Cruz) for 30 min. After a final rinse, coverslips were mounted with Gel/Mount
(Biomeda). The images were acquired by LSM 510 NLO, Carl Zeiss.

2.2.7 Computational Docking

The structure of BAX (PDB ID: 1F16) was obtained from the RCSB Protein Data Bank
(http://www.rcsb.org/pdb). The primary sequences of BCL-2 proteins were obtained from
UniProtKB (http://ca.expasy.org/uniprot). The BAX NMR encompasses 20 models. In order to
determine the best representative from all models, the program NMRClust (Kelley et al.
1996a;Kelley et al. 1997) was used to cluster the structures. The best representative of the cluster
(as determined by the most structures and the smallest RSMD for the cluster) was structure
number 6. This structure was used in all calculations and computational manipulations.
Computational site directed mutagenesis was performed by substituting individual residues
of BAX α9 helix with alanine using BioMed Cache 6.1.10 program (Fujitsu America, Inc.,
Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were performed
using parameters as described (Allinger et al. 1989b;Allinger et al. 1989a;Lii, Allinger 1989;Lii,
Allinger 1994;Lii, Allinger 1998a). Calculations were performed in vacuo, disregarding an
explicit water/membrane environment. The energy of each molecule was calculated until
convergence (energy minimization) was reached. Energy terms included Van der Waals,
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked; except
protons and side chains within a distance of 5Å from the mutation site. A conjugated gradient
was used to locate the energy minimum. Van der Waals interactions between atoms separated by
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more than 9.0Å were excluded. Optimization continued until the energy change was less than
0.001 kcal/mol. The estimated interaction energy (IE) was determined through separate
calculations of the energy of the BAX structure prior the mutation (E1), and the energy of the
BAX structure after single site mutation (E2), followed by the difference between these terms
(IE=E2- E1).
The peptides used in computational modeling and docking were peptides derived from BCLXL (UniProtKB ID: Q07817), BCL-2 (P10415), BAD (Q92934), BIM (O43521), BAK
(Q16611) and BAX (Q07812). All peptides used in the calculations were 20 amino acids in
length. BCL-XL BH3 peptide incorporated residues 82-101 (UniProt sequence numbering),
BCL-2 BH3 residues 89-108, BAD BH3 residues 107-116, BAX BH3 residues 54-73, BIM BH3
residues 146-165, and BAK BH3 residues 70-89. C-terminal peptides encompassed last 20
amino acids of the BCL-2, BCL-XL and BAX sequence.
The backbone of BAX α9 helix (residues 170-189) was used as a template on which
peptides of BH3 domains and C-termini were built as alpha helices in BioMed Cache 6.1.10
program and their energy minimized using MM3 force field calculations under parameters
described earlier. The atoms of the backbone were locked; atoms of side chains including
protons were unlocked.
To perform receptor-ligand docking simulations, C-terminus of BAX (residues 170-192)
was removed from the NMR structure to expose the hydrophobic groove. All the structures were
submitted to the docking server GRAMM-X (Tovchigrechko, Vakser 2005a;Tovchigrechko,
Vakser 2006a), where BAXΔ170-192 was assigned as a receptor and peptides as ligand. The
server returned 10 different docking solutions for each receptor-ligand combination. The energy
minimization was performed by MM3 force field calculation under parameters described earlier.
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All atoms except protons were locked. The interaction energy (IE), was estimated through
separate determination of the energy of the complex (Ecomplex), the complex without the peptide
(Ecomplex w/o peptide) and peptide alone (Epeptide), and by taking the difference between these terms
(IE=Ecomplex-(Ecomplex

w/o peptide+Epeptide)).

To determine the potential interaction energies for

different helical peptides with the hydrophobic pocket, the interaction energy obtained for each
peptide was compared with the interaction energy of BAX C-terminal peptide in the original
(forward) orientation within the pocket using the formula (IE=IEpeptide-IEC-terminus

BAX).

The

graphic images were produced by DS Viewer Pro 5.0 (Accelrys Software Inc.).

2.3 Results
2.3.1 Lys189 and Lys190 in the C-terminal α9 helix modulate the intracellular
localization of BAX.

The NMR structure of soluble, cytosolic-form of BAX shows that its C-terminal α9 helix
is partially buried in an internal hydrophobic pocket formed by helices 2, 3, 4 and 5(Suzuki et al.
2000). To serve as a potential transmembrane domain, the α9 helix must first disengage from the
hydrophobic pocket. Therefore, my first goal was to identify the residues within the α9 helix
that mediated the binding of the helix within the hydrophobic pocket. To begin this process, I
performed computational site-directed mutagenesis using the NMR structure of BAX as the
template. For this analysis, I chose the last twenty amino acids of the α9 helix. Each individual
amino acid was replaced with alanine and the effects on the interaction energy were determined.
Replacement of most of the amino acids throughout the C-terminus with alanine did not
significantly change the interaction energy of the residue within the helix (Figure 3). In contrast,
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the mutation of lysine 189 resulted in dramatically altered interaction energy, primarily through a
change in hydrogen bond energetics. This held true regardless of the orientation of the α9 helix
within the groove. Though this simulation did not conclusively rule out a role for other residues
within the α9 helix in the regulation of the activity of BAX, it does suggest that mutation of
Lys189 could potentially destabilize the binding of the α9 helix with the charged residues on the
margin of the hydrophobic pocket. Thus, lysine 189 might function as a loose anchor of the α9
helix through weak hydrogen bond interactions with acidic or polar residues within the
hydrophobic pocket. The C-terminus of BAX contains two lysine residues back-to-back, lysine
189 and lysine 190, a unique feature among BCL-2 family members.

My next step was to

experimentally test the conclusion determined by computational analysis.

Figure 3: Summary of the computational mutagenesis of Lys189.
Computational site-directed mutagenesis was performed using the BioMed Cache 6.1.10 suite. Individual
residues of the BAX α9 helix (amino acids 172-189) were substituted one at the time with the alanine. The resulting
interaction energies (IE) were determined. Substitution of Lys189 for alanine could potentially destabilize the
interaction of C-terminal α9 helix with the charged or polar residues on the margin of the hydrophobic pocket. IE =
E2-E1, IE – the interaction energy, E1 – the energy of BAX before mutation, E2 – the energy of BAX after the
mutation
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To experimentally test the computational predictions, a series of mutagenesis
experiments were performed targeting lysine 189 and 190 in the C-terminus of BAX. To
circumvent the spontaneous apoptosis caused by the toxicity of the wild-type BAX (Annis et al.
2005;Antonsson et al. 2001;Borner 2003;Gross et al. 1999) and its construct, I applied two
different strategies for expression in mammalian cells.

I engineered (1) HA-tagged-BAX

mutants for the tetracycline inducible expression in a 293 cell line, which did not cause
spontaneous apoptosis during short term induction, and (2) HA-tagged-BAX mutants which were
co-expressed with EGFP as a marker in a BAX-/- HCT116 cell line and the absence of EGFP+
cells was used as a measure of spontaneous apoptosis by microscopic inspection. I included the
wild-type and N- or C-terminal truncated BAX mutants as controls along with the BAX
Lys189/190 mutants. The 293 cells inducibly expressing wild-type BAX (BAX-KK) displayed a
typical partitioning between cytosol and mitochondria.

N-terminal truncated BAX mutant

(BAX-∆NT), lacking residues 1-19, was largely localized in mitochondria. C-terminal truncated
BAX (BAX-∆CT), lacking residues 173-192, was cytosolic (Figure 4).

The remaining

immunoblots demonstrating the results achieved for other C-terminal BAX mutants are not
shown since this work was performed by other lab technical personnel. For purposes of
discussion, the complete results for the C-terminal mutagenesis study are summarized in Table 4.
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Figure 4: Expression of HA-tagged BAX mutants in 293 cells.
HA-tagged BAX mutants were inducibly expressed in 293 cells using the Flp-In T-Rex expression system.
After 24 hours of induction with tetracycline, cells were lysed and mitochondrial and cytosolic lysates prepared. The
presence of HA-BAX was assayed by immunoblotting with an anti-HA antibody. As controls for loading and
subcellular fractionation, p38 MAPK was blotted for cytosolic content and Prohibitin was blotted for mitochondrial
content. Note that loss of the two charged lysines altered the migration pattern of BAX-LL in SDS-PAGE gels. The
mitochondrial translocation of other BAX mutants is summarized in Table 2.

Table 4: Summary of BAX mutagenesis in 293 cells.
Mutant
BAX-KK
BAX-ΔCT
BAX-ΔNT
BAX-LL
BAX-DD
BAX-EE
BAX-RR
BAX-QQ
BAX-KMGK
BAX-KMG
BAX-MGK
BAX-LK
BAX-KL
BAX-EK
BAX-KE

Mutations of the C-terminus
None
Δ173-192
Δ1-19
K189L, K190L
K189D, K190D
K189E, K190
K189R, K190R
K189Q, K190Q
K190M, M191G, G192K
ΔK190
ΔK189, K190M, M191G, G192K
K189L
K190L
K189E
K190E

Primary Localization
Cyto/mito
Cyto
Mito
Mito
Cyto
Cyto
Mito
Cyto/mito
Cyto/mito
Cyto/mito
Cyto
Cyto/mito
Mito
Cyto
Cyto/mito

The ability of BAX C-terminal mutant constructs to induce apoptosis was tested in the
absence of endogenous BAX by co-expressing EGFP, as a marker, with BAX mutants in the
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BAX-/- HCT116 cells. The extent of spontaneous apoptosis was estimated by the loss of EGFP+
cells through fluorescent microscopic analysis. This was the best available method to document
apoptosis, since low transfection efficiency (about 40%) and constitutive expression of the
apoptotic forms of BAX caused rapid cell death within hours of expression, making other
apoptotic assays (i.e. annexin staining, PI exclusion) difficult to perform. Overexpression of
BAX-KK and BAX-∆NT resulted in a massive spontaneous apoptosis, documented by a
significant loss of green fluorescent, EGFP+ cells (Figure 5), and BAX-∆CT remained
exclusively cytosolic and did not induce apoptosis as evident from the presence of EGFP+ cells
(Figure 5).

These results agree with most other published reports (del Mar et al.

2001;Nechushtan et al. 1999;Suzuki et al. 2000) and demonstrate that an intact C-terminus of
BAX mediates the membrane docking step and subsequent apoptosis, while the N-terminus
promotes cytosolic retention In the absence of the last 20 amino acids of the C-terminus,
encompassing the α9 helix, BAX cannot translocate to mitochondrial membranes or cause
apoptosis in mammalian cells.
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Figure 5: Co-expression of HA-tagged BAX mutants with EGFP in BAX-/- HCT116
cells.

HA-tagged BAX mutants were constitutively co-expressed with EGFP in BAX-/- HCT116 cells. After 48
hours, HCT116 cells were microscopically observed for loss of EGFP+ cells, indicative of apoptosis induced by coexpression of BAX mutants. Images shown were acquired at 40X magnification.

Subsequent mutagenesis of lysine 189 and 190 emphasized the importance of a positive
charge at the sites. Substitution of lysine 189 and 190 with a negatively charged residues,
aspartate or glutamate, resulted in complete cytosolic retention of BAX (BAX-DD, BAX-EE,
BAX-EK) in 293 cells, and no cell death was observed in BAX-/- HCT 116 cells (Figure 5, Table
4).

When lysine 189 and 190 were replaced with positively charged arginine (BAX-RR),

mitochondrial targeting and cell death resulted (Figure 5, Table 3). The mutation of lysine 189
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and 190 into glutamine caused predominantly a cytosolic distribution of BAX-QQ and
intermediate toxicity as compared to BAX-KK and BAX-RR (Figure 5, Table 4). I consistently
found that the loss of lysine 189 confined BAX to cytosol (BAX-EK, BAX-MGK), while loss of
lysine 190 did not have the same effect (BAX-KE, BAX-KMG, BAX-KMGK) (Figure 5, Table
4). These results suggest that the lysine 189 is an essential mediator of BAX subcellular
distribution.

I derive the conclusion from the mutagenesis studies that the presence of a

positively charged residue at position 189 is necessary for the mitochondrial membrane targeting
of BAX and the induction of spontaneous cell death, while a polar or negatively charged residue
at this position confines BAX to the cytosol and prevents apoptosis.
Mutations that replaced lysine 189 and/or 190 with hydrophobic leucines resulted in
spontaneous mitochondrial targeting (BAX-LL; Figure 4) and subsequent apoptosis (BAX-LL,
BAX-KL; Figure 5, Table 4). The reason for this was that increasing the hydrophobic content of
the C-terminus of BAX enhanced its membrane docking properties.

Further experimental

evaluation of this mutant demonstrated that it partitioned into the detergent phase of preparations
treated with Triton-114, indicative of increased hydrophobic content (Figure 6A).
Immunoprecipitation with an N-terminal and C-terminal specific BAX antibodies (Figure 6B)
and protease digestion (Figure 6C) further suggested that BAX-LL assumes a more relaxed
confirmation caused by the increased hydrophobicity of the C-terminal α9 helix and subsequent
membrane binding. Increased pH also enhanced protease digestion as previously shown by
Khaled et al. (Figure 6C). The effect of pH changes on BAX will be further examined in a later
section. It should be noted that by substituting lysines in the C-terminus and increasing the
hydrophobicity of this domain, the membrane binding of BAX was artificially induced in a
manner that may not be physiological as will be further discussed. These findings do suggest,
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however, that manipulation of the C-terminus altered the membrane-binding activity of BAX,
indicating its important role in this process, and an examination of how this could be achieved
was my next step.

C.

Figure 6: The BAX-LL mutant exhibits characteristics of an unfolded hydrophobic
protein.
(A) Mitochondrial protein lysates were prepared from 293 cells induced to express either BAX-KK (wildtype) or BAX-LL (leucine mutant). Lysates were treated with Triton-X-100 to separate proteins into those that
partitioned into an aqueous phase (A) and those that partitioned into a detergent phase (D). Proteins were assayed
by SDS-PAGE and immunoblotted for the HA-tagged BAX protein using an anti-HA antibody (Covance).
Compared to BAX-KK, more BAX-LL partitioned into the detergent (D) phase. (B) Cytosolic or mitochondrial
protein lysates were prepared from 293 cells induced to express either BAX-KK (wild-type) or BAX-LL (leucine
mutant). Lysates were immunoprecipitated with an N-terminal specific BAX antibody (N-20, Santa Cruz) or a Cterminal specific BAX antibody (ID3, Abcam). Immunoprecipitates were washed and assayed by SDS-PAGE and
the HA-tagged BAX protein immunoblotted using an anti-HA antibody (Covance). The N-terminal epitope specific
BAX antibody immunoprecipitated some cytosolic BAX but much more mitochondrial BAX, especially from cells
expressing the BAX-LL mutant. In contrast the C-terminal epitope specific antibody did not immunoprecipitate
cytosolic BAX, but could immunoprecipitate mitochondrial BAX from cells expressing either BAX-LL or BAXKK. The * indicates non-specific bands. (C) Mitochondrial protein lysates were prepared from 293 cells induced to
express either BAX-KK or BAX-LL. Lysates were treated with proteinase K, 0-10g/ml, in isotonic buffers at pH 7,
7.5 or 7.8. The BAX-LL mutant was more sensitive to protease digestion than BAX-KK at neutral pH, while both
BAX proteins were digested at alkaline pH. This suggests that the BAX-LL mutant is more unfolded than the wild
type protein and that alkaline pH further unfolds the protein.
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2.3.2 The C-terminal α9 helix of BAX directs EGFP to apoptotic mitochondria

The previous studies demonstrated that Lys189/190 critically regulated the subcellular
partitioning of BAX – positive charge at the positions 189/190 directing BAX to mitochondria,
negative or polar charge retaining BAX in the cytosol. I next determined whether the C-terminus
alone is able to direct a cytosolic protein to mitochondria. To test this, I engineered a fusion
protein EGFP-BAX-CT by attaching the C-terminus of BAX (25 amino acids) to EGFP and
evaluating its subcellular distribution in non-apoptotic and apoptotic cells.

In my initial

experiments, I fused only the last 20 amino acids of BAX to EGFP and did not achieve results of
any significance. A possible explanation is that when the C-terminus of BAX is directly attached
to a protein it requires the presence of a putative hinge region (Schinzel et al. 2004), containing a
proline, in order to provide the flexibility required for protein:protein interactions. Also I did not
express full length, wild-type BAX in this context since recall that the constitutive expression of
BAX-KK is extremely toxic, hence the reason for using the fusion protein to study the Cterminus of BAX.
Using confocal microscopy, I visually inspected the distribution of EGFP-BAX-CT
(green fluorescence) in BAX+/+ HCT116 cells for either a diffuse staining pattern, suggestive of
cytosolic localization, or a punctate staining, suggestive of membrane binding, upon induction of
apoptosis by staurosporine (Figure 7B). Staurosporine was chosen as the lethal insult since it is a
well-recognized method of inducing rapid apoptosis (Kuwana et al. 2005).

I did not observe

that the addition of the C-terminal of BAX to EGFP resulted in significant spontaneous
membrane binding in non-apoptotic cells as had been previously reported (Schinzel et al. 2004).
In healthy cells there were only minor differences in the staining patterns between cells
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expressing cytosolic EGFP and EGFP-BAX-CT, with the latter showing more membrane
association (Figure 7B). The drastic difference in the staining patterns between cells expressing
cytosolic EGFP and EGFP-BAX-CT occurred upon induction of apoptosis by staurosporine. A
distinctive punctate staining pattern, hallmark of membrane binding, was observed in apoptotic
cells expressing EGFP-BAX-CT.

This staining pattern significantly overlaid (yellow

fluorescence) with the mitochondrial marker, HSP60 (red fluorescence), demonstrating that
fusion of the last 25 amino acids of BAX to EGFP conferred membrane binding to EGFP, but
preferentially in apoptotic cells.

It was evident from these findings that the apoptotic

environment promotes the translocation of EGFP-BAX-CT from the cytosol to the mitochondrial
membrane. EGFP-BAX-CT thus mimicked the apoptotic behavior of BAX.
The mitochondrial co-localization studies were confirmed by immunoblotting
mitochondria for EGFP. I obtained mitochondrial fractions from healthy or apoptotic
mitochondria of BAX-/- HCT116 cells. Apoptosis was induced by staurosporine. Another set of
HCT 116 cells, BAX+/+ and BAX-/-, was transfected with EGFP-BAX-CT. I extracted cytosolic
fractions from the cells. In the final step I incubated the healthy or apoptotic mitochondria with
the cytosol containing EGFP-BAX-CT. Analysis by immunoblotting showed that more EGFPBAX-CT inserted into apoptotic mitochondria compared to healthy mitochondria (Figure 7A).
The ratio of EGFP/prohibitin increased two-fold (BAX-/- HCT116 cells) and four-fold (BAX+/+
HCT116 cells) in apoptotic cells, indicating that endogenous BAX contributed significantly to
the translocation of the EGFP-BAX-CT. Note that EGFP-BAX-CT itself was not exposed to the
apoptotic environment; hence the translocation of EGFP-BAX-CT to mitochondria had to be
caused by the apoptotic mitochondria. The results also suggest while the last 25 residues of BAX
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can confer mitochondrial targeting to EGFP, this is greatly enhanced in the presence of
endogenous BAX.

Figure 7: EGFP tagged with C-terminus of BAX confers mitochondrial membranebinding properties in apoptotic cells.

(A) BAX-/- HCT116 cells were treated with or without 1 μM staurosporine for 1 hour and mitochondria
harvested. Another set of BAX-/- or BAX+/+ HCT116 cells were transfected with EGFP-BAX-CT and, after 48
hours, cells were lysed and the cytosol was incubated with non-apoptotic or apoptotic mitochondria in a test tube for
20 min. Mitochondria were than washed several times with 1M NaCl to remove peripherally associated proteins.
Mitochondrial protein content was analyzed by SDS-PAGE and immunoblotted with an anti-EGFP antibody and an
anti-Prohibitin antibody as a mitochondrial loading control. (B) BAX+/+ HCT116 cells were transfected with EGFP
or EGFP-BAX-CT and cells assessed for EGFP expression (green) by confocal microscopy. Mitochondria were
identifies by staining with anti-HSP60 antibody followed by a rhodamine-labeled (red) secondary antibody.
Apoptosis was induced by treatment with 1μM staurosporine for 1 hour. Diffuse cytosolic staining pattern was
observed in all non-apoptotic cells or cells expressing EGFP, while in apoptotic cells that expressed EGFP-BAX-CT
a punctate staining pattern was detected that largely overlaid with mitochondria (indicated by arrows).

To confirm that endogenous BAX was contributing to the binding of EGFP-BAX-CT to
mitochondria, we repeated the expression of EGFP-BAX-CT in BAX-/- cells and did not observe
the same degree of mitochondrial translocation that was evident when EGFP-CT-BAX was
expressed in BAX+/+ cells

(Figure 8).
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Figure 8: EGFP tagged with C-terminus of BAX does not confers mitochondrial
membrane-binding properties in cells lacking endogenous BAX.

BAX-/- HCT116 cells were transfected with EGFP or EGFP-BAX-CT and cells assessed for EGFP
expression (green) by confocal microscopy. Mitochondria were identifies by staining with anti-HSP60 antibody
followed by a rhodamine-labeled (red) secondary antibody. Apoptosis was induced by treatment with 1μM
staurosporine for 1 hour. Diffuse cytosolic staining pattern was observed in all non-apoptotic cells expressing EGFP
or EGFP-BAX-CT. In apoptotic cells that expressed EGFP-BAX-CT a minimal mitochondrial overlay was detected
(note lack of yellow overlay compared to Figure 6B).

These studies strongly indicated that the presence of endogenous BAX influenced the
distribution of the fusion protein, EGFP-BAX-CT. To determine whether EGFP-BAX-CT could
be in physical association with endogenous BAX, I performed a protein cross-linking
experiment. I co-expressed the non-apoptotic form of BAX (BAX-∆CT) with EGFP-BAX-CT in
BAX-/- HCT116 cells (Figure 8). The intense band of cross-linked EGFP-BAX-CT heterodimers
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at ≥64 kDa was more pronounced than the weak band of EGFP-BAX-CT monomers at 36 kDa.
This indicated that almost all detectable EGFP-BAX-CT could be cross-linked and coimmunoprecipitated with BAX-∆CT. Furthermore, this result strongly suggested that EGFPBAX-CT and BAX-∆CT were in physical association in heterodimeric complexes. This was not
the case with EGFP and BAX-∆CT (Figure 8). Note that this experiment was not performed in
the presence of either constitutively expressed wild-type BAX, because of its toxicity, or nonapoptotic endogenous BAX, since it would not have undergone apoptotic conformational
changes. The summary of my results suggests that the C-terminus of BAX attached to EGFP can
bind to structural elements exposed in the C-terminal deleted form of BAX-∆CT and form
heterodimeric complexes that have the ability to integrate into the mitochondrial membrane.

Figure 9: EGFP-BAX-CT forms heterodimers with BAX-∆CT.

BAX-/- HCT116 cells were transiently co-transfected with EGFP or EGFP-BAX-CT and BAXΔCT. After
24 hours, cells were treated with or without the crosslinker (DSS), lysed and combined cytosolic/mithochondrial
proteins lysates prepared. Protein lysates were immunoprecipitated with BAX antibody (rabbit polyclonal, Ab-4),
specific to an internal epitope. Immunoprecipitates were analyzed by SDS-PAGE and blotted for EGFP with antiEGFP antibody (mouse monoclonal). EGFP-BAX-CT/BAXΔCT dimers (approximately 64 kDA) were detected in
crosslinked samples from cells in which EGFP-BAX-CT and BAX-ΔCT were co-expressed. The* indicates nonspecific bands, the most prominent being the heavy chain of immunoglobulins.
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2.3.3 Intracellular Localization of BAX Controlled by α9 helix

Based on previous observations, I next wanted to examine the binding of the C-terminus
of BAX to structural elements within BAX itself. Based on the NMR structure (Suzuki et al.
2000), I knew that the C-terminus of BAX, encompassing α9 helix, self-associates in forward
directional orientation within the hydrophobic pocket. The association of the BH3 peptides
derived from BH3-only proteins BIM (Liu et al. 2003), BAD (Petros et al. 2000) and BAK
(Sattler et al. 1997) with BCL-XL deciphered by structural studies demonstrated that those
peptides associate with the hydrophobic pocket of BCL-XL in a reversed directional orientation.
Such findings suggest that occupation of the hydrophobic pocket plays a major role in the
regulation of the intracellular distribution of BCL-2 family members. To explore this possibility,
I used a computational approach, employing the docking web server GRAMM-X
(Tovchigrechko, Vakser 2005b;Tovchigrechko, Vakser 2006b), in order to determine where on
the surface of BAX would the α9 helix preferentially bind. The underlying concept for this
approach was that BAX would be computationally treated like a receptor and the C-terminal α9
helix would be its ligand.
We submitted the C-terminus-truncated structure of BAX (based on the NMR structure
(Suzuki et al. 2000)) and the structure of the C-terminal α9 helix for testing. By truncating the
C-terminus, I mimicked a form of BAX with an unoccupied hydrophobic pocket, which could
occur also upon exposure of the α9 helix during apoptosis. Figure 9A represents the overlay of
10 docking solutions resolved by GRAMM-X. It is evident from my results that the α9 helix of
BAX fits predominantly within the hydrophobic pocket. This implies that the association of the
α9 helix with the hydrophobic pocket is energetically the most favorable location for interaction.
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In the next step I resolved the individual docking solutions. As shown in Figure 9B, the soluble,
cytosolic form of BAX emerged. The α9 helix was bound into the hydrophobic pocket in the
forward orientation, characteristic of the self-associated form, but surprisingly this forward
orientation of binding was not the most energetically favorable docking solution. The reverse
orientation of binding was the most energetically favorable (Figure 9C). In this reverse
orientation lysine 189 of the α9 helix is in binding proximity to the acidic residue glutamate 69,
a conserved site in the α2 helix, and asparagine 73, in the hinge between the α2 and α3 helices.
Both these residues are found within the BH3 domain of BAX.

Figure 10: The helical C-terminus of BAX associates with the hydrophobic pocket of
BAX in two orientations.
(A) Overlay of 10 docking solutions derived from the GRAMM-X docking software for the binding of the
α9 helix on the surface of BAXΔCT. The α9 helix binds predominantly within the hydrophobic pocket formed by
helices 2,3,4 and 5. (B) The forward binding model of the soluble form of BAX results when the hydrophobic
pocket is occupied by its own C-terminal α9 helix – the helix is bound in the pocket in the forward orientation and
Lys189 is solvent exposed. (C) The more energetically favorable reverse binding model results when the C-terminal
α9 helix binds in reverse orientation in the hydrophobic pocket of BAX. In this orientation, the Lys189 is in binding
proximity to Glu69, a conserved site and Asp73 (not shown) within the BH3 domain.
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In order to establish the validity of the computational docking analysis, I compared the
outcome of these findings with other potential binding partners of BAX. Using the same
methods, I estimated the binding energies which resulted from interactions between the BH3
peptides of BIM, BAD, BAX and BAK with the hydrophobic pocket. A number of published
findings support such interactions (Bouillet, Strasser 2002;Cosulich et al. 1997;Kuwana et al.
2005;Shangary, Johnson 2002;Simonen et al. 1997).

The results of the computations are

summarized in Table 4. Negative numbers indicate more favorable binding energies, while
positive numbers indicate less favorable binding energies. The binding energies of different
BH3 helices, which were docked in more energetically favorable reverse directional orientation,
were compared to the α9 helix of BAX bound in the forward orientation that occurs during selfassociation. The results of computational docking suggested that most BH3 domains of the
BCL-2 family members, including that of BAX itself, would not bind to the hydrophobic pocket
of BAX because of the unfavorable interaction energy (Table 5), suggesting that BH3
interactions are not the primary mode through which these proteins could heterodimerize. The
only exception was that of the BH3 domain of BCL-2 (Table 5) that I did observe could coimmunoprecipitate (not shown) and therefore interact with BAX. The interaction between BAX
and BCL-2, but not for example the interaction between BAX and BAD or BAX and BIM, is
also supported by findings in the literature (Kuwana et al. 2005;Shangary, Johnson
2002;Simonen et al. 1997).
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Table 5: Analysis of BH3 peptides docked into the hydrophobic pocket of BAX.
IE represents the difference in the binding energy between the complex, where the peptide is docked in the
reverse orientation, and the complex, where the C-terminal of BAX is docked in forward orientation: IE =IEpeptideIEC-terminus BAX.

Peptide
CT BAX-KK
BAK BH3
BAX BH3
BAD BH3
BIM BH3
BCL-XL BH3
BCL-2 BH3

Sequence
VTIFVAGVLTASLTIWKKMG
QDASTKKLSECLKRIGDELD
ASTKKLSECLKRIGDELDSN
QRYGRELRRMSDEFVDSFKK
IWIAQELRRIGDEFNAYYAR
PMAAVKQALREAGDEFELRY
VPPVVHLTLRQAGDDFSRRY

IE (kcal/mol)
-52.0
420.8
707.2
375.4
267.1
259.0
-7.7

I observed that BAX could not interact with another BAX molecule through its BH3
domains (Table 5). However, hypothetically, BCL-XL could interact with the hydrophobic
pocket of BAX via its C-terminal end. Therefore, I used computational docking to evaluate the
possibility that C-terminal helices, rather than BH3 domains, interacted with the hydrophobic
groove.

Additionally, I also examined how different BAX C-terminal Lys189/190 mutants

bound in the reverse orientation within the hydrophobic pocket of BAX. Table 5 presents
calculations derived from comparing the helical C-terminus of wild-type BAX, bound in the
forward orientation to the hydrophobic pocket, to the binding of the α9 helices of BCL-XL,
BCL-2 and a wild-type or C-terminal mutant of BAX bond in the more energetically favorable
(negative ΔIE) reverse orientation. Note that the C-terminus of BCL-XL bound favorably within
the hydrophobic pocket, and that his observation is supported by previously published data
showing that BCL-XL can directly interact with BAX-∆CT (Hsu et al. 1997).
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Table 6: Analysis of C-terminal peptides docked into the hydrophobic pocket of BAX.
IE represents the difference in the binding energy between the complex, where the peptide is docked in the
reverse orientation, and the complex, where the C-terminal of BAX is docked in forward orientation: IE =IEpeptideIEC-terminus BAX. * - See Table 2

Peptide

Sequence

∆IE (kcal/mol)

CT BAX-KK
CT BCL-XL
CT BCL-2
CT BAX-DD
CT BAX-EE
CT BAX-QQ
CT BAX-RR
CT BAX-LL

VTIFVAGVLTASLTIWKKMG
FLTGMTVAGVVLLGSLFSRK
LLSLALVGACITLGAYLGHK
VTIFVAGVLTASLTIWDDMG
VTIFVAGVLTASLTIWEEMG
VTIFVAGVLTASLTIWQQMG
VTIFVAGVLTASLTIWRRMG
VTIFVAGVLTASLTIWLLMG

-52.0
-134.0
53.6
223.1
103.3
11.8
-75.1
51.0

Membrane
Binding*
Yes
Yes
Yes
No
No
No
Yes
Yes

Those Lys 189/190 mutations (Table 6) which did not cause spontaneous apoptosis had
unfavorable binding energies (positive ΔIE) within the hydrophobic pocket (negatively charged
residues). While those Lys 189/190 mutations which did cause spontaneous apoptosis had
favorable binding energies within the hydrophobic pocket (positively charged residues). The
only exception was a leucine 189/190 mutant, which showed unfavorable energy of binding
within the hydrophobic pocket (Table 6) but caused significant spontaneous apoptosis (Figure 5),
likely due to the increase in the hydrophobic content achieved because of the replacement with
leucines (Figure 7). The computational docking analysis suggested a mechanism that would
explain the results of my mutagenesis studies (Table 4) and EGFP-BAX-CT expression studies
(Figure 7). The binding of the α9 helix within the hydrophobic pocket seems to be modulated by
lysine 189 and 190. In the forward orientation, Lys 189 and 190 interact with the margin of the
hydrophobic groove and are partially solvent exposed. In the reverse orientation, Lys 189 and
190 interact with multiple residues within the hydrophobic groove. In this manner, Lys 189 and
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190 may regulate the membrane-binding activity of BAX, disputing a sole role for the α9 helix
as a transmembrane anchor.

2.3.4 Occupancy of the hydrophobic pocket by the α9 helix mediates the translocation of
BAX to membranes.

We next wanted to determine whether the more energetically favorable binding of the α9
helix in the reverse orientation to the hydrophobic pocket caused the displacement of the α9 helix
bound in forward orientation (as it occurs during self-association within BAX to retain the
soluble, cytosolic form) in order to promote the mitochondrial association of the protein. To
investigate this possibility, a peptide that incorporated last 20 residues of BAX (C-terminal α9
helix) was commercially synthesized. This peptide did not include the “hinge region” since it
was not tethered to a protein (as in EGFP-CT-BAX) but was a free, soluble peptide. I isolated
the cytosol containing endogenous BAX from BAX+/+ HCT116 cells and added the BAX Cterminal peptide. After a short incubation, this mixture was added to the mitochondria enriched
from BAX-/- HCT116 cells. Analysis of the samples by immunoblotting showed that under these
cell-free conditions BAX integrated into mitochondrial membranes only when preincubated with
the free BAX C-terminal peptide. In addition, I overexpressed BAX-∆CT in BAX-/- HCT116
cells. Recall that this mutant does not induce spontaneous apoptosis (Figure 5) or translocates to
the mitochondria (Table 3). When I incubated the cytosol of these cells with the BAX Cterminal peptide, BAX-∆CT now associated strongly with the mitochondria despite the lack of
its own α9 helix. These results implied that the truncated version of BAX had higher affinity
toward to the BAX C-terminal peptide and that the BAX C-terminal peptide bound to the
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hydrophobic pocket of BAX molecules in a manner that leads to the exposure of other membrane
binding domains (e.g. a transmembrane region formed by the α5, α6 helices as will be
discussed).

Figure 11: BAX C-terminal peptide, not BIM BH3 peptide, induces the translocation of
wild-type and C-terminally truncated BAX.

Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAXΔCT.
The cytosol was incubated for 30 min with 25 µM of BAX α9 peptide (20-mer) or a BIM BH3 peptide (25-mer).
The cytosol was then incubated with mitochondria, isolated from BAX-/- HCT116 cells (in buffer at pH 7.0) for 20
min, and mitochondria were washed several times with 1M NaCl to remove peripherally associated proteins.
Mitochondrial proteins content was analyzed by SDS-PAGE and immunoblotted with an anti-BAX antibody and an
anti-Prohibitin antibody as a mitochondrial loading control.

Having determined the effect of the BAX C-terminal peptide upon the membrane binding
of BAX, I next examined a BH3 peptide derived from BIM. Such BH3 peptides have been
routinely used in experiments with artificial lipid vesicles and isolated mitochondria to show the
effect of these peptides upon membrane insertion (Kuwana et al. 2005).

Using the same

experiment as described earlier, I demonstrated that the BH3 peptide of BIM did not cause the
mitochondrial translocation of BAX or BAX-∆CT (Figure 10). This observation coincided with
the results obtained by computational docking, which indicated that the BH3 peptide of BIM
does not interact with the hydrophobic pocket of BAX in an energetically favorable manner
(Table 6). Next, I wanted to test if the computational docking predictions also held true for the
BAX-LL mutant. This mutant is highly toxic, and it spontaneously translocated to the
mitochondrial membrane, causing apoptosis (Table 4, Figure 5).
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Figure 12: BAX-∆CT does not insert into mitochondrial membrane upon addition of
BAX-LL peptide.

Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAX-ΔCT.
The cytosol was incubated for 30 min with 25 µM of BAX α9 peptide (20-mer) or a BAX α9 peptide in which
Lys189/190 were mutated to leucines (BAX-LL, 20-mer). The cytosol was then incubated with mitochondria,
isolated from BAX-/- HCT116 cells (in buffer at pH 7.0) for 20 min, and mitochondria were washed several times
with 1M NaCl to remove peripherally associated proteins. Mitochondrial proteins content was analyzed by SDSPAGE and immunoblotted with an anti-BAX antibody and an anti-Prohibitin antibody as a mitochondrial loading
control.

The computational docking results implied that this mutant would not bind to the
hydrophobic pocket due to unfavorable binding energy. I repeated the experiment described
above, only this time I used a BAX C-terminal peptide in which lysine 189 and 190 were both
replaced by leucines. Even in the case of the truncated version of BAX (BAX-∆CT), the leucine
mutant peptide did not cause the mitochondrial insertion of BAX-∆CT. Hence, charged residues
located at positions 189/190 are essential for the BAX C-terminal peptide to promote the
mitochondrial integration of the protein. To explain our earlier results with BAX-LL (Figures 4,
5 and Table 4), recall that these involved expression of the full-length BAX mutant protein,
enabling it to translocate to membranes because of the increased hydrophobicity of the Cterminus. But these results did not suggest that increased hydrophobicity was the physiological
mechanism by which BAX normally moves to mitochondria.
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Computational docking implied that binding of the α9 helix in reverse into the
hydrophobic pocket occurs because of the presence of a positive charge at residue 69 (glutamate)
within the BH3 domain, suggesting that Lys 189 and Glu 69 could interact. In addition, a
residue in the hinge between the α2 and α3 helices, Asn73, could also interact with Lys 189. I
performed computational site-directed mutagenesis of Glu 69 with different amino acids. A
preliminary assumption would be that the mutation of Glu 69 into an amino acid with a positive
charge (e.g., lysine) would “repel” the incoming α9 helix. Simply two positive positioned
lysines back-to-back at the far end of its C-terminus could prevent any further conformational
changes of BAX and thus inhibit its incorporation in the mitochondrial membrane and
consequently apoptosis. However, computational mutagenesis suggested that the mutation of
glutamate 69 to lysine or arginine would actually results in a stronger binding of the α9 helix
within the hydrophobic pocket in the forward directional orientation as it occurs during the selfassociation (Table 5). This could prevent the release of the self-associated α9 helix to expose the
hydrophobic groove. Mutation of Glu 69 to aspartate would make the BH3 domain more “BCL2/BCL-XL like” (Table 7), resulting in the destabilization of the binding of α9 helix in the
forward orientation and probably result in faster release of the self-associated α9 helix
independent of apoptotic stimuli. Because of this information, I opted to mutate Glu69 in BAXΔCT and not in full-length BAX. The alternation of this conserved residue could affect the selfassociation of the C-terminus, creating a more toxic form of BAX or nonfunctional BAX. The
results of the mutations Glu69Arg and Asn73Arg are presented in the Figure 13. The
mitochondrial targeting mediated by BAX C-terminal peptide was impeded when Glu69 was
exchanged for positively charged Arg.

This impediment of the BAX peptide-induce
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mitochondrial translocation was further increased upon double mutation, in which the conserved
Glu69 was exchanged for positive Arg and Asn73 to Arg. These results significantly strengthen
the conclusion that the reverse orientation of binding of α9 helix to the hydrophobic pocket
regulates the mitochondrial integration of BAX and that this involves interactions between the
charged residues, Lys 189/190, in the α9 helix, and Glu69/Asn73 within the hydrophobic pocket,
confirming computational predictions.
Our computational and experimental results led us to the conclusion, that the C-terminus
of BAX (encompassing α9 helix) might function as a membrane anchor, but more importantly, it
is most essential for promoting the apoptosis by interacting in reverse orientation with the
hydrophobic pocket of adjacent BAX molecule, forming dimers and inducing conformational
changes that expose additional transmembrane domains, leading to mitochondrial integration.
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Table 7: Summary of the computational mutations of conserved glutamate 69.
IE represents the difference in the binding energy between the α9 helix and the hydrophobic pocket after
the mutation and before the mutation of Glu69. IE =E2-E1, IE – the interaction energy, E1 – the energy before
mutation, E2 – the energy after mutation

Mutation
E69A
E69R
E69N
E69D
E69C
E69Q
E69G
E69H
E69I
E69L
E69K
E69M
E69F
E69P
E69S
E69T
E69W
E69Y
E69V

Electrostatics
(kcal/mol)
388.5
307.0
379.2
446.7
399.4
364.4
391.7
390.7
386.4
389.3
307.5
380.3
396.6
655.9
401.1
399.5
392.2
392.2
389.1

Hydrogen bond
(kcal/mol)
-35.9
-37.1
-6.5
13.3
-35.8
-49.2
-20.3
-38.1
-40.8
-39.6
-136.9
-41.2
-15.8
-25.8
-48.7
-8.6
-2.4
-2.4
-35.8

Van der Waals
(kcal/mol)
5.9
17.3
-0.4
3.7
6.8
6.8
2.2
10.4
8.8
19.3
-2.3
6.5
13.6
27.2
7.4
22.7
14.8
14.8
7.8

IE
(kcal/mol)
-95.2
-158.8
-87.2
24.0
-82.3
-143.5
-80.9
-57.1
-103.0
-78.5
-319.2
116.5
-47.3
-16.8
-99.8
-12.2
-45.7
-46.7
-89.0

Figure 13: BAX-∆CT R69R73 does not insert into mitochondrial membrane upon
addition of BAX- peptide.

Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAX-ΔCT
E69N73, BAX-ΔCT R69N73 and BAX-ΔCT R69R73. The cytosol was incubated for 30 min with 25 µM of BAX
α9 peptide (20-mer) or a mutant BAX α9 peptide in which Lys189/190 were mutated to leucines (BAX-LL, 20mer). The cytosol was then incubated with mitochondria, isolated from BAX-/- HCT116 cells (in buffer at pH 7.0)
for 20 min, and mitochondria were washed several times with 1M NaCl to remove peripherally associated proteins.
Mitochondrial proteins content was analyzed by SDS-PAGE and immunoblotted with an anti-BAX antibody and an
anti-Prohibitin antibody as a mitochondrial loading control.
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2.3.5 BAX responds on the changes in pH.

My results in the previous sections established that lysine 189 and 190 are important
mediators of intracellular localization of BAX, promoting mitochondrial membrane binding.
Based on these observations I wanted to study possible physiological processes that could be
involved in facilitating the movement of BAX to membranes. Previous work by Khaled et al.
demonstrated that changes in the intracellular pH are common features in the cytokine dependent
cell lines (Khaled et al. 1999). Briefly, during death induced by cytokine withdrawal in an IL-7dependent pro-T cell line (D1) or an IL-3-dependent pro-B cell line (FL5.12A), there was a
transient rise of intracellular pH above 7.8 several hours after cytokine removal. This rise in pH
coincided with the translocation of BAX to mitochondria. Treatment with inhibitors of the
sodium-hydrogen exchanger (NHE) or p38 MAP kinase inhibited alkalinization inhibited the
alkalinization process, indicating that these proteins were involved in mediating the change in
intracellular pH (Khaled et al. 1999). I observed that this same transient alkalinization also
occurred in BAX+/+ or BAX-/- HCT116 cells within 30 minutes to one hour of staurosporine
treatment (Figure 13A). Intracellular pH changes were measured by detecting the pH-sensitive
changes in EYFP fluorescence. Engineered mutants of EGFP that exhibit pH-dependent
absorbance and fluorescence emission properties are commonly used for the measurement of pH
changes within cells and cell organelles (Demaurex 2002;Llopis et al. 1998;Matsuyama et al.
2000;Wachter et al. 1998). Furthermore, Khaled et al. previously observed that BAX
translocation to the mitochondria could be controlled by manipulating pH levels (Khaled et al.
1999). A similar experiment is shown in Figure 14B. The translocation of BAX was regulated
by inducing or inhibiting alkalinization.

Intracellular pH in staurosporine-treated BAX+/+
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HCT116 cells was fixed at pH 7.2 with the ionophore, nigericin, in high K+ buffers, preventing
the mitochondrial translocation of BAX. These results indicated that changes in cytosolic pH
could affect the movement of BAX to the mitochondria. I observed that the rise in pH could
induce the translocation of BAX and neutral pH could prevent it.

A.

B.

Figure 14: The intracellular distribution of BAX depends on pH.
(A) BAX-/- or BAX +/- HCT116 cells, expressing pH-sensitive deYFP vector, were treated for 1 hour with
1µM staurosporine and intracellular pH measures by detecting changes in the EYFP fluorsence by flow cytometry
against a previously established calibration curve. Staurosporine treatment induced a transient alkalinization that is
independent of the presence of BAX. (B) BAX+/+ HCT116 cells were cultured with or without 1µM staurosporine
and permeabilized with 1 µM nigericin in a high K+ buffer at pH 7.2 or 7.8 for 30 min. Mitochondrial lysates were
prepared and BAX and Prohibitin (mitochondrial loading control) assayed by immunoblotting. Alkaline pH induces
the mitochondrial translocation of BAX, while neutral pH prevents it. The ratio of BAX to the control protein
Prohibitin was determined by densitometer.

2.3.6 Alkalinization Alters Mitochondrial Physiology

BAX translocates to the mitochondrial membrane during apoptosis or upon exposure to
alkaline pH in healthy cells. The question is: how does alkaline pH mediate the translocation of
BAX to mitochondrial membranes? Alkalinization may disrupt weak hydrogen bond interaction
between the C-terminal lysine 189 in the α9 helix when it is bound in the forward orientation
within the hydrophobic pocket, leading to local conformational changes which destabilize the
helix, exposing the hydrophobic pocket. This could also be initiated by the presence of lipid
membranes (Yethon et al. 2003). My experiments performing targeted mutagenesis of lysine
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189 and 190 could not mimic the subtle effects that intracellular alkaline pH could have on
hydrogen bond interactions. However, the observation that an intact positive charge at position
189 was required for apoptotic activity (Table 5) indicated that a positive charge at the distal end
of the C-terminus is required for the membrane association. Thus an alternative explanation is
that alkalinization may have a more pronounced effect by disrupting membrane dynamics and
facilitating the insertion of BAX.

To explore this possibility, I designed experiments to

determine whether the affinity of mitochondria toward BAX changed with pH.
Because previous experiments showed that intracellular pH rises within 30 minutes to 1
hour after the staurosporine treatment, I wanted to determine if EGFP-BAX-CT responded to
mitochondrial changes caused differences in pH. A similar experiment was performed with
apoptotic mitochondria and showed that apoptotic mitochondria attracted more BAX (Figure
7A).

To examine pH-dependent effects, I used non-apoptotic mitochondria from BAX-/-

HCT116 cells, which were exposed to conditions that equilibrated intracellular pH at 7.2 and 7.8.
The equilibration of intracellular pH was achieved by exposing BAX-/- HCT116 cells to high K+
buffer at pH 7.2 or 7.8 with the potassium ionophore, nigericin. The isolated mitochondria were
then incubated with cytosol from BAX+/+ HCT116 cells transfected with EGFP-BAX-CT. The
results showed that EGFP-BAX-CT preferentially associated with mitochondria exposed to an
alkaline environment (Figure 15).
To confirm this finding, I inspected the ability of EGFP-BAX-CT to associate with
mitochondria in alkalinized cells in experiments similar to ones performed with staurosporine to
induce apoptosis (Figure 8). As was shown in Figure 14A, alkalinization occurs as a result of
staurosporine treatment. EGFP-BAX-CT was mostly diffused throughout the cytosol of BAX+/+
HCT116 cells equilibrated at pH 7.2, while cells at pH 7.8, a pronounced punctuate pattern was
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observed (Figure 15A). The staining overlaid with mitochondria marker HSP60, suggesting that
the attachment of the last 25 amino acids of BAX C-terminus to EGFP conferred mitochondrial
membrane binding upon intracellular alkalinization. In BAX+/+ cells exposed to pH 7.2 as a
control also indicated a small amount of mitochondrial overlay. This was expected because the
C-terminus of BAX enabled some tagged EGFP to bind to mitochondria (Figure 16A).
However, this process was significantly enhanced by alkalinization.

These results, though

preliminary, suggest that that during apoptosis, intracellular alkalinization is an important
physiological event that alters the mitochondrial membrane and facilitates the movement of
BAX. Whether this occurs by enabling the release of the self-associated α9 helix from the
hydrophobic groove remains to be determined.

Figure 15: EGFP-BAX-CT preferentially associates with alkalinized mitochondria.

BAX-/- HCT116 cells were equilibrated to pH 7.2 or pH 7.8 by treatment with nigericin for 30 min and
mitochondria harvested. Another set of BAX+/+ HCT116 cells were transfected with EGFP-BAX-CT and, after 48
hours, cells were lysed and the cytosol harvested by high speed centrifugation. The EGFP-BAX-CT containing
cytosol was incubated with neutral or alkaline mitochondria in a test tube for 20 min and than the mitochondria were
washed several times with 1 M NaCl to remove peripherally associated proteins. Mitochondrial protein content was
analyzed by SDS-PAGE and immunoblotted with an anti-EGFP antibody and an anti-Prohibitin antibody as a
mitochondrial loading control.
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Figure 16: EGFP-BAX-CT displays different staining pattern in the presence than in the
absence of endogenous BAX upon alkalinization.

BAX+/+ and BAX-/- HCT116 cells were transfected with EGFP-BAX-CT and, after 48 hours, equilibrated to
pH 7.2 or pH 7.8 by treatments with nigericin for 30 min. Cells were assessed for EGFP expression (green) by
confocal microscopy. Mitochondria were identified by staining with anti-HSP60 antibody followed by a rhodaminelabeled (red) secondary antibody. A diffuse distribution of EGFP-BAX-CT was observed at pH 7.2, with increased
aggregation EGFP-BAX-CT at pH 7.8 which substantially overlaid with mitochondria suggestion mitochondrial
membrane binding. More EGFP-BAX-CT associated with alkalinized mitochondria in BAX+/+ cells than BAX-/cells.

2.4 Discussion

In response to an apoptotic signal, BAX translocates from the cytosol to the
mitochondria. This translocation is thought to be connected with significant conformational
changes and dimerization (Antonsson et al. 2000;Antonsson et al. 2001;Suzuki et al. 2000), but
the mechanism is still poorly understood.
The C-terminal α9 helix of BAX is in literature mostly designated as putative
transmembrane domain that anchors the protein in membranes (Annis et al. 2005;Antonsson et
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al. 2000;Antonsson et al. 2001;del Mar et al. 2001) . In the absence of C-terminal α9 helix,
BAX does not translocate to mitochondria (Annis et al. 2005;Antonsson et al. 2000;Antonsson et
al. 2001). The α9 helix of cytosolic BAX is buried in the hydrophobic pocket as demonstrated by
NMR (Suzuki et al. 2000). My computational mutations of the residues within α9 helix
demonstrated that lysine 189/190 is an important residue that mediates the binding of the α9
helix with the hydrophobic pocket. Computational results confirmed the findings from
mutagenesis and mitochondria translocation experiments, showing that the presence of two
positive charges at the distal end of C-terminus is necessary for the appropriate subcellular
distribution of BAX and its translocation to mitochondria during apoptosis. Additional
computational docking results suggested that the C-terminal α9 helix of BAX is not necessarily a
putative transmembrane domain as others have suggested. Computational docking predicted that
the α9 helix would associate in a reversed direction within the hydrophobic pocket of adjacent
BAX molecules that resulted in a more energetically favorable interaction. This is in comparison
with the less energetically favorable forward orientation that occurs during self-association of the
α9 helix within the hydrophobic pocket. The activation and predicted dimerization of BAX
would thus be dependent on the occupancy of the hydrophobic pocket by the α9 helix and not by
the BH3 domain as the prevailing dogma states. In support of this assumption, peptide mimics of
the α9 helix caused the translocation of wild type BAX and, importantly, the translocation of Cterminally truncated BAX – BAX deficient of its putative transmembrane C-terminal domain.
The same effect was not observed by adding the free BH3-only BIM peptide. The peptideinduced mitochondrial translocation of BAX C-terminal mutant was inhibited by the mutation of
Glu69/Asn73, conserved residues in the hydrophobic pocket that are in binding proximity of
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Lys189 when the α9 helix was bound in the reverse orientation. Mutations of residues in the Cterminus that abrogated the mitochondrial translocation of BAX further strengthened the
hypothesis, which states that the C-terminal α9 helix is the crucial regulatory domain in BAX
that is responsible for the translocation and induction of conformational changes, dimerization
and/or mitochondrial membrane insertion.
The model proposed states that the C-terminal α9 helix of BAX is not putative
transmembrane domain but is rather the mediator of membrane-binding conformational changes
and dimer formation. In response to apoptotic stimuli, the forward-bound, self-associated α9
helix is released from the hydrophobic pocket. This enables the binding of the α9 helix from
neighboring BAX molecules in the energetically more favorable reverse orientation within now
exposed hydrophobic pocket. This results in the exposure of a novel transmembrane domain and
the formation of dimers that permeabilize mitochondria and cause the release of the apoptogenic
factors. The C-terminal α9 helix thus regulates the subcellular localization of BAX. My findings
imply that the orientation and the type of peptide bound in the hydrophobic pocket of BAX direct
the subcellular distribution of the protein, retaining the soluble form of BAX in the cytosol or
inducing the lethal membrane-bound form.
The importance of the C-terminal helix in the regulation of BAX’s apoptotic activity has
parallels in the structural studies performed with the anti-apoptotic proteins, BCL-W and BCLXL. Examination of the structure of BCL-W demonstrated that the C-terminal α9 helix of BCLW is released during apoptosis by accommodating the BH3 domain of BIM (Denisov et al.
2003). The occupancy of the hydrophobic pocket is thought to regulate the pro-apoptotic activity
of BCL-W (Hinds et al. 2003). Similarly, the intracellular distribution of BCL-XL is regulated
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by the occupancy of the hydrophobic pocket by its C-terminal helix (Jeong et al. 2004). The
exchange of the C-terminal helices between two adjacent BCL-XL molecules led to the
formation of dimers and the cytosolic retention of BCL-XL, consequently modulating the antiapoptotic activity of this protein.
The prevailing dogma states that the pro-apoptotic function of BAX is modulated though
its interaction with BH3 domains of other BCL-2 family members (Borner 2003;Gross et al.
1999). This dogma was supported by studies which showed that BH3 peptides derived from BID
or BIM triggered the pore forming abilities of BAX, leading to the permeabilization of lipid
vesicles (Kuwana et al. 2005). Also, detergent treatment induced BAX-BIM association (Marani
et al. 2002). Yet oligomeric complexes of BAX with BH3-only proteins have not been described
(Wei et al. 2000), nor has BAX bound to BH3-only proteins been isolated from the apoptotic
cells (Zhu et al. 2004). BAX was also able to translocate to the mitochondria of the cells
deficient in the BH3-only proteins BIM and BAD, demonstrating that the redistribution of BAX
occurs independently of these BH3-only protein (Ekert et al. 2006).
My study suggests that the activation of BAX is not necessarily mediated by interactions
with BH3-only proteins, but rather by occupancy of the hydrophobic pocket with the C-terminal
α9 helix – a process that can suppress or facilitate the exposure of additional membrane-binding
domains. This finding resolves the controversy as to which domain(s) of BAX is required for
membrane integration. The C-terminal with its α9 helix is necessary for BAX to associate with
the mitochondria, since the deletion of this domain retained BAX in the cytosol. However, in the
absence of a directly attached α9 helix, but in the presence of free peptide mimics of the α9
helix, I demonstrated that BAX-ΔCT could associate with mitochondria. Thus BAX could
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contain other transmembrane domains. These domains may not be exposed unless the
hydrophobic pocket is occupied by the α9 helix in the more favorable reverse orientation. The
most likely candidates for the membrane-binding domain exposed by occupancy of the
hydrophobic pocket are helices α5 and α6, which others have shown can form a hairpin (GarciaSaez et al. 2005;Garcia-Saez et al. 2006). The peptides derived from the sequences of helices α5
and α6 could induce large-sized pores in artificial lipid vesicles (Garcia-Saez et al. 2006). A
study of the topology of BAX demonstrated that helices α5 and α6, as well α9, insert into the
mitochondrial membrane in a stepwise manner (Annis et al. 2005;Suzuki et al. 2000). The
question remains how the binding of helix α9 in reverse orientation to the hydrophobic pocket
promotes the exposure of helices α5 and α6. One could hypothesize that a release of selfassociates helix α9 and docking of adjacent helix α9 induces enough stress to cause the
deformation of the hydrophobic pocket and exposure of additional membrane spanning domains.
NMR structure of BAX indicates that α5 is a central helix of soluble BAX, buried deeply within
the protein (Suzuki et al. 2000). The exposure of this helix would thus require significant
structural rearrangement.
The findings presented further suggested that Lys189/190 and conserved residues within
BH3 domain, Glu69 and Asn73, were critical for the regulation of the subcellular localization of
BAX. A basic amino acid was required at the position 189/190, at the distal end of helix α9, in
order for BAX to associate with mitochondrial membranes and induce apoptosis. Attaching last
25 amino acids of BAX, which encompasses helix α9, to EGFP conferred mitochondrial
targeting to a cytosolic protein, mimicking the behavior of BAX during apoptosis. Studies of the
C-terminal domains of other BCL-2 family members demonstrated that a transmembrane domain
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flanked by basic amino acids could function as a targeting signal for mitochondria (Antonsson et
al. 2000), if this domain was long enough . I observed that the replacement of Lys189/190 with
leucines generated very potent mutant that spontaneously interacted with mitochondria and
induced apoptosis. These results indicated that by increasing the hydrophobicity of the helix α9,
I could turn the helix α9 into a potent transmembrane domain. However, these findings also
support the alternative function of helix α9 of BAX, where conserved acidic residue Glu69 plays
important role. Computational docking suggested that Glu69 and Asn73 at the wedge of the
hydrophobic pocket could interact with Lys189/190 in the helix α9, creating hydrogen bond
interactions that anchor the helix α9 within the pocket. Results from our mutagenesis studies
indicated that replacement with uncharged or acidic residues abolished this interaction, while
replacement by basic residues sustained it. Likewise, I showed experimentally that replacement
of Glu69 and Asn73 with basic residue abolished the capacity of free BAX C-terminal peptide to
induce conformational changes needed for the membrane association of BAX, lacking its helix
α9.
My results demonstrated that the C-terminal helix α9 is necessary for the regulation of
the activity of BAX, not as membrane anchor, but rather by binding in reverse orientation to a
hydrophobic pocket of adjacent BAX molecule to form membrane-binding dimers. Hence the
self-association or binding of the helix α9 in the forward orientation is functionally different
from binding in reverse; the former sequesters BAX in the cytosol while the latter promotes
membrane binding and dimerization.
I speculate that the initial exposure of the hydrophobic pocket could occur during the
transient alkalinization that occurs at the early stage of apoptosis. Khaled et al. previously
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reported that apoptotic stimuli induced a transient alkalization of the cytosol in the cytokine
dependent cell lines and caused the translocation of BAX (Khaled et al. 1999). Others have also
shown that the translocation of BAX to the mitochondrial membrane is associated with cytosolic
alkalization (Belaud-Rotureau et al. 2000;Kim et al. 2003;Lagadic-Gossmann et al. 2004;Tafani
et al. 2002).

I observed that HCT116 cells also alkalinized upon staurosporine treatment

independent of the presence of BAX. By the manipulation of intracellular pH, I demonstrated
that alkalinization could promote the mitochondrial localization of BAX as well as that of EGFPBAX-CT. Maintaining a neutral pH in apoptotic cells prevented the movement of BAX to the
mitochondria (Khaled et al. 1999).
Despite the fact that some physiological data support the motion that BAX is pHresponsive, there is no structural data available that demonstrates that significant conformation
changes are triggered by an alkaline pH.

An NMR study of BAX did not indicate any

conformational changes between pH 6-8 (Suzuki et al. 2000).

However, epitope-specific

antibodies, which recognize buried epitopes only in the apoptotic cells, did recognize these same
epitopes in cells with an alkaline cytosol (Cartron et al. 2004;Khaled et al. 1999). Alkaline
conditions also caused increased sensitivity of BAX to protease digestion, suggesting that pH
induces a more relaxed conformation and exposes hidden epitopes (Khaled et al. 1999). The
important difference between later experiments and the NMR study is that the NMR information
was acquired in the absence of lipids. Other results were derived in the presence of both BAX
and mitochondria or lipid vesicles. This is an important piece of information because it is well
documented that BAX undergoes conformational changes in the presence of lipids (Annis et al.
2005;Antonsson et al. 2000;Yethon et al. 2003). In support, I was able to demonstrate that the
affinity of mitochondria for BAX changes upon alkalinization. Alkalinized mitochondria were
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able to bind BAX as well EGFP-BAX-CT from the cytosol of non-apoptotic cells in a manner
similar to that observed with apoptotic mitochondria. Intracellular pH, through its effects upon
mitochondria, can be an important mediator of the conformational changes of BAX in the
presence of lipids.
The influence of an alkaline pH on the mitochondrial membrane physiology remains
speculative. A piece of supplementary data not shown was that the affinity of a free C-terminal
BAX peptide to lipid vesicles increased with an alkaline pH, suggesting that lipids could be the
pH sensitive component (Tschammer et al. 2007b). pH gradients across a lipid bilayer can affect
the diffusion and distribution of individual lipids, sequester some lipids, and induce increased
lipid bilayer assimetry (Hope, Cullis 1987). Increasing evidence exists that BAX can induce the
rate of lipid diffusion across a bilayer and move the cardiolipin from the inner to the outer
mitochondrial membrane (Epand et al. 2003). Recently, BAX was also found to mediate the
fusion and fission of mitochondria (Karbowski et al. 2006;Karbowski et al. 2002).
My experiments demonstrated that the C-terminal α9 helix is necessary for the proapoptotic function of BAX, not as a membrane anchor, but as the domain which interacts with
the hydrophobic groove of adjacent BAX molecules. This interaction can occur in two different
orientations: (1) binding in the reverse directional orientation within the hydrophobic pocket of
adjacent molecules, and (2) binding in the forward that occurs during self-association. The
forward orientation inhibits the pro-apoptotic function of BAX by sequestering the protein in the
cytosol, while the reverse orientation initiates conformational changes, mitochondrial membrane
integration and subsequent apoptosis. This process seems to be enhanced by transient
alkalinization of the cytosol, which increases the affinity of the mitochondrial membrane for
BAX.
59

3 HELICAL INTERACTION ENERGY DISTRIBUTION IN
TRANSITIONAL PROTEINS
3.1 Introduction

New developments in biotechnology resulted in an information explosion derived from
numerous eukaryotic sequencing projects and the subsequent gains in post-genomic research,
including novel structural studies and new discoveries in protein–protein interactions. One tool
that plays an important role in predicting structural and functional properties of the increasing
number of newly identified and characterized proteins is molecular modeling (Schlick 2006).
Because modeling predictions are based on existing data, they must be refined whenever new
and more detailed structures or relationships are available. Homology modeling (Rodriguez et al.
1998), threading techniques (Lu et al. 2003;McGuffin, Jones 2003), hidden Markov models
(HMMs) (Eddy 1996;Karplus et al. 1998) and secondary structure prediction using neural
networks (Lin et al. 2005) are only few examples of the structure-function predictions. A
drawback with these systems is that most models consider proteins as static objects, despite the
obvious fact that many proteins (e.g. signaling proteins) are highly dynamic and undergo
significant conformational changes upon execution of their function. The structural dynamics of
proteins can be thus depicted as a continuum with proteins characterized by very rigid structures
at one end and highly dynamic proteins at the other end. The dynamic nature of proteins
structure is important for many biological processes ranging from signaling events to enzymatic
activity. Changes in the protein structure can occur locally, for example within the active site,
where minute changes in the side chain position become complementary to the transition state
(Keough et al. 2005), or globally, where unstructured proteins adopt a well-defined three
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dimensional (3D) structure upon the formation of a protein complex (Demarest et al. 2002).
Although critically necessary to elucidate protein function, a method for probing the ability of
the protein to undergo transitions is not currently available.
The motivation for undergoing a computational examination of protein transitioning
originated in my studies on the pro-apoptotic protein BAX (Chapter 2), which is known to
undergo significant structural transitions in response to apoptotic stimuli. Analyzing the
interaction energy forces at the interface of the helices within the all α-helical bundle of BAX, I
sought to develop a measurable parameter that would describe the ability of such proteins to
undergo transitions.
Using the 3D structure of BAX, I initially studied the helix interaction energies of the
carboxyl-terminal region of BAX (known as the α9 helix) in an attempt to understand the role of
this C-terminal region in the regulation of subcellular distribution of BAX and its apoptotic
activity. We determined that the interaction of the α9 helix with an internal hydrophobic pocket
could explain how BAX transitions from a soluble cytosolic protein to a membrane associated
protein that appears to undergo dimerization as described in the findings presented in Chapter 2
(Tschammer et al. 2007b). However, the initiating events that enable interactions between the α9
helix and the hydrophobic pocket of BAX remained indefinable. In an attempt to elucidate the
initiating events, we measured the helical interaction energies of all helices within the BAX to
better understand the static packing arrangement of the helices across the entire 3D structure.
Our results indicated that BAX displays significant variation in helical interaction energies (IEs)
that may explain its ability to undergo structural transitions during apoptotic signaling events.
To test the hypothesis that a significant variation in helical interaction energies correlates
with biological function, we randomly selected coordinate sets for proteins from the Protein Data
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Bank (PDB) that were structurally similar to BAX to serve as controls in our calculations. These
proteins were meant to weigh the level of variation of helical interaction energies within protein
structures in the all alpha class. Our results demonstrated that a significant number of proteins
involved in DNA binding, viral invasion, transcription regulation, and other cellular signaling
events also have a significant variation in helical packing energies, while those proteins that are
known not to be transitional do not share this property. These results indicate that a measure of
propensity for transition may be afforded by analysis of the static structures based on the
statistical distribution of helical interaction energies within a well defined 3D structure.

3.2 Material and Methods
3.2.1 Structures

The 3D structures of proteins were obtained from the RCSB Protein Data Bank
(http://www.rcsb.org/pdb). The ensemble of coordinates representing the NMR structure of
BAX (PDB ID: 1F16) (Suzuki et al. 2000) was grouped into a conformationally related
subfamily using the NMRClust program (Kelley et al. 1996b). The most populated group was
used for one set of calculations (based on the statistics of the program) and a statistically distinct
group was used for another set of similar calculations. Based on the statistical deviation of helix
packing energies between these groups, our control proteins were primarily chosen from
structures determined by x-ray crystallography. When NMR structures were used, the most
populated group (as determined by the NMRClust program) was used for the analysis. The
selection criteria for our randomly chose set were as follows: a) under 300 amino acids in length,
b) belonging to the all alpha class, c) containing similar number of helices (ranging from 3-16),
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d) no co-factors such as ions or disulfides that might stabilize the proteins´s 3D fold, e) contained
a single peptide chain, and f) determined by x-ray crystallography. These selection criteria were
input into the PBD´s database search engine and resulted in 153 proteins that contained regions
of beta-strands, disulfides, and stabilizing co-factors. Additionally, some coordinate sets were
missing regions of the structure that prohibited their analysis. These were rejected from our test
set and the resulting number of structures available for analysis was found to be 74. Our results
as based on 53 (72%) of these available structures.
The graphic images were produced by PyMol v0.99 (DeLano Scientific, California).

3.2.2 Energy Calculations

In determining the level of calculations to perform a number of factors was considered.
Although QM/MM methods have become popular due to their accuracy they are computationally
expensive and are primarily used for active site analysis and reaction profiling (Cheng et al.
2005). Methods capable of simulating proteins side-chain flexibility using Monte Carlo
minimization are also available (Meiler, Baker 2006) and molecular dynamics simulations have
been shown to be reliable in evaluating protein-peptide interaction energies in dynamic systems
(Bartels et al. 2005). However, this study deals with the direct measurements of static structures,
achieving results on 53 independent coordinate sets that had an average of 8 helices each, which
required calculations for the helix alone, the helix in complex with the protein, and the protein in
the absence of the helix. Based on this criteria, the use of molecular mechanics (MM3) force files
with directional hydrogen bonding potentials was chosen to evaluate the static interaction energy
(Lii, Allinger 1998b). These values are presented as relative interaction energies due to the
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understanding that calculations completed with different force files potential will result in
different energy values. Calculations were performed in vacuo, disregarding an explicit
water/membrane environment, which would result in substantially lower energy values due to
entropic factors. Only the forces at the interface of each helix were considered in the
calculations.
The calculations were performed using the BioMed Cache 6.1.10 program (Fujitsu
America, Inc., Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were
performed using parameters as described in the literature. Separate energy calculations were
performed for: (1) the entire protein (no helices removed), (2) the entire protein, but the
investigated helix removed, and (3) the helix only. The energy of each molecule was calculated
until convergence (energy minimization) was reached. Energy terms included Van der Waals,
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked, except
protons were allowed to move during the calculations. This was done to ensure that no changes
in the atomic positions (other than protons) or bond characteristics would occur during the
calculations relative to the original coordinates in PDB file. A conjugated gradient was used to
locate the energy minimum. Van der Waals interactions between atoms separated by more than
9.0 Å were excluded. The interaction energy (IE) was estimated through separate determinations
of the energy of the complex (Ecomplex), complex without the investigated helix (Ecomplex w/o helix-n)
and helix alone (Ehelix-n), and by taking the difference between these terms (IE=Ecomplex-(Ecomplex
w/o helix-n

+Ehelix-n)). This difference in the relative energies terms provides the interaction energy

(IEhelix-n) at the interface of each helix being investigated with respect to the entire structure using
the MM3 potential.
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3.2.3 Protons and Ionization States

Because the proton positions are not available in structures determined by x-ray
crystallography, I edited each structure individually to ensure the proper location of hydrogen
atoms. This required adjustment in ionization states for individual amino acids in each protein.
The following guidelines were used for the setting of the ionizations states of the individual
amino acids: (1) cysteines were protonated, (2) glutamate and aspartate side chains had the
oxygen farthest from the backbone of the helix investigated assigned a formal negative (-1)
charge, (3) lysine side chains had a formal positive (+1) charge on the terminal amine, (4)
arginine side chains were assigned a positive (+1) charge on the nitrogen farthest from the
backbone of the helix investigated, (5) the new N-termini (generated upon removal of the helix
of the protein) for the both the protein (without the helix) and the helix itself was given a formal
positive (+1) charge, and (6) the new C-termini was changed to an aldehyde functional group (no
charge). For structures determined by NMR, the experimentally determined proton positions
were used for energy minimization.

3.2.4 Statistical Analysis

The IEhelix-n values for each helix were tabulated as shown in Table 7. The average (AVE)
helical interaction energy values are shown and provide a measure of the overall stability of the
helices within the protein structure. The standard deviation (SD) values are calculated to measure
the statistical variation of all helices within the entire 3D structure. Because different molecular
mechanics potential functions yield variable interactions energies based on the force fields
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employed, I propose that the absolute value of the variation over the average (|SD/AVE|)
provides a general statistical representation of the distribution of helical interaction energies that
should be independent of the force field potential used for the calculations. Based on the
distribution of |SD/AVE| values observed, it is apparent that proteins that are known to undergo
transitions based on experimental evidence have larger |SD/AVE| value compared to those that
do not undergo transitions. Although no formal cut-off value can be assigned based on the
proteins used in this study, it is clear that the |SD/AVE| values can serve as a measure of the
propensity for transition, which is similar to the Random Coil Index (RCI) (Berjanskii, Wishart
2005) and probabilistic scores (based on pair-wise energy profiles) (Dosztanyi et al. 2005) used
to assign random coil regions and intrinsically unstructured proteins.

3.3. Results and Discussion
3.3.1. Variation of helical IE values within each structure

In an attempt to understand the transitional mechanism of BAX, I hypothesized that the
propensity for transition has to be evident from the packing of the helices in 3D structure. The
calculation of the interaction energy values at the interface (IE) for all the helices in the protein
showed that the IE values were widely dispersed. Lacking a basis for comparison, I could not
estimate whether this was common for most proteins or specific for BAX. In order to make an
impartial evaluation, I randomly selected the proteins that were in the same structure class and
had similar molecular properties. This randomly selected set provides values for 72% of the
available proteins within the PDB that were comparable to BAX. After the analysis of IE values
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and ranking of the proteins by |SD/AVE| values, the correlation between the dispersion of IE
values and the property of the protein to undergo transition emerged. Proteins that undergo
structural transitions have more dispersed IE values compared to the proteins which do not
undergo structural transitions (Table 8, Figure 17).
The interaction energy values for all of the helices of protein phosphatase 5 (1A17) (Das
et al. 1998), phospholipase-C (1AH7)(Hough et al. 1989), and retinoblastoma tumor suppressor
(1AD6) (Kim, Cho 1997) were negative, representing favorable interaction energies. The
average and standard deviation of the interaction energies established that the stability is evenly
distributed across the entire structure. The ratio |SD/AVE| for all three of these proteins was
found to be 0.65, 0.73, and 0.94 for protein phosphatase 5, phospholipase-C and retinoblastoma
tumor suppressor, respectively (Table 9). In contrast, the IE values of BAX (1F16) (Tschammer
et al. 2007a) are not evenly distributed across the 3D structure. The core helix of BAX helix 5
had an IE of -405,14 kcal/mol. The average IE value was -40.57 kcal/mol, indicating a favorable
overall stability, but the ratio |SD/AVE| was 3.90, indicative of widely dispersed IE. These
values demonstrated an uneven distribution of helical interaction forces within the stable 3D
structure of BAX, which may elucidate its ability to undergo structural transitions related to its
apoptotic activity.
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Figure 17: Non-transitional proteins have less variability in helical stability.
Ribbon diagrams of non-transitional proteins and BAX as the representative of transitional proteins. The
color codes correspond to: blue – the most stable, green – stable, yellow – less stable, orange – unstable, red – very
unstable. As shown in the figure, the topology of the helices within the structures is similar, but the distribution
energies are not. Notably BAX has more unstable helices the structure compared to phospholipase C, PF27 and
FIS1.

No correlation appeared to exist between the helix length (and the corresponding number
of amino acids capable of interactions) and the interaction energy values (Table 9). As shown in
Equation IE=Ecomplex-(Ecomplex w/o helix-n +Ehelix-n), the numbers of atoms are the same (or corrected
for) in comparing the bound helix compared to the helix alone and the protein without the helix
present. My interpretation of these results is that the IE values represent a relative measure of
the static interaction forces based on: a) the type of interactions (van der Waals, electrostatics,
and hydrogen bonding) and b) the number of interactions that each helix is capable of making
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within the protein structure. This indicates that the forces involved in stabilizing a 3D structure,
or permitting a structural transition, are inherent to the forces involved at the interface and cannot
be understood based on visual inspection of such properties as helix length and/or the number of
helices within the structure.
Table 8: Statistical data on helix stabilities.
The entire set of randomly selected proteins (including BAX) used in this study sorted by |SD/AVE| in
descending order. At the top of the list are proteins involved in apoptosis, cellular signaling, DNA binding and
cellular toxicity which are known to undergo 3D structural transitions and at the bottom of the table are enzymes and
other proteins that are not involved in such transitions. The BAX protein (model 20) shows the highest |SD/AVE|
ratio and represents the statistical variation of helical interactions within the deposited NMR ensemble, while BAX
(model 1) was from the most populated cluster of the ensemble (see METHODS). Proteins that are involved in
membrane interactions are shown in italic and show moderate |SD/AVE| values that may reflect their mechanism of
transition being controlled through significant hydrophobic contact during their structural transitions.
SD Helix
Energy
(kcal/mol)
142.46
102.81
117.81

⎜SD/AVE⎜

Pro-apoptotic protein
Apoptotic protease
Antibacterial protein

AVE Helix
Energy
(kcal/mol)
-11.90
10.98
23.22

1F16
3WRP

Pro-apoptotic protein
DNA binding protein

-40.57
16.94

158.09
64.58

3.90
3.81

2YGS
1JMW

Apoptotic protease
Signaling protein

-28.23
-39.55

74.90
102.22

2.65
2.58

1HTJ

Signaling protein

-51.29

127.58

2.49

1B22
1ENH
1DDT
1AOA

DNA binding protein
DNA binding protein
Toxin
Actin binding protein

42.59
-75.30
-84.65
-166.30

93.64
161.05
166.43
303.62

2.20
2.14
1.97
1.83

1C03

Signaling protein

-176.01

300.13

1.71

1K40

Transferase

-72.72

106.52

1.46

1BJZ
1BGF
1M6T

Transcription regulation
Transcription factor
Electron transfer

-182.71
-131.19
-124.17

250.54
178.34
163.59

1.37
1.36
1.32

1URU

Endocytosis

-285.88

357.75

1.25

1FEW
1IZM

Apoptotic protein
Unknown function

213.09
414.86

262.03
491.59

1.23
1.18

Protein Name

PDB
ID

Physiological Role

BAX (NMR), model 20
APAF-1 CARD
Colicin E7 immunity
protein
BAX (NMR), model 1
DNA-binding domain of
TRP repressor
APAF-1 CARD domain
Methyl-accepting
chemotaxis protein II
RGS-like domain from
PDZ-RhoGEF
RAD51
Engrailed homeodomain
Diphtheria toxin
Actin-crosslinking
domain
Phosphorelay signaling
protein YPD1P
FAT domain of focal
adhesion kinase
Tetracyclin repressor
STAT-4 N-domain
B562RIL, a redesigned
four helix bundle
Amphiphysin BAR
domain
SMAC/DIABLO
YGFB

1F16
1C15
1CEI
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11.97
9.44
5.07

SD Helix
Energy
(kcal/mol)
129.89
48.11
139.42

⎜SD/AVE⎜

Circadian clock protein
Lipoprotein
Antibacterial protein

AVE Helix
Energy
(kcal/mol)
-110.49
-43.50
-126.01

1F0M
1CTJ
1FQI
1AD6

Signaling protein
Electron transfer
Signaling protein
Transcription regulation

-91.86
109.89
-176.33
-99.60

97.07
112.02
174.23
94.10

1.06
1.02
0.99
0.94

1DWR
1XWM

Oxygen transport
Unknown function

-150.58
255.99

139.98
235.99

0.93
0.92

1IAP

Signaling protein

-99.49

89.93

0.90

Histon HMFB from M.
fervidus
Bovine cyclin A3

1B6W

DNA binding protein

-128.78

114.10

0.89

1VIN

Binding protein

-118.63

102.56

0.86

Ribosomal protein S15

1A32

Ribosomal protein

-227.578

191.697

0.84

Glutathione S-transferase

13GS

-213.85

178.00

0.83

Calponin homology
domain from beta-spectrin

1BKR

Catalysis of the conjugation
of reduced glutathione
Acting binding

-90.43

75.14

0.83

CALM-N N-terminal
domain of clathrin
Endonuclease V

1HF8

Clathrin

-179.169

148.504

0.83

2END

Endonuclease

-266.10

210.00

0.79

Epsin N-terminal
homology domain
Middle domain of
EIF4GII
Phospholipase C

1EYH

Cell lycle

130.13

100.41

0.77

1HU3

Translation

-129.78

98.94

0.76

1AH7

-329.98

241.89

0.73

Interferon beta
Apolipoprotein E4

1WU3
1GS9

Hydrolysis of
phosphatidylcholine
Cytokine
Lipoprotein

-124.56
-200.75

123.89
143.94

0.71
0.72

N-terminal fragment of
NS1 protein
Hyperplastic disc protein

1AIL

RNA binding protein

-175.46

123.89

0.71

1I2T

Ligase

-133.62

90.02

0.67

Plasmodium falciparum
gamete gene PF27
Serine/threonine protein
phosphatase 5
BH domain from Graf

1N81

Unknown function

-228.95

148.64

0.65

1A17

Skeletal muscle calcium
binding protein
Signaling protein

-227.24

147.27

0.65

-101.77

64.31

0.63

Protein Name

PDB
ID

Physiological Role

KAIA homolog
Apolipoprotein
Pore-formin domain of
Colicin A
EPHB2
Cyochrome C6
RGS9 RGS domain
Retinoblastma tumor
suppressor
Myoglobin
Phosphate uptake
regulator
P115RhoGEF domain

1V2Z
1AEP
1COL

1F7C
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1.19
1.11
1.11

SD Helix
Energy
(kcal/mol)
49.90

⎜SD/AVE⎜

Mitochondrial fission

AVE Helix
Energy
(kcal/mol)
-82.50

2CRO

Gene regulation

-132.33

71.99

0.54

Troponin

1A2X

753.19

382.73

0.51

EPH receptor
Sperm lysin

1B0X
2LIS

Calcium-dependent regulator
of muscle contraction
Transferase
Cell adhesion

-63.62
-152.24

26.83
49.88

0.42
0.33

Protein Name

PDB
ID

Physiological Role

Human mitochondrial
fission protein Fis-1
CRO protein

1NZN

0.60

Table 9: Helical stability of three non-transitional proteins
Legend: AVE – average, SD – standard deviation

Helix
Number

PP-5
Sequence

(1A17))
Helix Energy
(kcal/mol)

Phospholipase C
Sequence

(1AH7)
Helix Energy
(kcal/mol)

1
2
3
4
5
6
7
8
9

22-40
44-57
62-74
78-91
96-108
112-125
130-164

-44.34
-71.50
-234.89
-149.35
-432.87
-369.85
-287.92

14-27
35-52
86-103
106-122
126-130
141-148
173-186
193-204
206-242

-147.49
-308.70
-221.21
-862.70
-254.66
-209.35
-463.81
-41.08
-460.79

AVE
SD
⎜SD/AVE⎜

-227.24
147.27
0.65

-329.98
241.89
0.73

Retinoblastoma
tumor
suppressor
Sequence
384-390
398-405
412-434
439-468
474-477
480-497
516-520
525-538
544-559

(1AD6)
Helix Energy
(kcal/mol)
-53.46
-59.11
-227.56
-281.28
-66.62
-83.43
-57.20
-88.23
20.46
-99.60
94.10
0.94

The distribution of IE values for the helices with the respect to the 3D structures of
phospholipase-C, PF27 (Sharma et al. 2003), FIS1 (Karbowski et al. 2002), and BAX are
graphically depicted in Figure 17. These structures demonstrate that IE of the helices varies
independently of the topological arrangement within the 3D structure. This is a further indication
that the number and types of interactions each helix is capable of making is the most important
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factor in understanding the variation in IE. The green and blue colors represent regions of high
stability (negative IE) and regions of orange and red colors represent regions of relative
instability (positive IE). The C-terminal helix in BAX (α9, shown in light green) had a favorable
IE (-76.71 kcal/mol) and is located next to two helices (#3 and #4) that are relatively unstable.
Helix α9 seems to be critical for membrane localization though its interactions with the
hydrophobic pocket (Tschammer et al. 2007b) and most likely plays a role in stabilizing or
destabilizing other helices, enabling a structural transition to occur that facilitates mitochondrial
membrane insertion or association with another BCL-2 related protein.
The complete set of randomly selected proteins (including BAX) used in this study is
provided in Table 8. The BAX protein (model 20) is at the top of the list with a |SD/AVE| ratio
of 11.97. This ratio was the highest in our study and appears to represent the statistical variation
of helical interactions within the deposited NMR ensemble for the BAX protein. BAX (model 1)
was from the most populated cluster of the ensemble (see Methods) and this structure had a value
of 3.91. The value 11.97 was obtained with one set of coordinates that was part of the deposited
ensemble, but did not cluster with model 1. For this reason, I used NMR structures sparingly in
the study and when they were used, only the most populated cluster from the ensemble was used
for IE calculations.
As shown in Table 8, the variation in IE values for proteins varies significantly even
though these proteins are in the all alpha-class and have similar molecular properties. This
distribution provided a basis for comparing the helical IE values within BAX, as well as other
proteins in the all alpha-class. Because BAX is known to undergo a structural transition, and is
near the top of the list, I interpret these results as a mean of measuring the propensity for the
transition for proteins with stable 3D structures. However, as described later in the report, the
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|SD/AVE| values may differ depending on the mechanism of transition and the involvement of
other proteins, or membranes, which are involved in initiating the transition for each protein.

3.3.2. Statistical variation within the randomly selected set
Following the analysis of BAX and comparing the IE values of this protein to those that
were randomly selected, I came to the understanding that the statistical variation in IE values
may represent a measure of propensity for transition within proteins that have a defined 3D fold.
When considering a protein that has a biological role in signaling, and undergoes a structural
transition, the forces required to induce this transition (which may be afforded though binding
another biological molecule or a membrane surface) must be stronger than those forces
stabilizing the structure prior the transition. For this reason, I suggest that the statistical variation
of IE represents regions within 3D structures that make these processes energetically favorable
and yet allow a global stability within protein structure that enables the molecule to remain in a
native state prior to transition.
The average value, standard deviation and absolute ratio |SD/AVE| for all the randomly
selected proteins (Table 8) showed trends that appear to correlate with each protein´s
physiological role. While BAX is near the top of the list, APAF-1 CARD (Caspase Recruitment
Domain) protein also shows a high |SD/AVE| ratio. This protein consists of six tightly packed
amphipatic alpha-helices. Its cellular role involves the activation of Caspase-9 though the
homophilic CARD/CARD interaction. The |SD/AVE| ratio for this protein is 9.44. The structure
of the protein has been determined in the unbound state (Zhou et al. 1999) and in complex with
pro-domain of pro-caspase 9 (Qin et al. 1999) and shows a significant structural mobility upon
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binding.

Almost all the helices within the protein undergo some level of structural

rearrangement upon ligand binding as demonstrated by the Cα trace (Figure 18). The protein
undergoes the smallest conformational rearrangement in the segment of the helix α5 (amino
acids 50-64). This segment had an IE of -190 kcal/mol and was the most stable helix in the
structure. The segments represented by helix α3 (amino acids 23-31) and helix α4 (amino acids
37-46) had the most unfavorable IE (97.45 and 115.24 kcal/mol, respectively) and showed the
most rearrangement upon ligand binding. These two helices are in direct contact with the CARD
domain of procaspase-9, which may indicate that regions of relatively unfavorable IE find
stability in binding their particular biological targets.
In addition to the analysis of the NMR structure of the APAF-1 CARD domain, a second
structure of APAF-1 CARD domain obtained by X-ray crystallography was analyzed. The
|SD/AVE| ratio for this from was 2.65. Although this ratio was considerably smaller that that of
the NMR structure (9.44), it positioned this protein among the proteins that undergo structural
transitions. Additionally, the helical segments of the two proteins (as given in the PBD header)
are slightly different. The most stable segments (amino acids 50-64 (NMR) and 48-61 (X-ray)
were consistent in both structures and the regions described above (that interact with the CARD
domain of procaspase-9) appeared to be less stable due to higher IE. These results suggested that
the IE values are not dependent on the method used for structure determination, the resolution, or
the helical limits, because the most stable segments were similar in both structures.
The TRP repressor (3WRP) has a |SD/AVE| ratio of 3.81. The structure of this protein
was determined by x-ray crystallography with a resolution of 1.8 Å (Orth et al. 1999). The
authors of this study found different forms of the proteins fro different crystallization conditions
and described this flexibility based on the TRP repressor´s ability to search for and adhere to its
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different operator sites (Orth et al. 1999). Therefore, this protein has an intrinsic flexibility that
had been well characterized and the |SD/AVE| ratio correlates well with these observations. The
TRP repressor undergoes rearrangement upon DNA binding, which can be observed in the Cα
trace of the bound (green) and unbound forms (red).The most stable region of this protein is
found to be the region around 79-91 (helix 5) with an IE value of -90,48 kcal/mol. This helix is
one of the helices that make direct contact with the DNA. The regions from 46-63 (helix 3) and
68-74 (helix 4) have IE of 61.24 and 88.27 kcal/mol, respectively, and are the least stable helices
within the structure. These two helices are on the outside of the structure and may find stability
by interacting with helix 5 (Figure 18). These two helices (along with helix 5) are found at the
interface of the bound DNA with helix 5 bound in the major groove (Figure 18). This helix also
overlays best in the Cα trace between the bound and unbound form, which may be interpreted as
a further measure of the stability of this helix. Unlike the APAF-1 CARD protein, the TRP
repressor uses regions of relative stable and unstable regions for DNA binding, but the regions
with higher IE appear to be involved in both cases.
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Figure 18: Structural changes for transitional proteins based on Cα overlays.
The green Cα trace represents the protein in the bound form and red traces represent the unbound form of
the proteins. For the Trp-repressor, APAF-1 CARD, and chemotaxis proteins, their respective ligands (DNA,
caspase-CARD domain, and aspartate) are shown to identify the regions of where interactions occur.

The ligand binding domain of the methyl-accepting chemotaxis protein II is also
represented in the PDB in a bound and unbound form. The unbound form (Figure 18) shown in
red is slightly different than the protein with bound aspartate (green). Although the changes in
the helical positions (based on Cα traces) are not as dramatic as those found for the TRP repressor
and the APAF-1 CARD domain, there are noticeable differences that can be observed in
comparing the two forms. The region with most favorable IE within this protein are 87-110 (140.08 kcal/mol) and 116-144 (-191.91 kcal/mol). These two helices are on the opposite face of
the aspartate binding region. Amino acids 40-75 (41.89 kcal/mol), 145-152 (22.59 kcal/mol), and
153-175 (50.15 kcal/mol) which represent helices #2, 5 and 6 are on the interface where the
aspartate molecule is bound and have the highest IE values. This protein has a |SD/AVE| ratio of
2.58, which is lower than the previously described proteins, but higher than most of the proteins
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from the randomly selected list. This lower |SD/AVE| ratio appears to correlate with the smaller
changes in the Cα traces compared to the previously described proteins. The APAF-1 CARD
proteins shows the most dramatic change (Figure 17) and has the highest |SD/AVE| ratio (9.44),
whereas the TRP repressor (3.81) and chemotaxis protein (2.58) have decreasing values that
correlate with more fine changes in the bound and unbound forms as seen though the Cα traces.
As demonstrated by the data above, the larger |SD/AVE| ratio correlates with those
proteins that are involved in protein-DNA and protein-protein interactions. Additionally, the
statistical variation in |SD/AVE| ratio as a measure of propensity for transition is supported by
changes in the structures when comparing the bound and unbound forms. However, as discussed
below, the degree of statistical variation within a single structure may vary depending on the
types of forces involved in initiating the transition.

3.3.3. IE distribution and protein function
A clear division of statistical variation within IE values would be a convenient mean of
predicting propensity of the protein to undergo transition. The comparison of |SD/AVE| ratio of
the proteins with the published experimental description of the proteins tendency to undergo
transition yielded |SD/AVE| ratio distribution between 1.11 and 9.44, and for the proteins which
do not undergo transition between 0.33 and 1.06. The approximate cut-off value could be around
1.1 with transitional proteins having |SD/AVE| ratio larger than 1.1 and non-transitional proteins
ratio smaller than 1.1.
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Proteins with the |SD/AVE| ratio of 1.1 or above have more unfavorable average IE
values compared to those having |SD/AVE| ratio less than 1.1 (Table 8), although no correlation
to function can be made based on average IE values alone. The non-transitional proteins show a
slight correlation that provides a slope of -1.08 in the plot of standard deviation vs average IE
value, while the transitional proteins appear to be more scattered and have varied average IE
values, as well as higher standard deviations (Figure 19). For this reason, the |SD/AVE| ratio
appears to be a better measure if propensity for transition than the average energy values alone.
As shown in Figure 19, it appears to be a region where the correlation (based on non-transitional
proteins) is lost. For example, proteins such as actin binding protein (1AOA, -166.30 kcal/mol),
the phosphorelay signal transduction protein YPD1P (1C03, -176.01 kcal/mol), tetracycline
repressor (1BJZ, -182.71 kcal/mol), and the BAR membrane curvature sensor protein (1URU, 285.88 kcal/mol) have all favorable IE, but have |SD/AVE| ratio above 1.2. This demonstrates a
wider statistical distribution of helical interaction forces across the entire protein structure in a
structure that appears to be very stable. Based on their functional classification, these types of
proteins would be expected to have some flexibility within their 3D structures, but this is not
apparent based on the average IE values and their stable 3D structures.
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Figure 19: Graphical representation of the average IE values and standard deviations.
The proteins that are known not to be involved in 3D structural transitions are shown with black diamonds
and those known (or described in the literature) to undergo structural rearrangement are shown with green circles.
While the non-transitional proteins have some correlation between their average IE values and deviations, the
transitional proteins appear to be more scattered and have no correlation.

3.3.4. Proteins with unknown function

Many proteins in the current databases are annotated as “unknown function”, because
their structures were obtained prior to any biological studies being performed. While 3D
structures are of values in many areas of research, the lack of biological information makes the
choice of further characterization of these proteins difficult. Based on the results presented in this
study, it may be possible to classify these unknown proteins based on their |SD/AVE| ratio to
determine which proteins may be of interest because of their potential role in signaling and/or
transition.
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Three of the proteins in our randomly selected set are annotated as unknown function in
the PDB. The first protein is a gametocyte protein essential for sexual development in
Plasmodium falciparum (1N81) known as Pfg27. This proteins has been described as a RNA and
SH3 domain binding protein capable of binding two SH3 domains simultaneously (Sharma et al.
2003). It has an average IE value of -228.95 kcal/mol and |SD/AVE| ratio of 0.65. Based on this
structure and the described biological roles, this protein does not appear to be involved in 3D
structural transitions related to its function.
The second protein of unknown function is annotated as a phosphate uptake regulator
(1XWM) homologous with PhoU proteins that function as negative uptake regulators in E.coli.
This protein has an average IE value of 255.99 kcal/mol with a |SD/AVE| ratio of 0.92. Based
on these values, we might predict that the deviation within helical energy distribution for this
protein may indicate a transition in the 3D structure being involved in the mechanism of
controlling phosphate uptake, but biological data to support this is still pending. It has been
shown that the PstSCAB transporter and PhoU may be regulated by a mechanism that may
involve their interactions with each other as well as inorganic phosphate and the sensor proteins,
PhoR (Steed, Wanner 1993). PhoU might use its lowered helical interaction energy to promote
interactions with the transporter protein, other proteins in the phosphate uptake pathway, or
possibly membrane lipids. However, this would require solid experimental evidence to support
this mechanism, and based on the distribution of |SD/AVE| ratio in this study, this protein is
clearly intermediate and one cannot determine the propensity of transition for this protein based
on these values.
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The third protein is HI0817 Haemophilus influenzae (1IZM) (Galkin et al. 2004). It has
an average IE value of 414.86 kcal7mol with a |SD/AVE| ratio of 1.18. This protein is classified
as a conserved hypothetical protein and homologous to a 24-member family that includes a brad
number of human (12), bovine, insect and plant pathogens. Although the biological mechanism
for this conserved pathogen is not known, I would predict based on these values (and those from
other proteins in my test) that its biological mechanism is related in some way to the statistical
distribution of interaction energies across the 3D structure. This would fit in the grouping of
proteins with relatively high IE values and |SD/AVE| ratio such as those found for the 1AEP and
1COL structures that are involved in membrane associated protein transitions. However,
experimental evidence is needed to support this proposed transition.
While further studies need to be completed to determine the biological function of
unknown proteins before they are classified as transitional, I feel the statistical methods outlined
in this report may provide insight for future studies on those proteins that are conserved across a
number of species, yet have no clear biological role.

3.4. Conclusions

Biological signaling is often controlled by the binding events that are transient in nature
involving random coil, molten globules, and proteins with stable 3D folds. While the
classification and mechanisms of signaling for random coil and molten globule proteins can be
understood based on their ability to undergo structural transitions, no measure of propensity for
transition is available for stable proteins that are involved in signaling. With the idea of a
“continuum of protein structure” being available to describe proteins involved in cellular
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signaling comes the understanding that these types of transitions (and the mechanism by which
they occur) should have some measurable parameter, even for proteins with stable 3D folds. For
intrinsically disordered and random coil proteins, these parameters are found in the pair-wise
indexing and random coil index, respectively. Although these parameters do not have statistical
cut-off values that clearly classify proteins as completely random or completely unstructured,
they do provide an indication of the degree of randomness and/or potential lack of 3D structure.
Analysis of helical interaction energies, as described in this study, appears to provide a similar
type of measurable parameter, with the difference being that static energies are used and the
proteins that are being compared need to be in the same structural class and lack factors that
stabilize the 3D fold.
Analysis of stable 3D structures using the method outlined in this study will be valuable
in guiding experimental efforts to understand the transitional mechanisms of proteins. With an
increasing number of proteins being discovered by structural genomics efforts (Stevens et al.
2001) (without experimental data such as 1IZM and 1XWM), parameters such as those examined
in this study may provide information about those areas of least stability within a protein’s 3D
structure and identify the region(s) of contact for the biological molecules that are involved in
the interaction(s). Although this study only addresses helical interaction energies in small
proteins of the all alpha-class, it is possible to assume that other types of proteins, of varying
structural complexity, will also have stability trends within their 3D structures that will assist in
understanding their ability to control biological signaling events and as well as elucidate the
mechanisms of transitioning that regulate their function.
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4 ANALYSIS OF HELICAL INTERACTION ENERGIES TO PROBE
THE STABILITY AND MECHANISMS OF STRUCTURAL TRANSITIONS IN
THE BCL-2 PROTEIN FAMILY

4.1 Introduction

Three-dimensional (3D) protein transitions are important for a number of biological
processes and signaling events ranging from host invasion to DNA binding and apoptosis (Hinds
et al. 2003;Patel et al. 1990). These structural transitions may occur locally at flexible loop
regions, or involve complex folding events like e.g. diphtheria toxin (Dumont, Richards 1988).
Because these structural transitions are governed by the stability of a protein’s localized domains
and/or secondary structural elements, the analysis of the thermodynamic stability of these
individual elements should provide insight into the mechanisms of the transitions. Such
measurements should provide a mean of computational classification of those proteins that have
a propensity for transition, as well as identify domains within the protein that are likely to be
involved in the initiation of 3D structural changes. My previous study (Tschammer et al. 2007a)
showed that this type of the parameter exists. Analysis of the static interaction energy (IE) for the
helices within all-alpha class proteins indicated that the transitional proteins have wider
distribution of IE, resulting in higher |SD/AVE| ratio compared to non-transitional proteins. BAX
appeared to be the protein with one of the broadest IE distribution among the evaluated proteins.
BAX is a member of BCl-2 family of apoptotic regulators (Borner 2003;Cory et al.
2003). The BCL-2 family can be divided in two functional categories – those that mediate
survival, such as BCL-XL and BCL-2, and those that mediate death, such as BAX, BID or BIM
– based on the presence of one or more BCL-2 homology (BH) domains. Structural studies of
83

BCL-2 family members demonstrated that the members retain a similar folded structure despite
their significant difference in the amino acid sequence (Petros et al. 2004). NMR or X-ray
structures are available for six family members (BCL-XL (Muchmore et al. 1996), BCL-2
(Petros et al. 2001), KSHV-BCL-2 (Huang et al. 2002), BCL-W (Denisov et al. 2003), BAX
(Suzuki et al. 2000) and BID (Chou et al. 1999;McDonnell et al. 1999). The solution structure of
BAX showed that BAX is folded in a similar manner than other BCL-2 family members. Helices
#2, #3, #4 and #5 form a hydrophobic pocket which is occupied by the C-terminal α9 helix
(Suzuki et al. 2000). BCL-XL structure contains similar pocket which is occupied by the bound
BH3 peptide mimics (Petros et al. 2004;Petros et al. 2000).
Based on my previous work in which I analyzed the mechanism of BAX activation
(Tschammer et al. 2007b) and the variations in the helical stability in static structures of proteins
(Tschammer et al. 2007a), I focused on the analysis of 3D structures of BCL-2 family members
deposited in the Protein Data Bank (PBD)(Berman et al. 2000). The reason for studying the
BCL-2 family proteins originates in their ability to undergo structural transitions during
execution of their biological function (Borner 2003;Schlesinger et al. 1997;Zhang et al. 2004).
Little is known how these structural transitions occur. Using methods of computational
modeling, I analyzed different BCL-2 family members and found that these proteins have,
similar as BAX, broad distribution of IE, although the force of interaction between various
helices within each structure varied. This variations in the IE within each structure and the
changes that occur upon peptide binding led to conclusion that these differences could reflect
different transitional mechanisms and/or functions for members of the BCL-2 protein family.

84

4.2 Materials and Methods
4.2.1 Structures

The

3D

structures

of

proteins

were

from

the

RCSB

Protein

Data

Bank

(http://www.rcsb.org/pdb). The representatives of BCL-2 family of proteins are: BAX (PDB ID
1F16) (Suzuki et al. 2000), BCL-W (1MK3) (Denisov et al. 2003), BCL-2, isoform 1 (1G5M)
(Petros et al. 2001), BCL-XL X-ray structure (1R2D) (Muchmore et al. 1996), BCL-XL NMR
structure (1MAZ) (Muchmore et al. 1996), human BID (2BID) (Chou et al. 1999), mouse
BID(1DDB) (McDonnell et al. 1999) and CED9 (1OHU) (Woo et al. 2003). BHRF1 protein
from Epstein-Barr Virus (EBV) (1Q59) (Huang et al. 2003) and BCL-2 homolog from Kaposi´s
sarcoma-associated herpes virus (1K3K) (Huang et al. 2002) are the representatives of viral
BCL-2 homologs. Coordinates of BCL-XL in complex with the peptides were as follows: BAD
(1G5J) (Petros et al. 2000), BAK (1BXL) (Sattler et al. 1997) and BIM (1PQ1) (Liu et al. 2003).
The coordinates for CED) in complex with the EGL-1 peptide were PDB ID code 1TY4 (Yan et
al. 2004).
The graphic images were produced by PyMol v0.99 (DeLano Scientific, California).

4.2.2 Energy Calculations

In determining the level of calculations to perform a number of factors was considered.
Although QM/MM methods have become popular due to their accuracy they are computationally
expensive and are primarily used for active site analysis and reaction profiling (Cheng et al.
2005). Methods capable of simulating proteins side-chain flexibility using Monte Carlo
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minimization are also available (Meiler, Baker 2006) and molecular dynamics simulations have
been shown to be reliable in evaluating protein-peptide interaction energies in dynamic systems
(Bartels et al. 2005). However, this study deals with the direct measurements of static structures,
achieving results on 53 independent coordinate sets that had an average of 8 helices each, which
required calculations for the helix alone, the helix in complex with the protein, and the protein in
the absence of the helix. Based on this criteria, the use of molecular mechanics (MM3) force files
with directional hydrogen bonding potentials was chosen to evaluate the static interaction energy
(Lii, Allinger 1998b). These values are presented as relative interaction energies due to the
understanding that calculations completed with different force files potential will result in
different energy values. Calculations were performed in vacuo, disregarding an explicit
water/membrane environment, which would result in substantially lower energy values due to
entropic factors. Only the forces at the interface of each helix were considered in the
calculations.
The calculations were performed using the BioMed Cache 6.1.10 program (Fujitsu
America, Inc., Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were
performed using parameters as described in the literature. Separate energy calculations were
performed for: (1) the entire protein (no helices removed), (2) the entire protein, but the
investigated helix removed, and (3) the helix only. The energy of each molecule was calculated
until convergence (energy minimization) was reached. Energy terms included Van der Waals,
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked, except
protons were allowed to move during the calculations. This was done to ensure that no changes
in the atomic positions (other than protons) or bond characteristics would occur during the
calculations relative to the original coordinates in PDB file. A conjugated gradient was used to
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locate the energy minimum. Van der Waals interactions between atoms separated by more than
9.0 Å were excluded. The interaction energy (IE) was estimated through separate determinations
of the energy of the complex (Ecomplex), complex without the investigated helix (Ecomplex w/o helix-n)
and helix alone (Ehelix-n), and by taking the difference between these terms (IE=Ecomplex-(Ecomplex
w/o helix-n

+Ehelix-n)). This difference in the relative energies terms provides the interaction energy

(IEhelix-n) at the interface of each helix being investigated with respect to the entire structure using
the MM3 potential.

4.2.3 Protons and Ionization States

Because the proton positions are not available in structures determined by x-ray
crystallography, I edited each structure individually to ensure the proper location of hydrogen
atoms. This required adjustment in ionization states for individual amino acids in each protein.
The following guidelines were used for the setting of the ionizations states of the individual
amino acids: (1) cysteines were protonated, (2) glutamate and aspartate side chains had the
oxygen farthest from the backbone of the helix investigated assigned a formal negative (-1)
charge, (3) lysine side chains had a formal positive (+1) charge on the terminal amine, (4)
arginine side chains were assigned a positive (+1) charge on the nitrogen farthest from the
backbone of the helix investigated, (5) the new N-termini (generated upon removal of the helix
of the protein) for the both the protein (without the helix) and the helix itself was given a formal
positive (+1) charge, and (6) the new C-temini was changed to an aldehyde functional group (no
charge). For structures determined by NMR, the experimentally determined proton positions
were used for energy minimization.
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4.2.4 Statistical Analysis

The IEhelix-n values for each helix were tabulated as shown in Table 8. The average (AVE)
helical interaction energy values are shown and provide a measure of the overall stability of the
helices within the protein structure. The standard deviation (SD) values were calculated to
measure the statistical variation of all helices within the entire 3D structure. The structures were
ranked in terms of their |SD/AVE| ratio to provide a measure of the propensity for transition as
described in Chapter 2. As shown in Table 8, significant changes in the |SD/AVE| ratios were
found when BCL-2 family members are in the complex with various peptides.

4.2.5 Changes in the secondary structure

The CED9 and BCL-XL proteins in this study were analyzed with and without small
peptides bound. In some cases changes in the secondary structure have occurred upon peptide
binding. In order to represent the interaction energies accurately, two sets of calculations were
completed. The first set used the same atoms for bound and free forms, irrespective of any
change in the secondary structure. The helical boundaries for CED9 and BCL-XL proteins
(without any bound peptide) were determined by the information in the PDB header. These same
atoms were then used for calculations for the bound form even if these atoms were no longer in a
helical conformation. This allowed direct comparison of the energies for the free and bound
forms using the same number of atoms in each calculation. Any change in the number (or type)
of atoms used would change the relative interaction energy values, and make the two sets of
values difficult to compare accurately. This set of values was designated as “Set 1”. In a second
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set of calculations, the interaction energies for the CED9 and BCL-XL complexes were
calculated with the helix boundaries taken directly from the PDB header. This allowed
comparison of any changes in helical interaction energy (IE) relative to the resulting changes in
the secondary structure. The data comprised “Set 2” in the tables. Specifically, the following
changes in the two structures occurred upon peptide binding (based on PDB secondary structure
annotation): (1) BCL-XL residues 103-106 are in a helix in the bound form, but form a beta-turn
in the free form, and (2) CED9 residues 141-144 form a beta-turn in the absence of the peptide,
but form a helix in the presence of the peptide.

4.3 Results

My previous analysis of the helical interaction energies (IEs) in the all alpha-class
proteins that are known to undergo structural transitions demonstrated a broad distribution of IEs
within the structure (Tschammer et al. 2007a). Within the randomly chosen set of proteins which
were used in the mentioned study, BAX was estimated to have one of the broadest IE
distributions of all the proteins analyzed. Based on this observation and the fact that BCL-2
family proteins employ structural transitions to regulate apoptotic events, I analyzed the IEs for
those BCL-2 family proteins for which structural information is available in free and bound form
with the intention to detect the changes in the IE distribution which occur upon ligand binding.
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4.3.1 Helix Stability and Packing of BCL-2 Family Members

The common feature of the known structures of the BCL-2 family members is so-called
core region of the protein represented by at least one helix. The other helices are arranged around
this core set and form α-helical bundle (Figure 20). Despite the overall similarity in the fold of
BCL-2 family members (Petros et al. 2004), I detected significant differences in the helix
stability and helical packing among different members (Table 10).
All of the BCL-2 family proteins analyzed in this study had |SD/AVE|values that were
greater than 1.1 when the protein was not in the complex with a peptide/ligand (Table 10). The
|SD/AVE| ratios ranged form 1.17 for BHRF1 (a viral BCL-2 homolog) to as high as 11.97 for
BAX (Model 20). The BAX structure with the |SD/AVE| ratio of 11.97 was derived from the
least clustered coordinate set obtained from the NMR ensemble of structures deposited in the
PBD (see 4.2 Material and Methods). The most populated cluster resulted in a |SD/AVE| value of
3.9 (BAX, Model 1). Even with this variability in |SD/AVE| ratio for different members of NMR
ensemble, BAX showed a significant distribution of IE within its 3D structure. The BCL-XL
structure (as determined by NMR) had a |SD/AVE| ratio of 4.38 and the structure determine by
X-ray crystallography 4.24. These results demonstrated that structures determined by NMR
(using the most populated group of structures within the ensemble) and X-ray crystallography
have comparable |SD/AVE| ratio and that the IEs are not dependent on the method of the
structure determination.
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Figure 20: BCL-2 family proteins have stabile central helix.
Ribbon diagrams of protein belonging to the BCL-2 family color coded by stability. The color codes
correspond to: blue – the most stable, green – stable, yellow – less stable, orange – unstable, red – very unstable. As
shown in the figure, the topology of the helices within the structures is similar, but the distribution energies are not.
Notably BAX has more unstable helices on the outer edge of the structure compared to BCL-W, BCL-XL, and BID.
I interpret these variations as potential differences in the mechanism of transition for each structure, which is
governed by each protein’s distribution of helical interaction energy values and overall stability.

The differences observed in the helical stability and packing of BCL-2 family proteins
mirrors their unique pro- or anti-apoptotic function. The BCL-2 family members with multiple
conserved BH domains, BAX, BCL-W, BCL-XL, BCL-2 and BCL-2 homolog of Kaposi’s
sarcoma virus, demonstrated distinctive pattern in the helical stability and the helical packing
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with only one core helix relatively stable (α5, the energy value in the range from -400 in BAX to
10 kcal/mol in BCL-2; Table 11). CED9 has two relatively stable helices (α5, α6) that form a
similar stable core (-280 to 380 kcal/mol). The central stable core helix (or helices in CED9) is
the main component of the hydrophobic groove, which is an essential structural and functional
element among anti- and pro-apoptotic BCL-2 family members (Petros et al. 2004).

Table 10: Statistical data on helix stabilities for BCL-2 family proteins.
Standard deviation (SD), average (AVE), and |SD/AVE| values for the BCL-2 protein family investigated
in this study. Values are sorted and ranked by |SD/AVE| value. Protein Data Bank (PDB) codes for the atomic
coordinates are also included. This distribution represents the variation in helical interaction energies for the various
BCL-2 protein family members and demonstrates their broad distribution of energies that may enable structural
transitions to occur.
SD Helix
Energy
(kcal/mol)
142.46
204.69
259.98
158.09
238.63
85.12

⎜SD/AVE⎜

Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Viral protein

AVE Helix
Energy
(kcal/mol)
-11.90
-46.75
-61.26
-40.57
66.83
-28.99

Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Apoptosis regulator
Viral protein

25.15
46.95
100.14
118.13
125.99
60.88
-157.48
210.73

72.14
133.93
259.49
179.90
184.24
86.95
190.35
247.39

2.9
2.9
2.6
1.5
1.5
1.4
1.2
1.2

Protein Name

PDB ID

Physiological Role

BAX, Model 20
BCL-XL
BCL-XL
BAX, Model 1
Human BID, Model 15
BCL-2 homolog from
KSHV
BCL-W, Model 1
BCL-2, Isoform 1
Human BID, Model 1
Mouse BID, Model 1
Mouse BID, Model 10
BCL-W, Model 10
CED-9
BHRF1

1F16
1MAZ
1R2D
1F16
2BID
1K3K
1MK3
1G5M
2BID
1DDB
1DDB
1MK3
1OHU
1Q59

12.0
4.4
4.2
3.9
3.6
2.9

BAX, BCL-W, BCL-XL, BCL-2 and the BCL-2 homolog of Kaposi’s sarcomaassociated virus further separate into two subgroups. The first subgroup, represented by BAX,
BCL-W and BCL-2 homolog of Kaposi’s sarcoma-associated virus, does not have the peripheral
helices more stable than the core helix α5. The second subgroup, represented by BCL-XL and
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BCL-2, has peripheral helices more stable than the core helix α5. The helices α1 and α2 have
energy values between -340 to -100 kcal/mol, compared to the range from -230 to 10 kcal/mol
for the core α5 (Tables 11, 15). This difference most likely originates in their structural
difference compared to other BCL-2 family members. Both BCL-2 and BCL-XL have a long,
highly dynamic unstructured loop between helices α1 and α2. The dynamic nature of this region
caused a lack of any structural information between the residues 28 and 81. Likewise, the 3D
structure of BCL-2 was noticeably altered by the replacement of the putative flexible loop region
with the same region from BCL-XL. This long and unstructured loop between the helices α1 and
α2 is thought to be the main site of proteins posttranslational modifications, including
phosphorylation and cleavage by caspases (Petros et al. 2004). The increased stability of helices
α1 and α2 could thus serve as an anchor for the highly flexible loop and contribute to the
stability of the BCL-2 and BCL-XL structure.
Human and mouse BID and BHRF1 (BCL-2 homolog from Epstein-Barr virus) displayed
a distinctive pattern of the helical packing that differed significantly from the BAX, BCL-W,
BCL-2 and BCL-XL. Their primary structures have low sequence homology with other BCL-2
family members (Petros et al. 2004) and have only one conserved BH domain (BH3 in BID, BH2
in BHRF1). Overall, the 3D structures of BID and BHRF1 displayed only 1-2 relatively stable
helices. The pronounced hydrophobic groove and the long flexible loop between α1 and α2
similar to those in BCL-XL and BCl-2 are absent in BID and BHRF1. Furthermore, BID lacks of
C-terminal transmembrane domain while BHRF1 has it. The differences in the 3D structures and
helical packing pattern indicated that different mechanisms govern the activity of BID and
BHRF1 compared to anti-apoptotic BCL-2 or BCL-XL and pro-apoptotic BAX.
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Table 11: Helical stability of BCL-2, BCL-W and BAX.
Data for the helical IE values of individual helices for the representatives of BCL-2 family proteins
demonstrating the patterns of stability observed within the various structures. Helix numbering, amino acids in each
helix, and the length of each helix is indicated. This data is comparable to Figure ?, where the distribution of
interaction energies in each structure varies for different members of the BCL-2 family. We interpret these
differences as an indication of potentially different mechanisms of transition for each member of the BCL-2 family.
Helix
Number

BAX
Sequence

1
2
3
4
5
6
7
8
9

15-36
53-72
73-81
87-100
107-128
129-147
149-155
158-165
170-189

AVE
SD
⎜SD/AVE⎜

(1F16)
Helix Energy
(kcal/mol)
-58.66
-132.36
31.02
55.02
-405.14
27.08
104.78
89.82
-76.71

BCL-2
Sequence
10-25
92-109
113-118
122-138
143-164
166-184
184-193
194-203

-40.57
158.09
3.90

(1G5M)
Helix Energy
(kcal/mol)
-168.85
-98.40
149.96
27.85
10.10
158.81
68.78
227.33

46.95
133.93
2.85
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BCL-W
Sequence
8-23
40-56
58-70
74-87
92-112
114-132
133-141
142-148
154-168

(1MK3)
Helix Energy
(kcal/mol)
-65.22
132.80
32.24
124.11
-71.19
30.47
-15.26
6.25
52.19
25.15
72.14
2.87

4.3.2 Homology and Topology

When comparing the helical packing energies of the proteins within one family like BCL2 family, the question of homology as a function of energy distribution became obvious. One
would expect a similar distribution of helical interaction energies in the case of two related
proteins which share significant sequence homology. The BCL-2 family proteins are all involved
in the regulation of apoptosis and have roughly similar folds, but their sequence homology is
quite low and does not correlate with the helical interaction energy distribution. A standard
BLAST search (NCBI BLAST, http://www.ncbi.nlm.nih.gov/BLAST) and hidden Markov
models (HMM) (Soding et al. 2005) were used to weigh similarities in both the overall sequence
and the individual helices themselves.
The standard statistical parameters for the BLAST analysis include percent identity (ID),
percent positives (P), and percent gaps (G) along the homologous number of amino acids. The
sequence of BAX was the base for the analysis. BCL-2 and BCL-XL had the highest homology
aligning to 152 and 147 amino acids (Table 11). The statistics for these alignments were 28% ID,
50% (P), and 7% (G) for BCL-2 and 25% (ID), 45% (P) and 10% (G) for BCL-XL. BCL-W and
hBID had to some extent better percentage statistics than BCL-XL, but only aligned with 132
and 129 amino acids. This homology analysis that represents the comparison of the BAX
sequences with the other BCL-2 family members enclosed in this study confirmed low
homologies, and demonstrated that the variation of IE distribution within each structure has no
correlation with the homology.
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Table 12: BLAST sequence search of BCL-2 family members
NCBI BLAST was used to search and obtain the statistics from the sequence alignment of the BCL-2
family members against BAX. Standard BLAST statistics is tabulated; ID – percent identity, P – percent positives,
G- percent gaps.

Protein
hBCL-2
hBCL-XL
hBCL-W
hBID
mBID
CED9
KSHV BCL-2
BHRF1

No. of amino acids
aligned
152
147
132
129
65
96
78
58

ID (%)

P (%)

G(%)

28
25
28
28
21
18
35
26

50
45
47
46
42
43
47
41

7
10
12
12
20
3
7
1

Hidden Markov models (HMM) analysis was used to investigate the similarities of
individual secondary structural elements in each structure. HMM analysis yields a HMM score
and a percent identity for each sequence analyzed. BCL-XL and BCL-W had the best homology
to BAX helices, with five helices showing HMM scores (Table 12). These helices were #2, #4,
#5, #6 and #8m which had HMM scores as high as 36.99 at 40% identity for BCL-XL and 35.78
(40% identity) for BCL-W. BCL-2, which had a moderate global (BLAST) alignment with BAX,
only showed three helices (#5,#6, and #8) with HMM scores of 36.57 (33% identity), 17.74
(21% identity) and 11.76 (25% identity). This demonstrated that the moderate homology
between many BCL-2 family members is found in the loop regions and not within those amino
acids that form helices. Additionally, I found no correlation between the HMM scores (and
percent identity) and the stability of the individual helices in each structure. These homologous
regions represent BH domain of the proteins, are similar in sequence, but vary in their respective
stabilization of the structure. Interestingly, helices #1 and #9 from BAX have no homology
(based on the HMM analysis) and represent two of the four helices within the BAX structure
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with negative (favorable) IE. Given that these helices are at the termini of BAX, and the helix-9
is known to facilitate localization of BAX to mitochondria, indicate that these helices may be
unique in their transitional roles compared to other BCL-2 family members.

Table 13a-c Analysis of hidden Markov Models homology of the BCL-2 family
members.
All listed BCL-2 family members were compared with BAX. Helix number and interaction energy (IE) is
listed for each protein. Analysis of hidden Markov model homology (HMM) analysis is provided next to each helix
and corresponds only to this specific helix. If no HHM score is listed, the homology (for that specific helix) is below
the statistical homology level for the HMM server.

a)
Helix Number
1
2
3
4
5
6
7
8
9

BAX
(1F16)
15-36
53-72
73-81
87-100
107-128
129-147
149-155
158-165
170-189

IE (kcal/mol)
-58.66
-132.36
31.02
55.02
-405.14
27.07
104.78
89.82
-76.71

AVE
SD
⎜SD/AVE⎜

BCL-2
(1G5M)
10-25
92-109
113-118
122-138
143-164
166-184
184-193
194-203

IE (kcal/mol)

-40.57
158.09
3.90

-168.85
-98.40
149.96
27.85
10.10
158.81
68.78
227.33

HMM score
(% identity)

36.57 (33%)
17.74 (21%)
11.76 (25%)

46.95
133.93
2.85

b)
Helix Number
1
2
3
4
5
6
7
8
9
AVE
SD
⎜SD/AVE⎜

BCL-W
(1MK3)
8-23
40-56
58-70
74-87
92-112
114-132
133-141
142-148
154-168

IE (kcal/mol)
-65.22
132.80
32.24
124.11
-71.19
30.47
-15.26
6.25
52.19

HMM score
(% identity)
19.54 (20%)
9.43 (29%)
35.78 (40%)
19.85 (21%)
11.01 (13%)

25.15
72.14
2.87

hBID (2BID)

IE (kcal/mol)

16-31
35-43
81-101
107-116
121-138
147-164
169-182
185-194

416.53
269.45
58.92
84.50
116.45
-40.76
200.88
-160.94
100.14
259.49
2.59
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HMM score
(% identity)

c)
Helix
Number
1
2
3
4
5
6
7
8
9

mBID
(1DDB)
15-27
32-39
83-100
106-113
125-138
142-162
167-180
185-192

IE (kcal/mol)

HMM score
(% identity)

416.53
293.92
148.88
379.87
140.63
-40.76
200.88
-160.94

AVE
SD
⎜SD/AVE⎜

CED9
(1OHU)
75-78
79-95
110-139
145-154
167-186
191-212
213-218
220-240

119.13
179.90
1.52

IE (kcal/mol)
-93.60
-223.38
-395.92
39.50
-289.80
-383.65
36.98
50.05

HMM score
(% identity)

33.32 (26%)
16.57 (21%)

-157.47
190.35
1.21

d)
Helix
Number
1
2
3
4
5
6
7
8
9

KSHV BCL-2
(1K3K)
10-19
34-55
61-71
71-77
83-101
105-114
114-124
124-131
134-144

AVE
SD
⎜SD/AVE⎜

IE (kcal/mol)
51.83
-49.39
31.90
8.78
-138.25
32.15
58.84
-165.27
-91.53

HMM score
(% identity)

37.48 (41%)
10.25 (14%)
13.16 (57%)

-28.99
85.12
2.94

BHRF1
(1Q59)
7-19
44-61
61-73
80-90
98-118
121-138
139-146
152-157

IE (kcal/mol)

HMM score
(% identity)

137.76
372.44
193.53
485.57
-319.07
360.99
134.31
320.33
210.74
247.39
1.17

4.3.3 Peptide Binding Changes Helical IE Distribution
The pro-apoptotic proteins BCL-XL and CED9 are deposited in the PDB database in two
forms – free and peptide bound. This gave me the opportunity to explore how the helical stability
and packing change upon peptide binding. CED9 and BCL-XL, free and with bound peptide, are
depicted in Figure 21.
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Figure 21: The BH3 only peptide binds into the hydrophobic groove of BCL-XL.
Ribbon diagrams of BCL-XL and CED9 bound to the BIM peptide and the peptide from EGL-1. Each
peptide binds to the hydrophobic groove in both the BCL-XL and CED9 structure in a position that spans the most
unstable (based on helical IE values) regions of both structures (represented in the Tables 14-17). BCL-XL, CED9
protein – teal, BIM, EGL-1 peptide – sticks.
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The structural analysis demonstrated changes in the secondary structure upon peptide
binding. To resolve this issue and to obtain comparable values, I performed two sets of
calculations. The first set used the same residues for both the free and bound forms, irrespective
of any change in the secondary structure. The second set of calculations includes the values of
the binding energy from free and bound protein as they are designated in their PDB headers. This
approach enabled us to compare any changes in helical interaction energy relative to the resulting
changes in secondary structure caused by ligand (peptide) binding. Both set of calculations
yielded similar pattern of helical stability and packing. I discuss in the detail only data sets with
the same residues for both free and bound protein.
Computational calculations of helical stability were performed with the peptide removed.
The peptide was treated as a ligand and the energy of the binding was calculated. The ratio
|SD/AVE| decreased upon ligand binding in BCL-XL (Tables 14-16) and also in CED9 (Table
17). Free BCL-XL had a |SD/AVE| ratio of 4.38 in the complex with BIM 2.75, BAD 0.92 and
BAK 0.95. The interaction energy between BCL-XL and BAD peptide was the strongest (428.93 kcal/mol; Table 16) and the lowest was between BCL-XL and BAK (-114.90 kcal/mol;
Table 15) and BCL-XL and BIM (-132.76; Table 14). It is important to mention that the
peptides differ in the length by 33 amino acids in the BIM peptide, 16 amino acids in the BAK
and 25 amino acids in BAD. Despite the differences in the peptide length, BAD and BAK
peptides displayed different effects on the structural changes in BCL-XL compared to the BIM
peptide. The BAD and BAK peptide seemed to significantly destabilize all the helices in the
protein; the average energy values of the helices changed from -46.7 kcal/mol to 198.43 kcal/mol
for BAD (Table 16).
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Table 14: Helical stability of unbound BCL-XL and BCL-XL/BIM complex.
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to
changes in secondary structure. Changes in secondary structure (due to peptide binding) are shown in the second
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all
structures. As shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.

Helix
Number

BCL-XL
Sequence

1
2
3
4
5
6
7
8
Peptide

2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-194

AVE
SD
⎜SD/AVE⎜

(1MAZ)
Helix Energy
(kcal/mol)
-277.61
-342.32
98.15
104.33
-238.75
23.75
79.06
179.43

BCL-XL/BIM
Sequence
3-19
82-102
103-106
107-112
118-131
136-158
159-185
186-196
83-115

-46.74
204.69
4.38

(1PQ1)
Helix Energy
(kcal/mol)
-269.25
-223.13
75.03
113.62
39.71
-248.49
-0.82
123.52
-132.76
-48.73
169.20
3.47

BCL-XL/BIM
Sequence
2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-194
83-115

(1PQ1)
Helix Energy
(kcal/mol)
-227.68
-322.04
88.54
63.42
-326.84
-383.01
185.12
201.32
-132.76
-90.15
248.05
2.75

BIM peptide, on the other hand, caused significant stabilization of the helices in BCLXL; the average energy of the helices changes from -46.74 kcal/mol to -90.15. Despite the
different effects of the bound peptides on the structure of BCL-XL, the most dramatic energy
changes involved helices α1, α2, α7 and α8 in all cases of BIM, BAK and BAD peptide binding.
Furthermore, the ratio |SD/AVE| dropped below my cutoff for transitional proteins, and the
energy values for helical stability were more evenly distributed.
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Table 15: Helical stability of unbound BCL-XL and BCL-XL/BAK complex.
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to changes in
secondary structure. Changes in secondary structure (due to peptide binding) are shown in the second row. The
average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all structures. As
shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.
Helix
Number

BCL-XL
Sequence

1
2
3
4
5
6
7
8
9
Peptide

2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-194

AVE
SD
⎜SD/AVE⎜

(1MAZ)
Helix Energy
(kcal/mol)
-277.61
-342.32
98.15
104.33
-238.75
23.75
79.06
179.43

BCL-XL/BAK
Sequence
3-20
25-27
42-104
119-130
139-157
160-176
179-185
187-194
199-204
572-587

-46.74
204.69
4.38

(1BXL))
Helix Energy
(kcal/mol)
-148.96
152.58
301.80
285.24
-24.07
182.11
433.45
411.06
206.21
-114.90
199.93
190.81
0.95

BCL-XL/BAK
Sequence
2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-94

(1BXL)
Helix Energy
(kcal/mol)
-3.96
114.14
261.44
284.91
6.44
174.31
427.25
411.06

572-587

-114.90
209.45
166.29
0.79

The final conclusion of the comparison among BIM, BAK and BAD binding to BCL-XL
were: (1) the |SD/AVE| ratio significantly decreased in all cases; (2) there were significant
changes in the interaction energy values from many of the helices; and (3) the bound peptide
interacted with the protein at regions that have some of the highest interaction energy values
when the protein was in the unbound form. This indicates that one can differentiate not only the
transitional proteins from others, but also enable the prediction of the regions within the protein
where the ligand will most likely bind.
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Table 16: Helical stability of unbound BCL-XL and BCL-XL/BAD complex.
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to
changes in secondary structure. Changes in secondary structure (due to peptide binding) are shown in the second
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all
structures. As shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.
Helix
Number

BCL-XL
Sequence

1
2
3
4
5
6
7
8
Peptide

2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-194

AVE
SD
⎜SD/AVE⎜

(1MAZ)
Helix Energy
(kcal/mol)
-277.61
-342.32
98.15
104.33
-238.75
23.75
79.06
179.43

BCL-XL/BAD
Sequence
2-25
27-31
45-105
106-110
122-136
139-161
164-181
183-212
301-325

-46.74
204.69
4.38

(1G5J)
Helix Energy
(kcal/mol)
-71.21
185.25
328.18
-43.49
298.20
460.95
190.22
519.87
-428.94

BCL-XL/BAD
Sequence
2-19
84-100
106-112
120-131
137-156
160-177
179-184
187-194
301-325

233.50
214.03
0.92

(1G5J)
Helix Energy
(kcal/mol)
53.86
-14.41
254.60
285.00
26.70
186.74
383.22
411.75
-428.94
198.43
163.07
0.82

Table 17: Helical stability of unbound CED9and CED9/EGL1 complex.
CED9 is shown in the table with calculations using the same atoms (not only helical regions) due to
changes in secondary structure. Changes in secondary structure (due to peptide binding) are shown in the second
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all
structures. As shown, peptide binding results in a minor decrease in SD/AVE values for CED9.
Helix
Number

CED9
Sequence

1
2
3
4
5
6
7
8
Peptide

75-78
79-95
110-139
145-154
167-186
191-212
213-218
220-240

AVE
SD
⎜SD/AVE⎜

(1OHU)
Helix Energy
(kcal/mol)
-93.60
-223.38
-395.92
39.50
-289.80
-383.65
36.98
50.05

CED9/EGL1
Sequence
75-78
79-95
110-140
141-145
146-159
167-187
191-211
220-236

-157.48
190.35
1.21

(1TY4)
Helix Energy
(kcal/mol)
1.87
-180.92
-241.03
30.87
-33.44
-155.06
-387.51
-23.00
-246.85

CED9/EGL1
Sequence
75-78
79-95
110-139
145-154
167-186
191-212
213-218
220-240

(1TY4)
Helix Energy
(kcal/mol)
6.33
-180.92
-262.34
-29.58
-240.55
-340.39
51.00
-23.00
-246.85
-127.43
146.10
1.15
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4.4 DISCUSSION

The BCL-2 family proteins are crucial regulators of mitochondrial apoptotic pathway.
Their activity is thought to be regulated by significant changes in their 3D structure. The analysis
of helical stability expressed as helical interaction energy (IE) revealed significant trends in their
IE distribution. These transitional proteins displayed regions of high helical stability
accompanied by regions that were relatively unstable.
The BCL-2 family members were partitioned in subgroups according to the distribution
of the helical stability. BAX, BCL-XL, BCL-2, BCL-W and the BCL-2 homolog from KSHV
displayed stable core helix surrounded by rather unstable outer helices. BCL-2 and BCL-XL
formed separate subgroups by displaying higher stability of α1 and α2 than their core helices. The
differences in the distribution of helical stability and packing could be related to the structural
and functional differences among BCL-2 family members. BAX, BCL-XL, BCL-2, BCL-W and
the BCL-2 homolog from KSHV have pronounced hydrophobic pockets which modulate the
activity of the proteins. Depending on the binding partner of the hydrophobic pocket, the
occupancy of the pocket inhibits or facilitates the activity of the apoptotic protein. BCL-2 and
BCL-XL also have a very long flexible loop between helices α1 and α2, which play a significant
role in the regulation of the activity of BCL-XL and BCL-2 (Borner 2003;Petros et al. 2004).
The BH3-only protein BID and the BCL-2 homolog from EBV did not group with the other
members of BCL-2 family, indicating that varied helical stability mediates structural transitions
specific to the function of the protein.
The occupancy of the hydrophobic pocket is predicted to regulate the intracellular
distribution of these proteins and consequently their activity (Denisov et al. 2003;Petros et al.
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2004;Petros et al. 2000;Tschammer et al. 2007b). Latent BAX is a cytosolic protein in healthy
cells, with the α9 helix sequestered within a hydrophobic pocket (Suzuki et al. 2000). During
apoptosis, BAX may undergo a conformational change that exposes transmembrane domains,
helix α9 and possibly helix α5 and α6, to promote mitochondrial membrane binding (Annis et
al. 2005). Similarly, BCL-W has its C-terminal helix folded into its hydrophobic pocket when
localized in the cytosol. In response to apoptotic stimuli, helix α9 is exposed and inserts into the
mitochondrial membranes (Denisov et al. 2003). The activity of the BCL-2 family proteins thus
seems to be regulated by the occupancy of the hydrophobic pocket. It is possible that the also the
helical stability of these proteins is regulated by the occupancy of the hydrophobic pocket. I
predict that the more stable structures, with hydrophobic pockets occupied by their C-terminal
helices, such as BAX or BCL-W, will not undergo structural transitions unless their C-terminal
helix is released or displaced from the pocket. This C-terminal α9 helix is one of the helices that
stabilize the 3D structure of the protein. These data support the role of the α9 helix as a type of
transitional switch that allows translocation of BAX from the cytosol to the mitochondria upon
apoptotic stimuli(Tschammer et al. 2007b).
BCL-XL, whose structure was determined with both an unoccupied pocket (displaying
the most flexible helices) and with peptides bound, demonstrated that the structural stabilization
occur upon binding of the BH3 peptides (BIM, BAD and BAK), but the extent of structural
changes depends on the binding partner. These data corroborate binding studies that were done
with BH3 peptides measured by plasmon resonance (Kuwana et al. 2005). In this study, the BIM
peptide had a dissociation constant of 9.2 ± 5.3 nM, and the BAD peptide had a binding constant
of 2.05 ± 0.8 nM. These data correlate well to my calculated binding energies for the peptides
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and demonstrates that the increase in (shown through my calculations and the dissociation
constants) affinity may regulate how much of a structural transition BCL-XL undergoes during
binding to different partners.
This may be a direct link to the functional role that each BCL-2 family member has in the
presence of various BH3 containing proteins. My findings indicate that the function of the BCL2 family members may be dependent on which BH-3 containing proteins interact with. The
current dogma states that the BH3-only proteins can be functionally subdivided into activators,
like BID and BIM, which induce the oligomerization of BAX and BAK, and sensitizers, like
BAD, NOXA or PUMA, which directly bind anti-apoptotic proteins (Certo et al. 2006). I
propose hat these activators or sensitizers both bind anti-apoptotic proteins, but may have
different consequences upon the stability of the anti-apoptotic proteins and its ability to transition
during apoptosis. The binding of BH3-peptides (or the entire BH3-only proteins) like that of
BAD to the hydrophobic groove may “lock” BCL-2 family protein into a structural state that is
resistant to conformational transitions, thereby negating its pro- or anti- apoptotic function, while
binding BIM may favor a degree of transitioning. By understanding how the interaction energy
(in the reference to the in vitro binding data) correlates with the level of structural transition, a
potential link between the various functions of BCL-2 family member with the respect to their
BH3 protein binding partners can be established.
The analysis of the helical stability contributes certain degree of knowledge to the
understanding how BCL-2 regulators of apoptosis undergo transitions, but additional studies are
required that better represent the biological conditions in vivo. Many of BCL-2 family proteins
are involved in membrane binding that allows the insertion into various organelles, most
noticeably mitochondria. These types of structural transitions cannot be accurately represented
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by the analysis where the proteins are considered static structures. The nature of these
transitional mechanisms, which are not amendable to current methods for high resolution
structure determination (because of the membrane binding and sample heterogeneity), represents
the dynamic nature of polypeptides and give insight into their mechanism of action. In the
absence of such high resolution data, our analysis of the static stability of the individual helices
gives insight into the protein’s mechanism of action, as well as enabling classification and
identifying peptide binding location.
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5 CONCLUSIONS
Apoptosis is essential for the development and the maintenance of cellular homeostasis.
Proteins of the BCL-2 family are key modulators of this process.

In response to diverse

apoptotic stimuli, the pro-apoptotic member of BCL-2 family BAX redistributes from the cytosol
to the mitochondria or endoplasmic reticulum and primes cells for death. The activation of this
lethal protein is poorly understood.
My study is comprised of three parts. First part was governed by the hypothesis that the
C-terminal α9 helix of BAX crucially regulates the intracellular distribution and activation of
BAX, not as putative membrane domain, but as “molecular switch” that triggers conformational
changes of BAX needed for the redistribution from the cytosol to mitochondrial membrane.
Computational analysis using molecular mechanics and computational docking using web based
server GRAMM-X indicated that the C-terminal α9 helix of BAX can dock into the hydrophobic
pocket of BAX in two directions – in forward orientation that occurs during self-association and
reverse orientation that might occur during dimerization. Co-immunoprecipitation and
crosslinking demonstrated that an EGFP tagged α9 helix of BAX associated with BAX lacking
its C-terminal. Peptide encoding last 20 amino acids of BAX efficiently induced the translocation
of wild type and C-terminally truncated BAX into the mitochondria, further confirming that the
C-terminal α9 helix of BAX serves as a “molecular switch”, triggering conformational changes
in BAX which are needed for the redistribution from cytosol to mitochondria. This is novel
discovery, which is not important only to reach a fuller understanding of how BAX is regulated,
but will enable the design of novel therapeutics which could modulate the activity of BAX.
Studies using peptides encoding BH3 domain sequences or small-molecule BCL-2 antagonists,
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which bound to the hydrophobic groove of BCL-2 with high affinity, showed that these
substances can act as competitive inhibitors of BCL-2 function, inducing the selective death of
cancer cells. We propose that similar peptides or small molecules derived from the sequence of
C-terminal α9 of BAX could in the same fashion inhibit or activate the function of BAX. As
example a small molecule could cause a displacement of self-associated C-terminus of BAX,
triggering conformational changes in BAX that lead to association with mitochondrial outer
membrane and induction of apoptosis. Specific targeting of such a compound to tumors or cancer
cells could trigger the apoptosis of these pathogenic cells. On the other hand, the design of a
peptide that would “lock” the C-terminal α9 of BAX and prevent its release could protect cells
from apoptosis in e.g. neurodegenerative, myocardic and ischemic diseases.
The second part of the study was computational and focused on examining the helical
stability of proteins. As a result my study, it became evident that BAX has a broad variation in
the distribution of the helical interaction energy, ranging from stable core helix to destabilized
helices on the periphery. This led to hypothesis that proteins which undergo 3D structural
transitions during execution of their function have broad variation in the distribution of the
helical interaction energy compared to the proteins which do not undergo such transitions.
Computational analysis of a random set of all-alpha proteins from the Protein Data Bank
demonstrated that the analysis of the helical interaction energy within the proteins yields a
measure of the propensity of the protein to undergo transitions and can be used to predict the
likelihood that the protein analyzed will undergo transitions. No measure of the propensity for
such transitions is currently available for stable proteins that are involved in signaling. Hence, I
developed a novel computational method for the prediction of the propensity for transition. With
an increasing number of protein structures being determined by structural genomics, parameters,
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such as the propensity for transition, will provide needed information about the areas of least
stability within a protein’s 3D structure and possibly identify novel region(s) of contacts for the
biological molecules that are involved in the interaction(s). This information may aid in the
design of experiments to elucidate a protein’s function in the context of its interaction with the
surfaces with other protein or ligands.
The third part of the study was a computational analysis of the BCL-2 family, using the
computational method developed in the second part of the study. I used this method to estimate
the propensity of individual BCL-2 family members to undergo transitions in relation to changes
in the distribution of the helical interaction energy upon ligand binding. The analysis resulted in
a strong correlation between the computational results and published experimental findings,
confirming the ability of the computational method to predict transitional proteins. Most
importantly, the computational method revealed that the binding of the ligand, such as a peptide,
to a protein can have stabilizing or destabilizing effect, carrying important consequences for the
activation or repression of the protein. One example of this is the previously described dual
function of the C-terminal α9 of BAX that is dependent upon the orientation of its binding to the
hydrophobic groove. A similar trend was observed for the anti-apoptotic protein, BCL-XL, in
that binding of a BH3 peptide from BIM, stabilized the protein, while binding of a BH3 peptide
from BAD within the same groove destabilized the protein. Furthermore, the distribution of IE
values decreased in the specific regions of the proteins which displayed the least structural
stability, indicating a potential application for the identification of the binding site for the ligand.
This computational analysis thus contributes to the better understanding of the function and
regulation of the BCL-2 family members.

110

REFERENCES

1. Allinger,N.L., Geise,H.J., Pyckhout,W., Paquette,L.A., and Gallucci,J.C. 1989a.
Structures of Norbornane and Dodecahedrane by Molecular Mechanics Calculations
(Mm3), X-Ray Crystallography, and Electron-Diffraction. Journal of the American
Chemical Society 111:1106-1114.
2. Allinger,N.L., Yuh,Y.H., and Lii,J.H. 1989b. Molecular Mechanics - the Mm3 ForceField for Hydrocarbons .1. Journal of the American Chemical Society 111:8551-8566.
3. Allinger,N. 1976. Calculation of molecular structure and energy by force-field methods.
Adv. Phys. Org. Chem. 13:1-85.
4. Annis,M.G., Soucie,E.L., Dlugosz,P.J., Cruz-Aguado,J.A., Penn,L.Z., Leber,B., and
Andrews,D.W. 2005. Bax forms multispanning monomers that oligomerize to
permeabilize membranes during apoptosis. EMBO J 24:2096-2103.
5. Antonsson,B., Montessuit,S., Lauper,S., Eskes,R., and Martinou,J.C. 2000. Bax
oligomerization is required for channel-forming activity in liposomes and to trigger
cytochrome c release from mitochondria. Biochem J 345 Pt 2:271-278.
6. Antonsson,B., Montessuit,S., Sanchez,B., and Martinou,J.C. 2001. Bax Is Present as a
High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic
Cells. J. Biol. Chem. 276:11615-11623.
7. Arokium,H., Camougrand,N., Vallette,F.M., and Manon,S. 2004. Studies of the
Interaction of Substituted Mutants of BAX with Yeast Mitochondria Reveal That the Cterminal Hydrophobic {alpha}-Helix Is a Second ART Sequence and Plays a Role in the
Interaction with Anti-apoptotic BCL-xL. J. Biol. Chem. 279:52566-52573.
8. Bartels,C., Widmer,A., and Ehrhardt,C. 2005. Absolute free energies of binding of
peptide analogs to the HIV-1 protease from molecular dynamics simulations. J Comput
Chem 26:1294-1305.
9. Belaud-Rotureau,M.A., Leducq,N., Macouillard,P., Diolez,P., Lacoste,L., Lacombe,F.,
Bernard,P., and Belloc,F. 2000. Early transitory rise in intracellular pH leads to Bax
conformation change during ceramide-induced apoptosis. Apoptosis 5:551-560.
10. Berjanskii,M.V. and Wishart,D.S. 2005. A simple method to predict protein flexibility
using secondary chemical shifts. J Am Chem Soc 127:14970-14971.

111

11. Berman,H.M., Westbrook,J., Feng,Z., Gilliland,G., Bhat,T.N., Weissig,H.,
Shindyalov,I.N., and Bourne,P.E. 2000. The Protein Data Bank. Nucleic Acids Res.
28:235-242.
12. Borner,C. 2003. The Bcl-2 protein family: sensors and checkpoints for life-or-death
decisions. Mol Immunol 39:615-647.
13. Bouillet,P. and Strasser,A. 2002. BH3-only proteins -- evolutionarily conserved
proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell
Sci. 115:1567-1574.
14. Brooks,B.R., Bruccoleri,R.E., Olafson,B.D., Swaminathan,S., States,D.J., and
Karplus,M. 1983. A Program for Marcomolecular Energy, Minimization, and Dynamics
Calculations. J Comput Chem 4:187-217.
15. Brusca,J.S. and Radolf,J.D. 1994. Isolation of integral membrane proteins by phase
partitioning with Triton X-114. Methods Enzymol 228:182-193.
16. Cartron,P.F., Oliver,L., Mayat,E., Meflah,K., and Vallette,F.M. 2004. Impact of pH on
Bax alpha conformation, oligomerisation and mitochondrial integration. FEBS Lett
578:41-46.
17. Case,D.A., Cheatham,T.E., Darden,T., Gohlke,H., Luo,R., Merz,K.M., Onufriev,A.,
Simmerling,C., Wang,B., and Woods,R.J. 2005. The Amber biomolecular simulation
programs. J Comput Chem 26:1668-1688.
18. Certo,M., Del Gaizo Moore,V., Nishino,M., Wei,G., Korsmeyer,S., Armstrong,S.A., and
Letai,A. 2006. Mitochondria primed by death signals determine cellular addiction to
antiapoptotic BCL-2 family members. Cancer Cell 9:351-365.
19. Cheng,Y., Zhang,Y., and McCammon,J.A. 2005. How does the cAMP-dependent protein
kinase catalyze the phosphorylation reaction: an ab initio QM/MM study. J Am Chem Soc
127:1553-1562.
20. Chipuk,J.E., Kuwana,T., Bouchier-Hayes,L., Droin,N.M., Newmeyer,D.D., Schuler,M.,
and Green,D.R. 2004. Direct Activation of Bax by p53 Mediates Mitochondrial
Membrane Permeabilization and Apoptosis. Science 303:1010-1014.
21. Chou,J.J., Li,H., Salvesen,G.S., Yuan,J., and Wagner,G. 1999. Solution structure of BID,
an intracellular amplifier of apoptotic signaling. Cell 96:615-624.
22. Cory,S., Huang,D.C., and Adams,J.M. 2003. The Bcl-2 family: roles in cell survival and
oncogenesis. Oncogene 22:8590-8607.
23. Cosulich,S.C., Worrall,V., Hedge,P.J., Green,S., and Clarke,P.R. 1997. Regulation of
apoptosis by BH3 domains in a cell-free system. Curr Biol 7:913-920.
112

24. Das,A.K., Cohen,P.W., and Barford,D. 1998. The structure of the tetratricopeptide
repeats of protein phosphatase 5: implications for TPR-mediated protein-protein
interactions. EMBO J 17:1192-1199.
25. Degenhardt,K., Sundararajan,R., Lindsten,T., Thompson,C., and White,E. 2002. Bax and
Bak Independently Promote Cytochrome c Release from Mitochondria. J. Biol. Chem.
277:14127-14134.
26. del Mar,M., Corbalan-Garcia,S., and Gomez-Fernandez,J.C. 2001. Conformation of the
C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with
membranes. Biochemistry 40:9983-9992.
27. Demarest,S.J., Martinez-Yamout,M., Chung,J., Chen,H., Xu,W., Dyson,H.J.,
Evans,R.M., and Wright,P.E. 2002. Mutual synergistic folding in recruitment of
CBP/p300 by p160 nuclear receptor coactivators. Nature 415:549-553.
28. Demaurex,N. 2002. pH Homeostasis of Cellular Organelles. News Physiol Sci 17:1-5.
29. Denisov,A.Y., Madiraju,M.S.R., Chen,G., Khadir,A., Beauparlant,P., Attardo,G.,
Shore,G.C., and Gehring,K. 2003. Solution Structure of Human BCL-w:
MODULATION OF LIGAND BINDING BY THE C-TERMINAL HELIX. J. Biol.
Chem. 278:21124-21128.
30. Dharap,S.S., Qiu,B., Williams,G.C., Sinko,P., Stein,S., and Minko,T. 2003. Molecular
targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J
Control Release 91:61-73.
31. Dijkers,P.F., Medema,R.H., Lammers,J.W., Koenderman,L., and Coffer,P.J. 2000.
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead
transcription factor FKHR-L1. Curr Biol 10:1201-1204.
32. Dosztanyi,Z., Csizmok,V., Tompa,P., and Simon,I. 2005. IUPred: web server for the
prediction of intrinsically unstructured regions of proteins based on estimated energy
content. Bioinformatics 21:3433-3434.
33. Dumont,M.E. and Richards,F.M. 1988. The pH-dependent conformational change of
diphtheria toxin. J. Biol. Chem. 263:2087-2097.
34. Earnshaw,W.C., Martins,L.M., and Kaufmann,S.H. 1999. Mammalian caspases:
structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem
68:383-424.
35. Eddy,S.R. 1996. Hidden Markov models. Curr Opin Struct Biol 6:361-365.
36. Ekert,P.G., Jabbour,A.M., Manoharan,A., Heraud,J.E., Yu,J., Pakusch,M.,
Michalak,E.M., Kelly,P.N., Callus,B., Kiefer,T., Verhagen,A., Silke,J., Strasser,A.,
113

Borner,C., and Vaux,D.L. 2006. Cell death provoked by loss of interleukin-3 signaling is
independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood 108:14611468.
37. Epand,R.F., Martinou,J.C., Montessuit,S., and Epand,R.M. 2003. Transbilayer lipid
diffusion promoted by Bax: implications for apoptosis. Biochemistry 42:14576-14582.
38. Galkin,A., Sarikaya,E., Lehmann,C., Howard,A., and Herzberg,O. 2004. X-ray structure
of HI0817 from Haemophilus influenzae: protein of unknown function with a novel fold.
Proteins 57:874-877.
39. Garcia-Saez,A.J., Coraiola,M., la Serra,M., Mingarro,I., Menestrina,G., and Salgado,J.
2005. Peptides Derived from Apoptotic Bax and Bid Reproduce the Poration Activity of
the Parent Full-Length Proteins. Biophys. J. 88:3976-3990.
40. Garcia-Saez,A.J., Coraiola,M., Serra,M.D., Mingarro,I., Muller,P., and Salgado,J. 2006.
Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid
pores. FEBS J. 273:971-981.
41. Gardai,S.J., Hildeman,D.A., Frankel,S.K., Whitlock,B.B., Frasch,S.C., Borregaard,N.,
Marrack,P., Bratton,D.L., and Henson,P.M. 2004. xPhosphorylation of Bax Ser184 by
Akt Regulates Its Activity and Apoptosis in Neutrophils. J. Biol. Chem. 279:2108521095.
42. Graham,F.L., Smiley,J., Russell,W.C., and Nairn,R. 1977. Characteristics of a human cell
line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
43. Gross,A., McDonnell,J.M., and Korsmeyer,S.J. 1999. BCL-2 family members and the
mitochondria in apoptosis. Genes & Dev. 13:1899-1911.
44. Hanson,G.T., McAnaney,T.B., Park,E.S., Rendell,M.E., Yarbrough,D.K., Chu,S., Xi,L.,
Boxer,S.G., Montrose,M.H., and Remington,S.J. 2002. Green fluorescent protein variants
as ratiometric dual emission pH sensors. 1. Structural characterization and preliminary
application. Biochemistry 41:15477-15488.
45. Hinchliffe,A. 2006. Molecular Modeling for Beginners. Wiley: West Suusex.
46. Hinds,M.G., Lackmann,M., Skea,G.L., Harrison,P.J., Huang,D.C.S., and Day,C.L. 2003.
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological
activity. EMBO J. 22:1497-1507.
47. Hope,M.J. and Cullis,P.R. 1987. Lipid asymmetry induced by transmembrane pH
gradients in large unilamellar vesicles. J. Biol. Chem. 262:4360-4366.

114

48. Hough,E., Hansen,L.K., Birknes,B., Jynge,K., Hansen,S., Hordvik,A., Little,C.,
Dodson,E., and Derewenda,Z. 1989. High-resolution (1.5 A) crystal structure of
phospholipase C from Bacillus cereus. Nature 338:357-360.
49. Hsu,Y.T., Wolter,K.G., and Youle,R.J. 1997. Cytosol-to-membrane redistribution of Bax
and Bcl-XL duringáapoptosis. PNAS 94:3668-3672.
50. Hsu,Y.T. and Youle,R.J. 1998. Bax in Murine Thymus Is a Soluble Monomeric Protein
That Displays Differential Detergent-induced Conformations. J. Biol. Chem. 273:1077710783.
51. Hsu,Y.T. and Youle,R.J. 1997. Nonionic Detergents Induce Dimerization among
Members of the Bcl-2 Family. J. Biol. Chem. 272:13829-13834.
52. Huang,Q., Petros,A.M., Virgin,H.W., Fesik,S.W., and Olejniczak,E.T. 2003. Solution
structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J
Mol Biol 332:1123-1130.
53. Huang,Q., Petros,A.M., Virgin,H.W., Fesik,S.W., and Olejniczak,E.T. 2002. Solution
structure of a Bcl-2 homolog from Kaposi sarcoma virus. PNAS 99:3428-3433.
54. Jeong,S.Y., Gaume,B., Lee,Y.J., Hsu,Y.T., Ryu,S.W., Yoon,S.H., and Youle,R.J. 2004.
Bcl-xL sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers.
EMBO J. 23:2146-2155.
55. Karbowski,M., Norris,K.L., Cleland,M.M., Jeong,S.Y., and Youle,R.J. 2006. Role of Bax
and Bak in mitochondrial morphogenesis. Nature 443:658-662.
56. Karbowski,M., Lee,Y.J., Gaume,B., Jeong,S.Y., Frank,S., Nechushtan,A., Santel,A.,
Fuller,M., Smith,C.L., and Youle,R.J. 2002. Spatial and temporal association of Bax with
mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159:931-938.
57. Karplus,K., Barrett,C., and Hughey,R. 1998. Hidden Markov models for detecting remote
protein homologies. Bioinformatics 14:846-856.
58. Kelley,L.A., Gardner,S.P., and Sutcliffe,M.J. 1996a. An automated approach for
clustering an ensemble of NMR-derived protein structures into conformationally related
subfamilies. Protein Eng 9:1063-1065.
59. Kelley,L.A., Gardner,S.P., and Sutcliffe,M.J. 1997. An automated approach for defining
core atoms and domains in an ensemble of NMR-derived protein structures. Protein Eng
10:737-741.
60. Kelley,L.A., Gardner,S.P., and Sutcliffe,M.J. 1996b. An automated approach for
clustering an ensemble of NMR-derived protein structures into conformationally related
subfamilies. Protein Eng. 9:1063-1065.
115

61. Keough,D.T., Brereton,I.M., de Jersey,J., and Guddat,L.W. 2005. The crystal structure of
free human hypoxanthine-guanine phosphoribosyltransferase reveals extensive
conformational plasticity throughout the catalytic cycle. J Mol Biol 351:170-181.
62. Khaled,A.R., Kim,K., Hofmeister,R., Muegge,K., and Durum,S.K. 1999. From the
Cover: Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria
through a rise in intracellular pH. PNAS 96:14476-14481.
63. Kim,H.Y. and Cho,Y. 1997. Structural similarity between the pocket region of
retinoblastoma tumour suppressor and the cyclin-box. Nat Struct Biol 4:390-395.
64. Kim,J.M., Bae,H.R., Park,B.S., Lee,J.M., Ahn,H.B., Rho,J.H., Yoo,K.W., Park,W.C.,
Rho,S.H., Yoon,H.S., and Yoo,Y.H. 2003. Early Mitochondrial Hyperpolarization and
Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment
Epithelial Cells. J. Pharmacol. Exp. Ther. 305:474-481.
65. Krammer,P.H. 2000. CD95's deadly mission in the immune system. Nature 407:789-795.
66. Kuwana,T., Bouchier-Hayes,L., Chipuk,J.E., Bonzon,C., Sullivan,B.A., Green,D.R., and
Newmeyer,D.D. 2005. BH3 domains of BH3-only proteins differentially regulate Baxmediated mitochondrial membrane permeabilization both directly and indirectly. Mol
Cell 17:525-535.
67. Lagadic-Gossmann,D., Huc,L., and Lecureur,V. 2004. Alterations of intracellular pH
homeostasis in apoptosis: origins and roles. Cell Death Differ 11:953-961.
68. Letai,A. 2005. Pharmacological manipulation of Bcl-2 family members to control cell
death. J. Clin. Invest. 115:2648-2655.
69. Lii,J.H. and Allinger,N.L. 1989. Molecular Mechanics - the Mm3 Force-Field for
Hydrocarbons .2. Vibrational Frequencies and Thermodynamics. Journal of the American
Chemical Society 111:8566-8575.
70. Lii,J.H. and Allinger,N.L. 1994. Directional Hydrogen-Bonding in the Mm3 Force-Field
.1. Journal of Physical Organic Chemistry 7:591-609.
71. Lii,J.H. and Allinger,N.L. 1998a. Directional hydrogen bonding in the MM3 force field:
II. Journal of Computational Chemistry 19:1001-1016.
72. Lii,J. and Allinger,N. 1998b. Directional hydrogen bonding in the MM3 force field:II.
Computational Chemistry 19:1001-1016.
73. Lin,K., Simossis,V.A., Taylor,W.R., and Heringa,J. 2005. A simple and fast secondary
structure prediction method using hidden neural networks. Bioinformatics 21:152-159.
74. Linseman,D.A., Butts,B.D., Precht,T.A., Phelps,R.A., Le,S.S., Laessig,T.A.,
Bouchard,R.J., Florez-McClure,M.L., and Heidenreich,K.A. 2004. Glycogen Synthase
116

Kinase-3{beta} Phosphorylates Bax and Promotes Its Mitochondrial Localization during
Neuronal Apoptosis. J. Neurosci. 24:9993-10002.
75. Lipford,E., Wright,J.J., Urba,W., Whang-Peng,J., Kirsch,I.R., Raffeld,M., Cossman,J.,
Longo,D.L., Bakhshi,A., and Korsmeyer,S.J. 1987. Refinement of lymphoma
cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70:1816-1823.
76. Liu,X., Dai,S., Zhu,Y., Marrack,P., and Kappler,J.W. 2003. The structure of a BclxL/Bim fragment complex: implications for Bim function. Immunity 19:341-352.
77. Llopis,J., McCaffery,J.M., Miyawaki,A., Farquhar,M.G., and Tsien,R.Y. 1998.
Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green
fluorescent proteins. PNAS 95:6803-6808.
78. Locksley,R.M., Killeen,N., and Lenardo,M.J. 2001. The TNF and TNF receptor
superfamilies: integrating mammalian biology. Cell 104:487-501.
79. Lu,L., Arakaki,A.K., Lu,H., and Skolnick,J. 2003. Multimeric Threading-Based
Prediction of Protein-Protein Interactions on a Genomic Scale: Application to the
Saccharomyces cerevisiae Proteome. Genome Res. 13:1146-1154.
80. Machida,K. 2007. Principles of Molecular Mechanics. Wiley.
81. Marani,M., Tenev,T., Hancock,D., Downward,J., and Lemoine,N.R. 2002. Identification
of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To
Trigger Apoptosis. Mol. Cell. Biol. 22:3577-3589.
82. Matsuyama,S., Llopis,J., Deveraux,Q.L., Tsien,R.Y., and Reed,J.C. 2000. Changes in
intramitochondrial and cytosolic pH: early events that modulate caspase activation during
apoptosis. Nat Cell Biol 2:318-325.
83. McDonnell,J.M., Fushman,D., Milliman,C.L., Korsmeyer,S.J., and Cowburn,D. 1999.
Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic
agonists and antagonists. Cell 96:625-634.
84. McGuffin,L.J. and Jones,D.T. 2003. Improvement of the GenTHREADER method for
genomic fold recognition. Bioinformatics 19:874-881.
85. Meiler,J. and Baker,D. 2006. ROSETTALIGAND: protein-small molecule docking with
full side-chain flexibility. Proteins 65:538-548.
86. Minko,T., Dharap,S.S., and Fabbricatore,A.T. 2003. Enhancing the efficacy of
chemotherapeutic drugs by the suppression of antiapoptotic cellular defense. Cancer
Detect Prev 27:193-202.
87. Muchmore,S.W., Sattler,M., Liang,H., Meadows,R.P., Harlan,J.E., Yoon,H.S.,
Nettesheim,D., Chang,B.S., Thompson,C.B., Wong,S.L., Ng,S.L., and Fesik,S.W. 1996.
117

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
Nature 381:335-341.
88. Nechushtan,A., Smith,C.L., Hsu,Y.T., and Youle,R.J. 1999. Conformation of the Bax Cterminus regulates subcellular location and cell death. EMBO J. 18:2330-2341.
89. Nechushtan,A., Smith,C.L., Lamensdorf,I., Yoon,S.H., and Youle,R.J. 2001. Bax and
Bak Coalesce into Novel Mitochondria-associated Clusters during Apoptosis. J. Cell
Biol. 153:1265-1276.
90. Nelson,D.A. and White,E. 2004. Exploiting different ways to die. Genes & Dev. 18:12231226.
91. Nomura,M., Shimizu,S., Sugiyama,T., Narita,M., Ito,T., Matsuda,H., and Tsujimoto,Y.
2003. 14-3-3 Interacts Directly with and Negatively Regulates Pro-apoptotic Bax. J. Biol.
Chem. 278:2058-2065.
92. Ohtsuka,T., Ryu,H., Minamishima,Y.A., Macip,S., Sagara,J., Nakayama,K.I.,
Aaronson,S.A., and Lee,S.W. 2004. ASC is a Bax adaptor and regulates the p53-Bax
mitochondrial apoptosis pathway. Nat Cell Biol 6:121-128.
93. Orth,P., Saenger,W., and Hinrichs,W. 1999. Tetracycline-chelated Mg2+ ion initiates
helix unwinding in Tet repressor induction. Biochemistry 38:191-198.
94. Patel,L., Abate,C., and Curran,T. 1990. Altered protein conformation on DNA binding by
Fos and Jun. Nature 347:572-575.
95. Petros,A.M., Nettesheim,D.G., Wang,Y., Olejniczak,E.T., Meadows,R.P., Mack,J.,
Swift,K., Matayoshi,E.D., Zhang,H., Thompson,C.B., and Fesik,S.W. 2000. Rationale for
Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical
studies. Protein Sci. 9:2528-2534.
96. Petros,A.M., Olejniczak,E.T., and Fesik,S.W. 2004. Structural biology of the Bcl-2
family of proteins. Biochim Biophys Acta 1644:83-94.
97. Petros,A.M., Medek,A., Nettesheim,D.G., Kim,D.H., Yoon,H.S., Swift,K.,
Matayoshi,E.D., Oltersdorf,T., and Fesik,S.W. 2001. Solution structure of the
antiapoptotic protein bcl-2. PNAS 98:3012-3017.
98. Pryde,J.G. 1998. Partitioning of proteins in Triton X-114. Methods Mol Biol 88:23-33.
99. Putcha,G.V., Moulder,K.L., Golden,J.P., Bouillet,P., Adams,J.A., Strasser,A., and
Johnson,E.M. 2001. Induction of BIM, a proapoptotic BH3-only BCL-2 family member,
is critical for neuronal apoptosis. Neuron 29:615-628.

118

100. Puthalakath,H., Huang,D.C., O'Reilly,L.A., King,S.M., and Strasser,A. 1999. The
proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the
dynein motor complex. Mol Cell 3:287-296.
101. Qin,H., Srinivasula,S.M., Wu,G., Fernandes-Alnemri,T., Alnemri,E.S., and Shi,Y. 1999.
Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1.
Nature 399:549-557.
102. Rodriguez,R., Chinea,G., Lopez,N., Pons,T., and Vriend,G. 1998. Homology modeling,
model and software evaluation: three related resources. Bioinformatics 14:523-528.
103. Ruffolo,S.C., Breckenridge,D.G., Nguyen,M., Goping,I.S., Gross,A., Korsmeyer,S.J.,
Li,H., Yuan,J., and Shore,G.C. 2000. BID-dependent and BID-independent pathways for
BAX insertion into mitochondria. Cell Death Differ 7:1101-1108.
104. Sattler,M., Liang,H., Nettesheim,D., Meadows,R.P., Harlan,J.E., Eberstadt,M.,
Yoon,H.S., Shuker,S.B., Chang,B.S., Minn,A.J., Thompson,C.B., and Fesik,S.W. 1997.
Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of
Apoptosis. Science 275:983-986.
105. Schinzel,A., Kaufmann,T., Schuler,M., Martinalbo,J., Grubb,D., and Borner,C. 2004.
Conformational control of Bax localization and apoptotic activity by Pro168. J. Cell Biol.
164:1021-1032.
106. Schlesinger,P.H., Gross,A., Yin,X.M., Yamamoto,K., Saito,M., Waksman,G., and
Korsmeyer,S.J. 1997. Comparison of the ion channel characteristics of proapoptotic BAX
and antiapoptoticáBCL-2. PNAS 94:11357-11362.
107. Schlick,T. 2006. Molecular Modeling and Simulation; An Interdisciplinary Guide.
Springer: New York.
108. Shangary,S. and Johnson,D.E. 2002. Peptides derived from BH3 domains of Bcl-2 family
members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax
oligomerization, induction of cytochrome c release, and activation of cell death.
Biochemistry 41:9485-9495.
109. Sharma,A., Sharma,I., Kogkasuriyachai,D., and Kumar,N. 2003. Structure of a
gametocyte protein essential for sexual development in Plasmodium falciparum. Nat
Struct Biol 10:197-203.
110. Simonen,M., Keller,H., and Heim,J. 1997. The BH3 domain of Bax is sufficient for
interaction of Bax with itself and with other family members and it is required for
induction of apoptosis. Eur. J. Biochem. 249:85-91.
111. Soding,J., Biegert,A., and Lupas,A.N. 2005. The HHpred interactive server for protein
homology detection and structure prediction. Nucleic Acids Res. 33:W244-W248.
119

112. Steed,P.M. and Wanner,B.L. 1993. Use of the rep technique for allele replacement to
construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role
for the PhoU protein in the phosphate regulon. J. Bacteriol. 175:6797-6809.
113. Stevens,R.C., Yokoyama,S., and Wilson,I.A. 2001. Global Efforts in Structural
Genomics. Science 294:89-92.
114. Suzuki,M., Youle,R.J., and Tjandra,N. 2000. Structure of Bax: coregulation of dimer
formation and intracellular localization. Cell 103:645-654.
115. Tafani,M., Cohn,J.A., Karpinich,N.O., Rothman,R.J., Russo,M.A., and Farber,J.L. 2002.
Regulation of Intracellular pH Mediates Bax Activation in HeLa Cells Treated with
Staurosporine or Tumor Necrosis Factor-alpha. J. Biol. Chem. 277:49569-49576.
116. Tovchigrechko,A. and Vakser,I.A. 2005a. Development and testing of an automated
approach to protein docking. Proteins 60:296-301.
117. Tovchigrechko,A. and Vakser,I.A. 2006a. GRAMM-X public web server for proteinprotein docking. Nucleic Acids Res. 34:W310-W314.
118. Tovchigrechko,A. and Vakser,I.A. 2005b. Development and testing of an automated
approach to protein docking. Proteins 60:296-301.
119. Tovchigrechko,A. and Vakser,I.A. 2006b. GRAMM-X public web server for proteinprotein docking. Nucleic Acids Res. 34:W310-W314.
120. Tremblais,K., Oliver,L., Juin,P., Le Cabellec,T.M., Meflah,K., and Vallette,F.M. 1999.
The C-terminus of bax is not a membrane addressing/anchoring signal. Biochem Biophys
Res Commun 260:582-591.
121. Tschammer,N., Khaled,A.R., and Selby,T.S. 2007a. Analysis of helix packing energies to
probe the stability and mechanism of structural transitions in proteins. submitted.
122. Tschammer,N., Selby,T.S., and Khaled,A.R. 2007b. Structural transitions that regulate
the apoptotic activity of BAX are dependant on its C-terminal alpha-9 helix. submitted.
123. Tsuruta,F., Sunayama,J., Mori,Y., Hattori,S., Shimizu,S., Tsujimoto,Y., Yoshioka,K.,
Masuyama,N., and Gotoh,Y. 2004. JNK promotes Bax translocation to mitochondria
through phosphorylation of 14-3-3 proteins. EMBO J 23:1889-1899.
124. Utz,P.J. and Anderson,P. 2000. Life and death decisions: regulation of apoptosis by
proteolysis of signaling molecules. Cell Death Differ 7:589-602.
125. Wachter,R.M., Elsliger,M.A., Kallio,K., Hanson,G.T., and Remington,S.J. 1998.
Structural basis of spectral shifts in the yellow-emission variants of green fluorescent
protein. Structure 6:1267-1277.
120

126. Wei,M.C., Lindsten,T., Mootha,V.K., Weiler,S., Gross,A., Ashiya,M., Thompson,C.B.,
and Korsmeyer,S.J. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to
release cytochrome c. Genes & Dev. 14:2060-2071.
127. Woo,J.S., Jung,J.S., Ha,N.C., Shin,J., Kim,K.H., Lee,W., and Oh,B.H. 2003. Unique
structural features of a BCL-2 family protein CED-9 and biophysical characterization of
CED-9/EGL-1 interactions. Cell Death Differ 10:1310-1319.
128. Yan,N., Gu,L., Kokel,D., Chai,J., Li,W., Han,A., Chen,L., Xue,D., and Shi,Y. 2004.
Structural, biochemical, and functional analyses of CED-9 recognition by the
proapoptotic proteins EGL-1 and CED-4. Mol Cell 15:999-1006.
129. Yethon,J.A., Epand,R.F., Leber,B., Epand,R.M., and Andrews,D.W. 2003. Interaction
with a Membrane Surface Triggers a Reversible Conformational Change in Bax
Normally Associated with Induction of Apoptosis. J. Biol. Chem. 278:48935-48941.
130. Yoshida,T., Tomioka,I., Nagahara,T., Holyst,T., Sawada,M., Hayes,P., Gama,V.,
Okuno,M., Chen,Y., Abe,Y., Kanouchi,T., Sasada,H., Wang,D., Yokota,T., Sato,E., and
Matsuyama,S. 2004. Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem
Biophys Res Commun 321:961-966.
131. Zhang,H., Kim,J.K., Edwards,C.A., Xu,Z., Taichman,R., and Wang,C.Y. 2005. Clusterin
inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7:909-915.
132. Zhang,Z., Lapolla,S.M., Annis,M.G., Truscott,M., Roberts,G.J., Miao,Y., Shao,Y.,
Tan,C., Peng,J., Johnson,A.E., Zhang,X.C., Andrews,D.W., and Lin,J. 2004. Bcl-2
Homodimerization Involves Two Distinct Binding Surfaces, a Topographic Arrangement
That Provides an Effective Mechanism for Bcl-2 to Capture Activated Bax. J. Biol.
Chem. 279:43920-43928.
133. Zhou,P., Chou,J., Olea,R.S., Yuan,J., and Wagner,G. 1999. Solution structure of Apaf-1
CARD and its interaction with caspase-9 CARD: A structural basis for specific
adaptor/caspase interaction. PNAS 96:11265-11270.
134. Zhu,Y., Swanson,B.J., Wang,M., Hildeman,D.A., Schaefer,B.C., Liu,X., Suzuki,H.,
Mihara,K., Kappler,J., and Marrack,P. 2004. Constitutive association of the proapoptotic
protein Bim with Bcl-2-related proteins on mitochondria in T cells. PNAS 101:76817686.

121

